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Ventricular tachycardia ablation: indications and techniques 





The growing role of catheter ablation for ventricular arrhythmias in patients with and with-
out structural heart disease reflects the progress made in this field over the last decades. Due 
to the high ablation success for non scar-related VA catheter ablation has become a first 
line therapy for symptomatic idiopathic VT and PVCs or VA presumed to cause ventricular 
dysfunction. In patients with scar-related VT development of substrate based techniques, 
irrigated tip catheter ablation and the introduction of an percutaneous epicardial approach 
in selected patients has rendered many VT previously considered ‘unmappable’ approach-
able for ablation. Catheter ablation may be considered in post MI patients even after a first 
VA episode to prevent VT recurrences during follow-up or to avoid drug therapy, provided 
that the procedure can be performed safely. The underlying heart disease affects the sub-
strate that determines VT characteristics. Better understanding of the VT substrate in different 
diseases and individual patients is important for the improvement of mapping and ablation 
strategies. Advances in substrate imaging technologies and their integration during ablation 
procedures may provide more insights into the substrates and may guide VT ablation in 
the future. Since treatment strategies and prognosis of scar-related and non scar-related VT 
differ, the distinction between these entities is of great relevance and may be enhanced by 
identification of the VT substrate during catheter mapping. Ablation failure is frequently due 
to the anatomical localization of the target site. However, evolving new catheter techniques 






Since the first report in 1959 of surgical ventriculoplasty abolishing recurrent ventricular 
tachycardia (VT) in a patient after myocardial infarction1 ablation of VT has evolved from 
surgical treatment to radiofrequency catheter ablation (RFCA). Over the last decennium 
indications have broadened and techniques have been developed resulting in an increasing 
use of RFCA for different types of VT.2
Patients presenting with VT and underlying structural heart disease are at risk for sudden 
cardiac death (SCD).3 The use of implantable cardioverter defibrillators (ICDs) has resulted 
in a significant reduction in SCD in this patient population.3-5 ICDs effectively terminate VT 
but cannot prevent VT recurrence and after an initial episode of VT or ventricular fibrillation 
(VF) up to two thirds of patients receive one or more appropriate therapies within two years.6, 
7 An important number of VT termination requires shocks which have an significant impact 
on quality of life.8 In addition, in patients with heart failure ICD shocks are associated with 
an increased risk of death.9 Therapies that prevent episodes of VT are therefore warranted. 
RFCA can prevent VT recurrence, thereby decreasing the number of ICD shocks in patients 
with structural heart disease by modifying the VT substrate.6, 7
Ventricular arrhythmias (VA) that occur in the absence of structural heart disease are 
generally considered benign and are associated with a favorable prognosis.10 Distinction 
between patients with scar-related and idiopathic (non scar-related) VA is therefore of key 
relevance. However, a small number of patients presents with malignant VA without (todays) 
evidence of structural heart disease or scar and some patients have idiopathic VA that cause 
a potential reversible cardiomyopathy.11, 12 
Since its first use in 1978 RFCA for idiopathic VA has been proven to be curative and safe 
and is now considered a first line therapy in highly symptomatic patients.2 
Even though RFCA for VT is recognized to be of value in structural heart disease, the 
appropriate patient selection, methods to use, optimal timing and best endpoint are still 
matter of debate. Individual patient factors and operator experience play an important role 





Reentry is the prevailing mechanism for VT related to scar. The requirements for reentry to 
occur are areas of slow conduction, sites of fixed or functional conduction block and an 
initiating stimulus or sequence of stimuli. 
The time that is needed for propagation through slow conduction areas allows for 
repolarization of the remaining parts of the circuit so that the reentrant wavefront does not 
encounter block during its progression. 
Histological evaluation of slow conduction areas showed tracts of viable myocardial 
cells traversing areas of fibrous tissue.13 Several factors may contribute to the reduction 
in conduction velocity. Fibrosis between strands of viable cells functionally prolongs the 
pathway for impulse propagation.14 In addition, changes in cell coupling by a decreased 
number of gap-junctions and altered connexin expression may contribute to slow conduc-
tion on a cell to cell level.14, 15 
Conduction velocity is also influenced by the direction of wave front propagation and 
architecture of fibrosis. Wavefront propagation perpendicular to fiber direction is slower 
than propagation parallel to the fiber direction.15
Areas of fixed or functional conduction block influence reentrant circuit characteristics 
and form the borders of a protected channel or ‘isthmus’ of viable myocardial cells. Dense 
fibrosis and other unexcitable tissue like valve annuli and surgical scars may serve as areas 
of fixed conduction block.16, 17 In contrast, functional block is not present during normal 
rhythm but can evolve due to change in refractoriness in response to a premature excitation 
and may be equally important defining the reentrant circuit isthmus.18 The 3-dimensional 
geometry of myocardial scar plays an important role in the formation of block and may even 
predict the location of potential reentry circuits.19
The critical part of a reentry circuit is an area of slow conduction bordered by two lines of 
fixed or functional conduction block, the critical isthmus. Reentry is initiated by a premature 
excitation wavefront that enters this isthmus through its entrance and traverses it slowly. 
At the exit of the isthmus, often located at the border of the scar, the wavefront emerges 
to rapidly depolarize the remainder of the ventricles. The activation propagates along the 
border of the scar (the outer loop) to reactivate the excitable entrance of the circuit thereby 
closing the circle. (Figure 1) The dimensions of a reentry circuit are 3-dimensional and 
parts of the circuit may lay subendocardial, intramural and subepicardial, depending on the 







Schematic of a scar-related reentrant circuit. The gray areas represent dense scar and white areas 
represent conducting myocardium. Numbers indicate different reentrant circuit sites encountered 
during mapping.
1. Exit site. The activation wavefront exits the scar to activate the remainder of the ventricles. 
During VT concealed entrainment, a difference between post pacing interval (PPI) and VT cycle 
length ≤30ms and a short stimulus to QRS interval (<30% of VT cycle length) are typically found at 
this site.
2. Critical isthmus. Protected area of slow conduction through the scar. Concealed entrainment, a 
difference between PPI and VT cycle length ≤30ms and an intermediate stimulus to QRS interval 
(31 – 50% of VT cycle length) are encountered at this site during VT.
3. Adjacent bystanders. Slow conducting areas in the scar not part of the reentry circuit under 
evaluation. Even though during VT concealed entrainment can be found the differnence between 
PPI and VT cycle length is usually long (>30ms). 
4. Entrance site. The activation wave front enters the circuit isthmus. Features: Concealed 
entrainment, a difference between PPI and VT cycle length ≤30ms and a long stimulus to QRS 
interval (51-70% of VT cycle length).
5. Outer loop. Rapid activation of the ventricular myocardium from exit toward entrance site. 
Mapping during VT reveals entrainment with QRS fusion.
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Non	scar-related	idiopathic	ventricular	arrhythmia	
Idiopathic VA is a term used for VA that is known to occur in the absence of clinically 
apparent structural heart disease.2 Most idiopathic VA have a focal origin in the ventricu-
lar outflowtracts (OT) making them susceptible to discrete radiofrequency ablation. The 
mechanism underlying focal repetitive monomorphic VT (RMVT) can be triggered activity 
or automaticity. Most focal VA respond to adenosine, verapamil or beta blockers, agents 
interfering with the cAMP mediated inward calcium current. In particular the specific 
effect of adenosine indicates that triggered activity induced by cAMP-mediated delayed 
afterdepolarizations is the major mechanism underlying these focal VA.21, 22 More rarely the 
mechanism of focal VA may be automaticity provoked by adrenergic stimulation or arising 
from damaged purkinje fibers.23 
Although most idiopathic VA have a focal origin it has been demonstrated that reentry is 
the underlying mechanism for a distinct subset of VT, idiopathic left ventricular tachycardia 
(ILVT),  arising from the area of the left posterior or anterior fascicle. The mechanism of this 
verapamil sensitive form of VT, although not completely understood, may be intrafascicular 
reentry or involves abnormal Purkinje tissue in which slow conduction is dependent on the 
slow inward calcium current in partially depolarized cells.24
Ablation	of	VT
Catheter ablation of VT aims to abolish the arrhythmic source in VT with a focal origin or 
to permanently interrupt the circuit in reentrant VT. The strategy for catheter mapping and 
ablation is determined by the type of VT and the location of the underlying substrate. The 




When reentrant VT is stable and hemodynamically well tolerated point by point catheter 
mapping can be performed to identify the critical isthmus allowing for interrupting the cir-
cuit with a limited number of RF lesions during ongoing VT.26, 27 The QRS of the VT begins 
when the excitation wavefront emerges from the exit of an isthmus often located at the scar 
border zone. 
Thus the depolarization of the slow conducting isthmus occurs prior to QRS onset. Isth-
mus sites may be recognized by recording isolated low amplitude, presystolic or diastolic	
potentials (DP) during VT. These potentials are generated by the depolarization of isolated 





and help to identify sites where RF ablation can terminate VT.27-29 However, DP are  also 
seen in bystander areas outside the critical isthmus of the VT under evaluation.27 Isthmus 
and bystander sites can be discriminated by entrainment mapping or pacing from a remote 
site to dissociate the DP from the VT.29 
Entrainment mapping is used to distinguish different components of the reentry circuit. 
Pacing slightly faster than the VT continuously resets the reentry circuit. Interpretation of 
entrainment depends on the assumption that pacing does not alter the conduction through 
the circuit path or initiate another VT. At circuit isthmus sites, pacing entrains VT without 
changing the ventricular activation remote from the scar, producing entrainment	with	con-
cealed	fusion recognizable by the same paced QRS as recorded during VT. Entrainment with 
QRS fusion is observed when pacing is performed from sites outside the protected isthmus 
resulting in an altered ventricular activation and consequently a different QRS morphology 
than during VT.28
At reentry circuit sites the post-pacing interval (PPI) is equal to the revolution time through 
the circuit, which is the tachycardia cycle length. The PPI increases with increasing distance 
and/or conduction time from the pacing site to the circuit. If the difference	between	PPI	
and	VT	cycle	length	is	≤30ms the pacing site is considered to be part of the reentry circuit. 
The electrogram (EGM) selected for measuring the PPI is important and should represent 
the local depolarization at the pacing site. The selection of farfield signals is a common 
reason for incorrect measurement of the PPI. The local signal is not visible during pacing and 
reappears when pacing is ceased. Farfield signals are usually not obscured by the stimulus 
artifact and may be recognized by the fact that they remain visible during pacing. 
At reentry circuit isthmus sites the stimulus to QRS interval (S-QRS) equals the conduc-
tion time from the pacing site to the reentry circuit exit, and is short (e.g., <	30% of the 
tachycardia CL) near the exit region, and longer at sites proximal to the exit. At inner loop 
sites, the stimulus to QRS time may be longer than 70% of the VTCL. Outer loop sites 
are recognized from a PPI that approximates the VTCL, however at these sites QRS fusion 
occurs.28, 30 (Figure 1)
VT unstable for mapping
Only one third of patients after myocardial infarction (MI) and less than 45% of patients with 
non-ischemic cardiomyopathy referred for ablation of VT are only inducible for VT stable for 
mapping during ongoing arrhythmia.25, 31 The majority of patients has ‘unstable’ VTs that are 
either hemodynamically not tolerated or not reproducibly inducible. Furthermore, multiple 
morphologies of VT are frequently inducible while data from the spontaneous VT may only 
be available from ICD interrogation, preventing the definite identification of the clinical 
VT.25, 32 Therefore the focus of VT ablation has shifted away from mapping of single VT 
reentry circuits during ongoing VT to a substrate based approach targeting broader regions 
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of scarred myocardium likely containing the critical part of the reentry circuit without the 
need for mapping during VT. 
Substrate mapping
Substrate based mapping and ablation techniques use local EGM characteristics obtained 
during stable sinus rhythm (SR) or paced rhythm to identify myocardial scar and areas 
of abnormal electrical conduction. The reduction of myocytes in scar areas reduces the 
amplitude of recorded EGMs, allowing areas of scar to be recognized from the peak to 
peak EGM voltage. Animal studies to validate the method were performed in a model of 
homogeneous dense, infarct scar surrounded by a small scar border zone. It has been shown 
that a value of ≤1.5mV peak to peak bipolar EGM voltage best demarcated infarct scar 
areas.33 In addition, more than 95% of EGMs in normal human ventricles have a voltage 
of ≥1.55mV.34 Areas with low voltage EGM can be visualized in 3-dimensional anatomical 
maps by colour-coding peak-to-peak EGM voltage (voltagemaps). (Figure 2A-C) Ablation of 
the entire low voltage area or its circumference is usually not feasible. Therefore additional 
criteria to further select ablation targets within the scar have been applied. 
EGM characteristics obtained during SR can be suggestive for potential reentry circuit sites. 
Slow and heterogeneous conduction through the scar area may result in broadening and 
fractionation of the local EGM. Longer	duration (>40ms) and fractionated (>4 deflections) 
EGM have been associated with successful ablation sites for VT after myocardial infarc-
tion.35 Similar to diastolic potentials that precede the QRS complex during VT, isolated	late	
potentials that follow the QRS during SR may indicate the presence of slow conducting 
channels and can be considered as target sites for ablation. Late potentials may be better 
recognized during right ventricle (RV) apex pacing in selected patients.36 (Figure 2C)
Conducting channels within dense fibrosis may have larger voltage amplitudes than the 
surrounding non-conducting areas. Lowering the voltage criteria for the colour coding of 
dense scar may allow for the identification of these channels.37
Pacemapping
Pacemapping can be employed to identify potential VT exit and isthmus sites at the border 
of the scar during SR. By pacing along the scar-borderzone regions can be identified where 
the paced 12-lead ECG QRS morphology resembles the VT QRS morphology. Pacing	sites	
with	a	matching	QRS	morphology are likely to be near the exit of the reentry circuit. During 
pacemapping a stimulus-to-QRS	(S-QRS)	delay	of	≥40ms indicates slow conduction away 
from the pacing site.(Figure 2C) A paced QRS matching the VT QRS in combination with a 
long S-QRS interval is consistent with a potential VT isthmus site.32, 34 Pacing performed at 
a site more proximal in the circuit may however result in a different QRS morphology since 







Example of a patient presenting with VT due to non-ischemic cardiomyopathy in whom combined 
endocardial and epicardial catheter ablation was performed using image integration of CE-MRI 
derived data sets and electroanatomical substrate mapping techniques during sinus rhythm. 
A and C. Successful integration of the CE-MRI derived LV and aortic cusp anatomy with the LV 
endocardial electroanatomical voltage map (EAVM) (voltages>1.5mV defined as normal and color 
coded in purple) using the left main coronary artery (LM) as a single landmark for registration. 
B. The fluoroscopy image shows contrast injection through the ablation catheter (MAP) to confirm 
its position in the LM. Other catheters shown are located at the right ventricular apex (RVa), 
coronary sinus (CS) and a pigtail catheter in the pericardial space. 
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Pacing within the scar may further be used to identify area with electrically unexcitable 
scar (EUS), defined as sites with a unipolar pacing threshold of ≥10mA at 2ms pulse width. 
Areas of EUS and anatomical boundaries such as valve annuli may form regions of fixed 
conduction block bordering the VT reentry circuit isthmus; targeting these isthmuses by 
connecting the anatomical boundaries to EUS or the areas of EUS by linear RF lesions can 
abolish VT.17, 38
Linear	ablation	lines along the scar border in the region of a presumed exit site or through 
an identified isthmus performed during SR can be also effective in controlling VT. Additional 
ablation lesions connecting to dense scar areas or anatomical boundaries or perpendicular 
to the scar border into the scar have also been applied.32, 34, 38
Substrate mapping can also be combined with limited mapping during VT, allowing for 
identification of the regions of interest during stable SR first. After VT induction evaluation 
of VT EGMs, entrainment mapping, and ablation can be restricted to predefined regions and 
may be feasible also for poorly tolerated VT.32
Non-contact mapping
Unstable VTs can be mapped aswell using multielectrode mapping arrays that sample and 
mathematically reconstruct virtual EGMs from multiple distant sites simultaneously. These 
D. Identification of mid-wall to subepicardial scar at the posterior base of the LV by contrast 
enhanced MRI. 
E. The location of intramural scar of the inner half of the wall (green) is superimposed on the 
endocardial MRI derived anatomy. Please note the normal endocardial voltage map which is 
displayed side by side.  
F. The limited epicardial voltage map with a basolateral low voltage area (colors according to the 
bar) and the endocardial voltage map are displayed side by side with the corresponding MRI data. 
The location of the non-transmural subepicardial scar was projected on the MRI derived epicardial 
surface and displayed in blue together with the endocardial MRI derived anatomy.  Please note the 
extend of the subepicardial scar which corresponds to the low voltage area.
G – I. Different substrate based mapping and ablation techniques were used. 
G. 12-lead VT QRS morphology. 
H. Limited epicardial voltagemapping (color coded according to the bar); green tags represent sites 
where isolated potentials were recorded. The activation time of the isolated potential at site 1 was 
82ms and was longer (113ms) at site 2 located deeper in the scar area which may be consistent 
with a slow conducting channel. 
I. This was confirmed by pacemapping showing a matching pacemap with increasing stimulus to 
QRS duration between the two sites (69 and 111ms respectively).  
J – K. Fluoroscopy (Left anterior oblique (LAO) and right anterior oblique (RAO) views; ablation 
catheter located at the ablation site (RF). Contrast injection in the left coronary artery (LCA)) 
showed sufficient distance for ablation between the target site and the coronary artery and 
confirmed the good registration accuracy between the coronary anatomy derived from multislice 
computed tomograpy and the electroanatomical map. To exclude vicinity of the phenic nerve high 
output pacing was performed (not shown). A short linear ablation lesion along the scar borderzone 







Example of a patient presenting with frequent highly symptomatic non-sustained idiopathic VT 
in whom combined endo- and epicardial electroanatomical mapping and ablation was performed 
facilitated by integration of CT derived anatomy. 
A. 12-lead QRS of the non-sustained VT.
B. Endocardial activation mapping showing limited maps of the aortic cusps (AoSV), great cardiac 
vein (GCV), right ventricular outflowtract (RVOT) and left ventricle (LV). Earliest local activation time 
(LAT) was recorded in the GCV but ablation at this site was not successful. C. A limited epicardial 
activation map overlaying the endocardial maps; epicardial LAT during VT is earlier than the earliest 
LAT in the GCV. 
D. Short axis slice of contrast enhanced multislice computed tomography scan (CT) showing the 
left and right ventricles (LV and RV) and pericardial fat in the interventricular groove and RV lateral 
wall. 
E and H. Different views of CT derived anatomy showing the proximal aorta, left main coronary 
artery and pulmonary artery with overlaying CT derived mesh of the epicardial surface. Color 
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systems enable mapping of the ventricular activation in a single beat.39-41 Non contact map-
ping may be able to identify the VT exit site in >90% of VTs and some diastolic activity in 
two-thirds of VTs.40, 41
However, a complete diastolic pathway could only be identified in 21% of patients in 
one study.41
Intramural	and	Epicardial	Circuits
Although parts of scar-related reentry circuits are usually located subendocardially, circuits 
may extend deep into the myocardium. Inability to define an adequate endocardial ablation 
target where catheter ablation can interrupt the reentry circuit is an important cause for 
ablation failure. Ablation using open, irrigated tip catheters increases lesion size and may 
therefore be more effective targeting circuits extending deep into the myocardial wall.32 
Epicardial ablation
In an important number of patients with scar-related VT RV or left ventricular (LV) endocar-
dial ablation may however be insufficient despite the use of irrigated tip catheters. In these 
patients part of the reentry circuit may be located at the subepicardium and a transcutaneous 
epicardial ablation approach should be considered. The necessity of an epicardial ablation 
may be different according to the underlying disease causing the substrate for VT.42 The VT 
surface ECG can be helpful in identifying VT of epicardial origin prior to the procedure. The 
time needed for the activation wave front to initially traverse the myocardial wall may result 
in a prolonged initial component of the VT QRS that may be suggestive of an epicardial 
origin.43 
Access to the pericardial space can be obtained by a subxyphoid pericardial puncture.44 
If adhesions from prior cardiac surgery or pericarditis limit the access, a surgical approach 
via a subxyphoid pericardial window may allow at least limited pericardial mapping and 
ablation.31, 42 
Epicardial substrate and VT mapping approaches are similar to those employed during 
endocardial mapping.44, 45 Epicardial fat however can limit the feasibility of voltage, pace 
coding of CT derived mesh shows the epicaridal fat distribution. (Purple = >4mm fat thicknes, 
Orange = >1mm and <4mm fat thickness, Green = no epicardial Fat) 
F. Successful integration of the epicardial voltagemaps with the CT derived anatomy and fat 
distribution. The area of earliest local activation is directly adjacent to the left descending coronary 
artery, implying that ablation could result in coronary injury. In addition, the area of earliest local 
activation is in an area of >4mm fat implying that ablation is likely to be unsuccessful. For these 
reasons no ablation attempt was made.
G. Fluoroscopy images (Right anterior oblique (RAO) and left anterior oblique (LAO) views; the 
ablation catheter is located epicardially at the earliest LAT site (MAP), reference catheter in the 
GCV. Contrast injection in the left coronary artery (LAD) confirmed that the target site for ablation 





and entrainment mapping due to the local reduction of the bipolar amplitude and a higher 
stimulation threshold or no capture of the myocardium covered by fat. In addition, epicardial 
fat (>5mm) can prevent effective ablation lesion formation in the underlying myocardium.46, 
47 (Figure 3) The real time integration of CT derived coronary anatomy and fat distribu-
tion to aid RFCA is further studied in chapter 6. RFCA in the vicinity of coronary arteries 
or the phrenic nerve should be avoided. Coronary arteries may be visualised by coronary 
angiogram or by integration of pre-acquired multislice CT imaging; a distance of >5mm 
between the ablation catheter and the coronary artery during RF delivery is recommended.2, 
46, 48(Figure 2 and 3) The course of the phrenic nerve traversing the lateral LV pericardium 
can be identified by diaphragmatic stimulation during pacing.49
The results of epicardial ablation after failed endocardial ablation in selected patients is 
encouraging; however data are derived from experienced centers and may not be applicable 
to less experienced operators.2
Substrate	imaging
Most of 3-dimensional electroanatomical mapping systems allow for the integration of 
pre-acquired cardiac images with electroanatomical voltagemaps. Currently, different 
imaging modalities are used to facilitate substrate mapping and ablation. Integration with 
pre-acquired Multislice computed tomography (MSCT) images can facilitate real-time 
visualization of the proximal coronary arteries and the distribution of epicardial fat during 
epicardial mapping and ablation.48, 50  (Figure 2 and 3)
Information derived from imaging modalities like positron emission tomography (PET) 
CT and contrast enhanced magnetic resonance imaging (CE-MRI) that provide not only 
anatomical data but potential information on VT substrate may be of complementary value 
before and during ablation procedures. 
PET can detect non-viable myocardial scar and the combination with CT may accurately 
delineate location and extend of scar. The integration of PET/CT derived data with electro-
anatomical mapping has shown to be feasible and accurate. Potential advantages of these 
techniques are limitation of procedure and fluoroscopy times, the identification of false 
positive low voltage areas, due to poor catheter contact, and perhaps the identification of 
viable channels through the scar.51 However, the substrate information provided by PET 
represents local glucose metabolism and does not visualize fibrosis. Furthermore, despite 
the high spatial resolution of CT the resolution of PET is relatively poor thereby limiting the 
visualization of smaller viable channels within the scar. 
CE-MRI allows for the visualisation of the three-dimensional geometry of myocardial 
fibrosis and is the gold standard for the detection of subendocardial and non-transmural 
scar.52, 53 In patients with non ischemic cardiomyopathy (NICM) CE-MRI can sensitively 
detect intramural and epicardial scars, which might help to choose the appropriate map-
ping strategy (endocardial, epicardial or combined).54-56 (Figure 2B) In addition, CE-MRI 
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can characterize scar heterogeneity based on signal intensity (SI) the extend of which has 
been associated with spontaneous VT.57 Furthermore, animal studies have shown that the 
detailed scar geometry as assessed by in vitro CE-MRI can predict the location of VT reentry 
circuits.19, 58
Real time integration of CE-MRI derived scar information with electroanatomical map-
ping may allow for visualisation of intramural or epicardial scars and scar characteristics 
during the procedure and facilitate mapping and catheterablation.54, 55, 59 (Figure 2A) (This 
topic is further studied in chapter 5) 
In the process of merging imaging derived data sets with electroanatomical maps ana-
tomical landmarks are of key importance. Several studies have used the combination of 
the LV apex, mitral annulus and the aorta for registration.51, 54, 55, 59 Others have used the 
ostium of the left main coronary artery located by contrast injection which has the potential 
to preclude rotation errors.48, 55 (Figures 2 and 3)
Whether integration of CE-MRI or PET/CT derived information with electroanatomical 
mapping during ablation procedures translates in to improved outcome needs further evalu-
ation. 
Ablation	of	Focal	VT
The activation wavefront of focal arrhythmias spreads radially from the source to depolarize 
the ventricles creating monomorphic VT or premature ventricular contractions (PVC). 
Most focal VA are hemodynamically well tolerated allowing for point by point mapping 
and evaluation of the recorded local unipolar and bipolar EGM. Unipolar EGMs provide 
information about the direction of the activation wavefront: an initial positive deflection 
of the unipolar EGM indicates propagation towards the catheter and has a high negative 
predictive value for a successful ablation site in focal VA. As the wavefront reaches the 
electrode and propagates away, the deflection turns negative. When the catheter is located 
at the focal source the wavefront propagates away producing a monophasic QS configura-
tion.(Figure 4) However, unipolar EGMs provide information about a relatively large area 
and contain important far field signals. In contrast, in bipolar EGMs the far field signal is 
subtracted out thereby providing information about the local electrical activity, but do not 
contain information about the direction of the wavefront. Currently, most ablation proce-
dures for focal arrhythmias are guided by local activation time defined by the initial peak 
of the bipolar EGM or the rapid negative deflection of the unipolar EGM and in addition 
by an unipolar QS configuration.60 (Figure 4)Targeting the arrhythmia focus based on local 
activation time is successful in >85% of patients.61
However, additional mapping criteria that can increase mapping resolution may be 
helpful to enhance effectiveness and limit the number of required radiofrequency lesions. 





fibrillation, chapter 3 further studies the use of this mapping criterion for idiopathic RVOT 
VA.62 (Figure 4)
When mapping during arrhythmia is not feasible due to infrequent occurrence of the 
arrhythmia pacemapping may be an alternative mapping strategy. Pacemapping compares 
the 12-lead surface ECG QRS morphology while pacing at a particular site to the morphol-
ogy of the spontaneous arrhythmia. A good match or ‘pacemap’ however might have an 
inferior mapping resolution as compared to mapping of local activation time.63 
Idiopathic VA usually originate from the ventricular outflowtract region that includes a num-
ber of anatomical structures confined to a limited 3-dimensional space. Prior to the ablation 
procedure the surface ECG QRS morphology may already indicate the site of origin.22, 43, 
64 In > 80%of idiopathic VT the RVOT is the site of origin. However, focal VT can also 
Figure	4.	Mapping	criteria	for	focal	idiopathic	ventricular	arrhythmias	(for	figure	in	color	see	
page:	254)
Example of a patient presenting with frequent symptomatic premature ventricular contractions 
(PVCs) successfully ablated from the right ventricular outflow tract (RVOT). 
A. 12-lead ECG of the PVC QRS.  B. Limited activation map or the RVOT (local activation time (LAT) 
color coded according to the colorbar, reference R-peak of surface ECG lead II)
C. Fluoroscopy images showing the left anterior oblique (LAO) and right anterior oblique (RAO) 
views. The ablation catheter is located at the successful ablation site (MAP) and the reference 
catheter in the CS/GCV. 
D. Intracardiac signals at the successful site show (1) LAT of 26ms prior to the PVC QRS onset, (2) 
the presence of reversed polarity of bipolar adjacent electrograms recorded from the distal and mid 
electrode pair of the mapping catheter and (3) an unipolar QS configuration.
E. Good pace-match of the PVC QRS with the paced QRS at this site. 
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originate from the pulmonary artery, the parahisian region, the left ventricular outflow tract 
(LVOT), the mitral annulus, aortic sinuses of Valsalva and the epicardium (in particular in 
the proximity of the venous system) requiring a transvenous or trans-pericardial approach.43
In addition, VA arising from the papillary muscle or the Purkinjesystem are described. 
Ablation of PVC’s originating form the purkinje system may be effectively abolished by 
targeting sharp purkinje potentials preceding the local EGM during arrhythmia and local 
activation during SR.11, 65 
New	technologies
The reason for VA ablation failure and recurrence after ablation is often unclear. One 
important cause for may be insufficient lesion formation due to poor catheter contact, 
which might be improved by the use of real time ablation tip contact force measurement.66 
Effective ablation of deep septal reentry circuits or intramural circuits and focal sources that 
are not abolished from the endo- or epicardium may require deeper ablation lesions. In 
animal studies enhancement of ablation lesions was demonstrated by using bipolar abla-
tion between two catheters on either side of the interventricular septum or by the use of 
intramural needle ablation.67, 68
Specific	Substrates
Ischemic	Cardiomyopathy
The incidence of VT in patients late after myocardial infarction (MI) is 1-2%, often occurring 
after an interval of several years.2 Most research on VT reentry circuits and catheter ablation 
of VT was performed in animal models of MI and in patients after MI. 
Substrate
The substrate of VT after MI is determined by the geometry of myocardial fibrosis which is 
influenced by the extent of irreversible injury and surviving myocyte bundles. During MI 
the injury develops as a wave front beginning in the subendocardial myocardium progress-
ing towards the subepicardium.69 Scar size and geometry are among others determined by 
the duration of coronary artery occlusion. Timely reperfusion of the infarct related artery 
terminates the wave front of necrosis resulting in non-transmural necrosis whereas late 
reperfusion or permanent coronary occlusion may result in a uniform transmural necrosis.70 
Infarct size is also influenced by collateral perfusion during the acute MI71, which may be 
present in variable degrees in humans. The finding that in post MI patients the endocardial 
scar area as defined by voltagemapping is generally larger than the epicardial scar47 is 





Much of our understanding of the VT substrate after MI is based first on animal models of 
a chronically occluded coronary artery which typically results in a dense scar with only a 
small scar borderzone; and secondly on interaoperative mapping studies in post-MI patients 
with a chronically occluded artery and typically aneurism formation. However, currently 
early reperfusion strategies have become the standard treatment of acute MI. Whether early 
reperfusion affects electroanatomical scars and impacts late VT characteristics is studied in 
chapter 4 and 9.72 
Outcome
Early single-center studies reported acute ablation success rates of up to 90% abolishing the 
targeted or clinical VT. Recurrence rates were 26-37 % over a follow-up of 34-41 months.73, 
74 In these studies only selected patients with drug refractory, monomorphic, hemodynami-
cally tolerated and reproducibly inducible VTs were included and mapping and ablation 
was performed using standard RF catheters. Due to the formation of larger and deeper 
lesions cooled or irrigated RF ablation has proved to be more effective for terminating scar-
related VT compared with standard RF and is now preferred for ablation of scar related VT. 
In the first multicenter study, which evaluated the efficacy and safety of  irrigated tip catheter 
ablation only stable VTs were targeted in 146 patients; all mappable VT’s were successfully 
ablated in 75% of patients. The 1-year recurrence rate was 56%; however a major reduction 
of VT frequency was observed in most patients. Importantly in 40% of patients fast VTs 
(<300ms) could be induced that were not targeted.75
The high incidence of VT unstable for mapping during ongoing tachycardia has lead 
to the development of substrate based ablation approaches. In small single-center studies 
including 9-40 post MI patients all inducible VTs were treated by using additional sub-
strate based criteria to identify ablation target areas. In these series linear RF lesions were 
applied. In 45-47% of patients no monomorphic VT was inducible after the procedure. The 
recurrence rate was 25-38% during 8- 10 months follow-up and was higher if VT was still 
inducible after the procedure or if a VT isthmus could not be identified.32, 34
The current status and outcome of VT-ablation in post MI patients is probably best reflected 
by two recently conducted multi-center trails. The Multicenter Thermocool Ventricular 
Tachycardia Ablation Trail reported on 231 patientes from 18 centers and the Euro-VT-study 
on 63 patients from 8 centers.25, 76 Both trails included patients with recurrent or incessant 
VT for ablation with irrigated open tip catheters using substrate and entrainment mapping 
facilitated by a 3-D electroanatomical mapping system. The mean number of inducible VTs 
was 3±2 per patient and unmappable VTs were present in 69 and 63% of patients.25, 76 
In the Thermocool study ablation abolished at least one VT in 81% and all VTs in 49% 
of patients. During a follow-up period of 6 months 51% of patients experienced a recurrent 
VT. However, the frequency of VT episodes was reduced by ≥75% in 67% of patients. The 
periprocedural mortality rate was 3%, mainly attributable to uncontrollable arrhythmia.25
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In the Euro-VT study ablation was acutely successful in 81% of patients. During 12 
months follow-up 37% of successfully ablated and 49% of all patients experienced a VT 
recurrence. One patient experienced a major complication in this study.76  
In a subgroup of patients presenting with incessant VT or VT storm catheter ablation 
can be life saving. Acute termination of VT can be achieved in 89% of patients, with a VT 
recurrence rate of 34% in 22 months as reported by Carbucicchio et al.77 
An epicardial ablation approach to control recurrent VT seems to be less frequently 
needed in post MI patients as compared to patients with NICM. Surgical mapping studies 
have demonstrated that only a minority of VT reentry circuits was located in the subepicar-
dium, in particular in patients after inferior MI.20 In a large observational study epicardial 
ablation was performed in only 7% of 278 ablation procedures for post MI VT.42 However, 
a significant number of these patients has undergone coronary artery bypass graft (CABG) 
surgery in the past which has perhaps restricted the epicardial ablation approach. 
Early ablation for VT
Recent studies indicate that there might be a role of early catheter ablation after a first 
episode of VT in post-MI patients concomitant with ICD implantation. 
The Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia 
(SMASH-VT) trail included 128 post MI patients with a planned or recent ICD implantation 
for secondary prevention for hemodynamically untolerated VT, syncope with inducible 
VT during EP study or VF. Patients were randomized to implantation of ICD alone or ICD 
implantation with adjunctive catheter ablation of VT using a substrate based approach.6 
During 22.5 months follow-up 12% of patients in the ablation group and 33% of patients 
in the control group experienced at least one appropriate ICD therapy, a reduction of 65%. 
Catheter ablation led to a 73% reduction in ICD shocks. Of interest, there was a trend 
towards a reduced mortality in the ablation group versus the control group (9% vs. 17%).6
In the multicenter Ventricular Tachycardia Ablation in Addition to Implantable Defibril-
lators in Coronary Heart Disesase (VTACH) trail 107 post MI patients presenting with stable 
VT and reduced LV ejection fraction were randomized to ICD alone or ICD with adjunctive 
catheter ablation. Mean follow-up was 22.5 months. The median time to first episode of VT 
or VF was significantly prolonged in the ablation group. The median number of appropriate 
ICD therapies was reduced by 93% per patient per year.7 
No procedure related death was reported in both studies. Non-fatal, procedure related 
complications occurred in 4.7% and 3.8% of patients, respectively. 6, 7 Based on these find-
ings an early use of catheter ablation may be considered in selected patients who receive 
and ICD as alternative to drug therapy, provided that the procedure can be performed safely.
A recent meta-analysis including 5 studies with a total of 457 participants, 58% treated 
with adjunctive catheter ablation, showed a 35% reduction in the number of patients with 





significant difference in mortality was observed.78 Further controlled trails with longer 
follow-up are warranted to evaluate the effect of early catheter ablation on mortality. 
Substrate	in	Dilated	Cardiomyopathy.
Even though uncommon, VT also occurs in patients with DCM. The mechanism of VT in 
DCM is scar-related reentry in 80% of patients, with the remainder being due to bundle 
branch reentry or a focal origin.31 At necropsy only 14% of patients with DCM have grossly 
visible left ventricular scars, in the majority of patients however interstitial or replacement 
fibrosis is found at histological evaluation.79 A CE-MRI study performed in patents with 
clinically defined DCM reported on subendocardial scar in 13% and midwall scar in 28% 
of patients. No delayed enhancement at all was found in 59% perhaps because of the 
inability of CE-MRI to detect microscopic interstitial fibrosis.56 Of interest, the presence 
of scar detected with CE-MRI and increasing scar thickness have been associated with VT 
inducibility in DCM patients. Accordingly  evidence of scar is often present in patients 
who undergo catheter ablation for VT. Areas of endocardial abnormal EGMs as depicted 
by voltagemapping are relatively small, commonly <25% of the endocardial surface.80 In 
patients who underwent epicardial voltage mapping the electroanatomical scar tends to 
be larger on the epicardial surface.31, 45, 81 Scar areas are commonly found at the basal 
LV with a predilection at the inferolateral LV wall both endo- and epicardially.31, 45, 80, 81 
Epicardial EGMs in low voltage areas are characterised by low amplitude (<1.0mV) and 
long duration (>80ms).45 Late potentials, that likely reflect areas of slow conduction in a 
fixed substrate, however may be observed less frequently in DCM patients than in post MI 
patients.81(Figure 2C) The latter finding may suggest that in DCM patients’ functional block, 
rather than isthmuses bordered by fixed lines of block are important for the occurrence of 
reentry circuits. This is in line with findings from de Bakker et al. who found short and long 
strands of fibrous tissue running parallel to the myocardial fiber orientation in human hearts 
after transplantation for DCM. In these samples activation delay and EGM fractionation was 
caused by discontinuous and circuitious conduction through zones of patchy fibrosis, which 
plays an important role for non-uniform anisotropy.82
Catheter ablation
Data on catheter ablation for VT in DCM are derived from small single-center studies 
performed in selected groups of patients. The success of endocardial ablation may be 
disappointing; acute complete success rates of 27% and 33% have been reported, with 
a VT recurrence rate of 58% and 47%, respectively in two different series.31, 80 However, 
after endocardial ablation failure an epicardial approach might be effective. Eighteen of 22 
patients who underwent endo- and epicardial catheter ablation after a previous endocardial 
ablation failure were rendered non-inducible at the end of the procedure. During 18 months 
follow-up 71% of patients were free of VT recurrence.45
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RV	scar	related	VT
Patients with scar-related right ventricular tachycardia (VT) are at risk for VT recurrence 
and sudden cardiac death. An important cause of RV scar is arrhythmogenic right ven-
tricular cardiomyopathy/dysplasia (ARVC/D), a progressive and most likely genetic disease. 
However, in more than 50% of affected patients no familial occurrence or disease-specific 
genetic mutations83 are found; therefore, diagnosis of ARVC/D is based on criteria proposed 
by a generally accepted consensus report by an international task force (TF).84 ARVC/D 
is histologically characterized by loss of right ventricular myocytes, which may be due to 
impaired function of the cell adherence complex in combination with mechanical stress, 
resulting in myocardial cell death with replacement by fibro-fatty tissue. This process begins 
in the subepicardium and progresses towards the subendocardium.83, 85 
Although predominantly found in the RV, dysplasia can also involve the LV.85 Areas of 
scar as identified by electroanatomical voltage mapping are commonly localized adjacent 
to the lateral tricuspid annulus, the RVOT, and RV apex.86, 87 Macroreentrant circuits tend to 
be clustered around the tricuspid annulus and RVOT and focal activation patterns, perhaps 
the endocardial breakthrough of an epicardial reentry circuit, have been observed at the RV 
free wall.87 
Other diseases like post inflammatory myopathy or sarcoidosis can mimic ARVC/D. 88 In 
sarcoidosis active granulomatous inflammation can be replaced by fibrosis thereby provid-
ing the substrate for reentrant VT. Catheter mapping may reveal low voltage areas in both 
the RV and LV.88
Subtle or early forms of RV fibrosis as substrate for RV tachycardia may only be detected 
by electroanatomical mapping which may have important prognostic and therapeutic impli-
cations by excluding an idiopathic VA. 89, 90 
Outcome
Prior to the widespread use of substrate based ablation techniques two series reported acute 
ablation success rates, defined as non-inducibility at the end of the procedure, of 46 and 
45% using conventional mapping techniques. The two year VT recurrence rate was 71 and 
41% respectively.90, 91 The concept of substrate mapping and ablation including the applica-
tion of linear lesions to encircle or connect scars facilitated by 3-dimensional mapping 
systems has evolved over the last decennium. Three more recently conducted studies using 
a substrate based approach reported much higher acute success rates (74-88%).86, 87, 92 
Long term success rates varied between 53, 76 and 89% of patients who were free of VT 
recurrence after 36, 26 and 27 months, respectively. 
Results of RFCA of scar-related VT due to sarcoidosis seem to be disappointing. In one 
small series reporting on 8 patients VT remained inducible at the end of the ablation proce-





Both ARVC/D and sarcoidosis are progressive diseases and VT recurrence rates may also be 
due to further development of substrate over time. 
However, similar to DCM patients with ARVC/D have more extensive epicardial scar. 
A combined endo- and epicardial approach after prior endocardial ablation can be highly 
effective in abolishing VTs in selected patients and might improve long-term results. Eighty-
five percent of patients were non-inducible for VT after ablation and 77% were free of 
recurrence during 18 months follow-up in one series.93
Factors influencing outcome of scar-related VT from the RV including subtle scars only 
detected by electroanatomical mapping is further evaluated in chapter 8. 
VT	after	cardiac	surgery
Catheter ablation can be an effective treatment option for scar-related VT occurring after 
surgical intervention. Surgical scars or patch material may contribute to the substrate for 
VT late after repair of congenitial heart disease, valve surgery or ventricular reconstructive 
surgery for heart failure. 
Small series of patients who underwent RFCA for recurrent VT after corrected congenital 
heart disease (CHD), the majority after repair of tetralogy of Fallot have been reported.17, 94 
Ablation guided by mapping during VT can be successful in selected patients who present 
with stable VT with recurrence rates of up to 40% in 3.8 years.94 However, the majority of 
patients after repair of CHD has fast VTs that require a substrate based ablation approach. 
Electroanatomical mapping performed during SR can identify unexcitable surgical scars, 
patch material and anatomical boundaries such as valve annuli that anatomically define the 
critical isthmus for VT. Transecting these isthmuses with linear RFCA lesions resulted in 91% 
freedom of VT recurrence after a follow-up of 30 months in one series.17
VT after aortic or mitral valve surgery in the absence of prior myocardial infarction is 
rare. In a small series of 20 patients 14(70%) had VT due to scar-related reentry, the majority 
having scars adjacent to the replaced valve annulus. Ablation abolished 98% of inducible 
VT and 11(55%) patients remained free of recurrence during a 2.1 year follow-up.95
Catheter ablation of VT occurring after surgical ventricular restoration for heart failure in 
ischemic cardiomyopathy is studied in chapter 10.
Idiopathic	VT
Despite a good prognosis idiopathic VA can cause severe symptoms including palpitations, 
chest pain, syncope and fatigue.22 Catheter ablation for idiopathic VA is associated with a 
high success rate, 76-100% of patients are without arrhythmia at the end of the procedure 
and the recurrence rate is very low.22, 43, 60, 61, 63 
Perhaps due to chronic hemodynamical effects frequent premature ventricular contrac-
tions (PVC) may affect the ventricular function. One study following patients with frequent 
PVCs and normal cardiac function for 4 years showed a modest but significant decline in LV 
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ejection fraction in 5% of patients.10 Single center studies have reported on mild to severe 
reduced LV ejection fraction and increased ventricular dimensions associated with frequent 
PVCs in selected patients.12 These detrimental effects of PVCs seem to be reversible after 
suppression of PVCs by medication or successful catheter ablation.12 In a recent obser-
vational study of 174 patients referred for catheter ablation of PVCs the only independent 
predictor for LV dysfunction at presentation was PVC burden. The best cut-off was 24% 
PVCs in 24 hours but some patients with >10% PVCs may also be at risk.97 However, the 
clinical relevance of frequent PVCs in asymptomatic patients without LV dysfunction in 
the unselected general population is not fully understood and a benefit of “preventive” 
RFCA in these patients has not been proven. Whether subclinical LV dysfunction undetected 
by normal imaging techniques may be already present in patients with frequent PVCs as 
compared to normal control patients is studied in chapter 7.96
It has been demonstrated that the short coupled variant of PVCs originating from the 
purkinje system or from the outflow tracts can induce episodes of polymorphic VT and VF. 
These PVCS can be targeted for ablation to prevent VA episodes.11 Longer coupling intervals 
in benign RVOT PVC/VT as compared to those associated with malignant polymorphic VT 
and idiopathic VF have been reported.98 However, in the largest series including 16 patients 
with polymorphic VT or VF originating from the RV outflow tract, the frequency of isolated 
PVCs and their coupling intervals were not different to those observed in 85 patients with 
idiopathic monomorphic RV tachycardia. Ablation targeting the initiating PVCs prevented 
recurrence of VF during a follow-up of 54 months.99
Indications
Evidence for a benefit of catheter ablation for the treatment of VA is mainly based on uncon-
trolled trails, single center experience and experts opinion. For patient with structural heart 
disease the current guidelines of the American College of Cardiology(ACC)/American Heart 
Association(AHA)/European Society of Cardiology(ESC)100 state that catheter ablation can 
be beneficial as a palliative and adjunctive therapy to ICD implantation in patients who 
receive multiple ICD shocks due to drug refractory sustained VT (Class I, level of evidence 
C), for incessant VT after failed drug therapy (Class IIa) and in patients with bundle branch 
reentry (Class I, C). Ablation can be useful in patients with otherwise low risk of SCD, like 
patients without structural heart disease with idiopathic VA, who present with sustained 
VT (Class I), symptomatic nonsustained VT (Class IIa) or symptomatic PVCs (Class IIa) for 
which drug therapy is ineffective, not tolerated or not desired. For patients with prior MI, 
but relatively preserved left ventricular (LV) ejection fraction (>40%), curative ablation may 
be considered in lieu of ICD therapy (Class IIb). In patients with congenital heart disease 





I, C). Ablation of ectopic foci that trigger recurrent polymorphic VT is an acceptable strategy 
for controlling electrical storm (Class IIb).100
In the recently published expert consensus document the European Heart Rhythm 
Association (ERHA) and the Heart Rhythm Society (HRS) recommend to consider ablation 
for recurrent monomorphic VT in post MI patients with an LVEF >30% as alternative to 
amiodarone, in post MI patients with LV ejection fraction >35%, even if they have not failed 
drug therapy and in patients with VA presumed to cause ventricular dysfunction.2 
Catheter ablation is contra-indicated for NSVT/PVC that are asymptomatic and not sus-
pected to cause ventricular dysfunction and for VT due to transient and reversible causes. 
Endocardial catheter ablation is furthermore contraindicated in the presence of a mobile 
ventricular thrombus for the risk of embolization.2 
Individual patient characteristics, available facilities and technical expertise may deter-
mine the possible risks and benefits of the ablation procedure and should therefore be taken 
into consideration when selecting patients for catheter ablation of VT. 
Aim	and	outline	of	the	thesis
The growing role of catheter ablation for ventricular arrhythmias in patients with and 
without structural heart disease reflects the progress in this field over the last decades. The 
aim of the current thesis was to study the determinants for the substrate causing VT, the VT 
characteristics and outcome specifically after invasive treatment and to develop techniques 
that facilitate and thereby potentially improve outcome after catheter ablation.
In part I determinants of the VA substrate and techniques for substrate identification are 
studied in patients referred for catheter ablation of VA. 
In patients presenting with VA the discrimination between scar-related reentry and an 
idiopathic focus as underlying mechanism is guiding for further evaluation and treatment. 
Chapter 2 studies the diagnostic value of the VA 12-lead surface ECG to determine the 
presence or absence of myocardial scar underlying the arrhythmia. In this chapter a simple 
stepwise algorithm based on surface ECG characteristics is developed to aid clinical deci-
sion making in patients presenting with VA. Even though non scar-related idiopathic VA is 
generally considered benign, catheter ablation can be indicated in symptomatic patients. 
During ablation in otherwise healthy myocardium it is desirable to limit the number of 
lesions to the minimum. In chapter 3 catheter mapping is used to evaluate reversed polarity 
as an additional mapping criterion to improve the determination of successful ablation sites 
for idiopathic RVOT VA.
Post MI scar is the substrate in the majority of patients presenting with clinically sig-
nificant scar related VT. Early reperfusion as standard treatment of the acute MI has been 
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developed over the last decennia. Chapter 4 describes the affect of early reperfusion on 
the substrate of VT as determined by electroanatomical mapping and histology and on VT 
characteristics. Substrate based methods for catheter ablation of VT, rely on delineation of 
scar by electroanatomical catheter mapping. CE-MRI can be used to visualize the three-
dimensional geometry of myocardial fibrosis and is the gold standard for the detection of 
nontransmural scar. Chapter 5 focuses on the feasibility of integrating these two modalities 
to facilitate catheter ablation and evaluates additional value of the use of CE-MRI in a head 
to head comparison.
Over the last years percutaneous epicardial approach in selected patients has rendered 
many VT previously considered ‘unmappable’ approachable for ablation. The determination 
of VT substrate by electroanatomical mapping and catheter ablation is limited by the pres-
ence of epicardial fat and coronary arteries. In chapter 6 the use of CT derived information 
to determine fat distribution and coronary artery anatomy during epicardial catheter abla-
tion procedures is studied. 
After determination of VA substrate, catheter ablation has the potential to abolish the sub-
strate, reentry circuit or arrhythmogenic focus, for VA. In addition differences in VA substrate 
between patients may impact clinical outcome. The focus of Part II is on the outcome in 
different ventricular tachycardia substrates.
Non scar-related VA are generally considered benign and in the majority of patients with 
frequent VA the LV ejection fraction is normal. Reversible deterioration of LV ejection frac-
tion due to, perhaps hemodynamical effects, of frequent PVCs have been described in a 
limited number of patients. Chapter 7 assesses the effect of non scar related frequent PVCs 
on RV and LV function in patients with preserved LVEF. In addition, the effect of successful 
RFCA of frequent PVCs on LV and RV function is evaluated. 
In contrast to non scar-related VA, patients with scar-related VA may be at risk for sudden 
cardiac death. Chapter 8 studies determinants of outcome in scar-related VA originating 
from the right ventricle. Baseline characteristics, diagnosis and acute ablation success are 
related to VT recurrence during follow-up. 
Chapter 9 aims to extend the findings demonstrated in chapter 4 in a larger population 
of post MI patients who underwent electrophysiological evaluation prior to implantation of 
an ICD. The effect of early reperfusion during acute MI on inducibility of VT, characteristics 
of VT and VT recurrence during long-term follow-up is evaluated. 
Chapter 10 addresses the substrate, VT characteristics, catheter ablation and VT recur-
rence in the, until now underexposed, subgroup of patients who present with VT after surgi-
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Background: A left bundle branch block-like (LBBB) pattern with a dominant S-wave in V1 
is common in idiopathic ventricular arrhythmias (VA). Discrimination between idiopathic 
and scar-related LBBB pattern VA has important clinical implications. We hypothesized 
that the VA QRS morphology is influenced by the presence of ventricular scar allowing 
electrocardiographic discrimination of VA arising from structurally normal versus scarred 
myocardium. 
Methods and results: Twelve-lead ECGs of 297 LBBB pattern monomorphic VA were 
recorded during catheter ablation procedures. QRS morphology characteristics associated 
with scar-related VA were identified in retrospective analysis of 118 LBBB pattern VA (95 
scar-related, 23 idiopathic) to develop a stepwise algorithm, that was prospectively tested in 
179 LBBB pattern VA (120 scar-related, 59 idiopathic). The diagnosis of scar was based on 
sinus rhythm surface ECG, cardiovascular imaging and electroanatomical catheter mapping. 
A precordial transition beyond V4, notching of the S-wave downstroke in lead V1 or V2 and 
a duration from the onset of QRS to the S-nadir in V1>90ms were independent predictors for 
scar-related VA. The proposed algorithm classified a VA as scar-related if any of these criteria 
was met. If none of the criteria was present a VA was classified as idiopathic. In prospective 
validation the algorithm was highly sensitive(96%) and specific(83%) for the identification 
of scar-related LBBB pattern VA. 
Conclusions: The QRS morphology of VA is different between scar-related and idiopathic 
VA. A simple ECG algorithm is sensitive for identifying scar-related LBBB VA, which could 
be helpful in guiding further evaluation of these patients.
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Introduction
Monomorphic ventricular arrhythmias (VA) in patients without structural heart disease 
referred to as ‘idiopathic’ VA are considered benign in the majority of cases.1, 2 In contrast 
patients with scar-related monomorphic VA may be at risk for sudden cardiac death (SCD).3, 
4 Discrimination between idiopathic and scar-related VA therefore has important prognostic 
and therapeutic implications. 
Most idiopathic VA have a left bundle branch block (LBBB) like morphology in lead V1.5 
LBBB pattern VA however can also arise from right ventricular (RV) and septal myocardial 
scars due to cardiomyopathies including arrhythmogenic RV cardiomyopathy and sarcoid-
osis. 
The QRS morphology of a VA is determined by the location of the site from which a focal 
VA arises or from the location of the reentry circuit exit from which the excitation wavefront 
emerges to depolarize the surrounding myocardium, but may also be influenced by the 
presence and extend of myocardial scar. 
We hypothesized that the VA QRS morphology may be influenced by the presence of 
ventricular scar allowing electrocardiographic discrimination of VA arising from structurally 
normal versus scarred myocardium. 
Methods
Data was analyzed from 213 patients with LBBB pattern VA who were referred to Brigham 
and Women’s hospital, Boston, MA, USA and The Leiden University Medical Center, Leiden, 
The Netherlands for catheter ablation of VA. Twelve-lead ECGs of 297 LBBB pattern mono-
morphic VA were documented and stored during radiofrequency catheter ablation (RFCA). 
The ECG algorithm was developed from retrospective analysis of 118 LBBB pattern VA from 
81 consecutive patients (65 male, age 53±16years) studied between November 2002 and 
July 2006. The ECG algorithm was then prospectively validated in 179 LBBB pattern VA 
registered during RFCA in 132 patients (94 male, age 53±17years) between July 2006 and 
April 2009. 
Algorithm	development	
All patient records were reviewed to establish or rule out the presence of myocardial scar. 
Scar was diagnosed by any of the following: (1) The presence of pathologic Q-waves in 
≥2/12 leads of the baseline surface ECG), (2) akinetic or dyskinetic wall motion abnormalities 
and/or (3) global ventricular dilatation with dysfunction on echocardiography, ventricular 
angiography or MRI and/or (4) areas of delayed enhancement on contrast enhanced MRI 
(5) fixed perfusion defects on nuclear imaging; or (6) regions with adjacent, fragmented, 
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prolonged (≥3 positive deflections, ≥40ms signal duration)6 and low amplitude bipolar 
electrograms (≤1.5mV) on contact electroanatomical voltage mapping (EAM).  
Electrophysiology	study	and	Electroanatomic	Mapping
Electrophysiological evaluation included electrical programmed stimulation (EPS) and EAM. 
Studies were performed in the post absorptive, non-sedated state. Antiarrhythmic drugs were 
discontinued for 5 half-lives, with the exception of amiodarone. The EPS-protocol consisted 
of 2 or 3 drive-cycle lengths (600, 500 and 400ms) and up to 3 ventricular extrastimuli from 
2 right ventricular sites and burst pacing. Burst pacing and programmed stimulation during 
intravenous infusion of isoprotenerol (2-8µg/min) were used if the VA was not inducible at 
baseline. Twelve-lead ECGs and intracardiac electrograms were recorded simultaneously 
(Cardio-Lab 4.1; Prucka Engineering, Houston, TX, USA) and stored in digital format for 
off-line analysis. More than three monomorphic, consecutive beats were classified as ven-
tricular tachycardia (VT) and ≤3 consecutive monomorphic beats as premature ventricular 
contractions (PVCs). Bipolar EAM of the RV and/or LV was performed in all patients, facili-
tated by a 3D EA mapping system (CARTO XP EP system Biosense Webster Inc, Diamond 
Bar, CA, USA) during sinus rhythm in 193(91%) patients and paced rhythm in 20(9%). A 
4mm or 3.5mm tip, irrigated quadripolar mapping catheter (NaviStar or Navistar Thermo-
Cool, Biosense Webster Inc, Diamond Bar, CA, USA) was used inserted via a transvenous 
or retrograde aortic approach. In the algorithm development group mapping was restricted 
to the RV in 35(43%), to the LV in 35(43%), both ventricles were mapped in 11(14%) and 
epicardial voltage mapping through a subxyphoid puncture was performed in 4 patients. 
A VA exit site was determined based on activation and entrainment mapping for map-
pable VA and based on pace-mapping for unmappable VA. During activation mapping VA 
exit sites were defined as sites with the earliest ventricular activation and a local unipolar 
QS-pattern for focal VA and/or sites where pacing entrained the VT with concealed fusion 
and a postpacing interval within 30ms of the VT cycle length and a S-QRS of ≤30% of VT 
cycle length for reentry tachycardia. During pace-mapping VA exit sites were defined as sites 
with a paced QRS morphology that matches the VA QRS morphology (≥11/12 lead QRS 
pace-match). VA were considered scar-related if a VA exit site was located in or near an area 
of scar.  
ECG	analysis
All 12-lead surface ECGs of spontaneous or induced VA were analyzed by two independent 
observers blinded to the findings of imaging and EAM. In case of discrepancy agreement 
was reached by consensus. Measurements were performed on the digitally recorded elec-
trograms at a sweep speed of 100mm/s (Cardio-Lab 4.1; Prucka Engineering, Houston, TX, 
USA) using electronic callipers. 
Based on previous literature and theoretical considerations analysis included:
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(1) QRS duration (QRSd) measured from the QRS onset, defined as the earliest deflection 
from the isoelectric line in any ECG lead to the QRS offset, defined as the latest intercept of 
the S or R-wave with the isoelectric line in any ECG lead.
(2) Frontal plane axis categorized as inferior (≥0° and <180°) or superior (≥180° and <0°).
(3) Precordial transition defined as the first precordial lead with an R/S ratio of >1. An 
R wave transition beyond V4 (e.g. V5, V6, or negative concordance) was considered ‘late’ 
(transition>V4).
(4) QRS-S (QRS-SV1) interval in precordial lead V1 defined as the interval from QRS 
onset in any lead to the nadir of the S wave in V1. 
(5) Total amplitude of the QRS complex (QRSa) in precordial lead V2 
(6) The total number of notched QRS complexes in all leads (notch total)
(7) The presence of a notch in the downstroke of the S-wave in precordial lead V1 and V2 
(Notch S downstroke V1/2).
Statistical	analysis
Continuous variables are expressed as mean±SD, and categorical variables as frequency (%) 
or percentage (95% confidence interval). Differences between scar-related and non-scar-
related VA were assessed using the unpaired student t-test. Dichotomous variables were 
compared using chi-square test. Since the exit site and the propagation wavefront which 
determine the surface ECG characteristics of a VA differ between VA in one patient, multiple 
VA in the same patient were regarded as independent for the primary analysis. Variables 
where the means or frequencies were significantly different between groups  were consid-
ered for further analysis. Cutoffs were based on choosing the value where the sensitivity 
and specificity were the same for the prediction of scar. Sensitivity and specificity for each 
individual value were calculated based on the cut point chosen by the ROC curve.
Variables were categorized accordingly. Next, these variables were analyzed in univari-
ate and multivariable binary logistic regression. Multivariable analysis was performed in a 
backward stepwise fashion excluding the variable that was the least significant with for each 
consecutive step until all remaining variables in the model had a p-value lower than 0.25. 
These variables were incorporated in a stepwise algorithm. If any of the algorithm variable 
criteria for scar was met, outcome was considered positive for scar. If none of the variable 
criteria for scar was met, the outcome was considered idiopathic. 
All statistical analyses were performed with SPSS software (version 16 SPSS Inc., Chicago, 
Illinois). For all tests a p-value ≤0.05 was considered significant.
Algorithm	validation
The algorithm was then prospectively evaluated in 179 LBBB type VA recorded and stored 
during RFCA in 132 patients. All 12-lead surface ECGs of the VA were analyzed by two 
independent observers blinded to the results of scar detection. Each algorithm criterion was 
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separately classified as positive or negative. In case of discrepancy agreement was reached 
by consensus. A VA was defined as scar-related if ≥1 out of the variables selected for the 
algorithm were positive, a VA was classified as idiopathic if all criteria were negative. 
These results were compared to the results of scar detection based on baseline ECG, 
imaging and EAM according to the defined criteria for scar. All patients underwent 12-lead 
ECG recording, 2-dimensional echocardiography and endocardial EAM as described. In 
the algorithm development group only the RV was mapped in 76(58%) patients, only the 
LV in 37(28%), both ventricles in 19(14%) and epicardial voltage mapping was performed 
in 24(18%). To rule out scar-related VA further analysis was performed including coronary 
angiography, MRI/contrast enhanced-MRI, nuclear imaging and biopsy if appropriate. Seven 
VA in 6 patients with evidence of scar on baseline ECG, imaging or EAM but with a VA exit 
mapped to an area of normal myocardium and remote from scar areas were excluded from 
the analysis. 
Follow-up
Data regarding survival was collected for all patients (from the social security death index 
for the US patients and from long-term follow-up visits for the Netherlands patients). The 
date of last contact, heart transplantation or death was considered the date of last follow-up.
Results
Algorithm	development
One hundred-eighteen LBBB type VA were analyzed. A total of 95 VA were scar-related and 
23 arose from normal myocardium. The etiology of scar and the modality of scar detection 
are summarized in table 1.
ECG	analysis
Scar-related VA had a longer QRSd, a longer QRS-S duration in V1, and a smaller QRS 
amplitude in V2 as compared to non scar-related VA. In addition, a superior axis, a notch in 
the downstroke of the S-wave in lead V1 or V2 and a late precordial transition were more 
frequent in VA that arose from scar areas. The total number of notched QRS complexes 
was higher in scar-related VA, the difference however did not reach statistical significance 
between both groups (p=0.055). 
The best cutoff values to discriminate between scar-related and non-scar-related VA were 
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In multivariable analysis a late transition, a notch in the S downstroke of V1 or V2 and 
a QRS-S interval of >90ms were independently predictive for the presence of scar and 
therefore selected for the algorithm (table 3, figure 1). 
Prospective	validation
The developed algorithm was validated in 179 VA collected prospectively in 132 patients 
during consecutive RFCA procedures. In 31 patients >1 LBBB pattern VA was recorded. 
Scar was detected by ECG, imaging and/or EAM in 76 patients with a total of 120 
documented VA. The remaining 59 VA recorded in 56 patients were considered to be non 
scar-related. The results of scar detection and the etiology of scar in scar-related VA are 
summarized in table 1. 
The outcome of the algorithm was positive for scar in 125(70%) VA and negative for 
scar in 54(30%) VA (table 4). Based on scar detection the outcome of the algorithm was 








  Ischemic cardiomyopathy 48(41) 40(22)
  Dilated cardiomyopathy 18(15) 31(17)
  ARVC/D 13(11) 20(11)
  Congential 6(5) 5(3)
  Sarcoidosis 4(3) 0
  Valvular 6(5) 2(1)
  Hypertrophic cardiomyopathy 0 1(1)
  Scar of unknown etiology 0 21(12)
Idiopathic 23(19) 59(33)
Scar detected by 
  ECG + imaging + EAM 36(31) 30(17)
  Imaging + EAM 51(43) 62(35)
  Only ECG 0 0
  Only imaging 3(3) 6(3)
  Only EAM 5(4) 22(12)
VT/PVCs 107/11 136/43
ARVC/D indicates arrhythmogenic right ventricular cardiomyopathy/dysplasia; ECG, 
electrocardiogram; EAM, electroanatomical mapping; VT, ventricular tachycardia; PVC, premature 
ventricular contraction; VA, ventricular arrhythmia. Values are displayed as frequency(%) or 
mean±SD. 
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negative in 5 VA. This results in a sensitivity of 96%(90-98) and specificity of 83%(71-91) 
to discriminate between scar-related and non scar-related VA (Figure 2). The values for each 
algorithm component are provided in table 4. 
Since sustained VT was more common in patients with scar (116(85%) scar-related 
sustained VT) as compared to patients without scar (20(34%) non scar-related sustained VT) 
the algorithm was separately evaluated for the prediction of scar in VT and PVC subgroups. 
Sensitivity and specificity were found to be high for the prediction of scar in VT (sensitivity 
96%(90-98) and specificity 70%(46-87)) and PVCs (sensitivity 100%(40-100) and specificity 
90%(75-97)). Likely attributable to the different prevalence of PVCs and VT in scar-related 
and non scar-related groups the positive predictive value (PPV) for scar-related VA was low 
for PVCs (PPV 50%(17-83)) with a negative predictive value (NPV) of 100%(88-100). For VT 
the PPV was 95%(89-98) and the NPV 74%(49-90). 









QRSd (ms) 184±43 147±15 <0.001 à QRSd >155ms 76(64)
Superior Axis 35(37) 3(13) 0.028 à Axis 180°≥ and <0° 38(32)
Transition >V4 50(53) 1(4) <0.001 à Transition >V4 51(43)
QRS-S interval V1 
(ms)
107±29 83±18 <0.001 à QRS-SV1 >90ms 77(65)
QRS amplitude V2 1.5±0.7 2.1±1.2 0.005 à QRSa V2 >1.55 55(46)
Notch total 3.0±2.4 1.9±2.0 0.055
Notch S 
downstroke V1/2
35(37) 3(13) 0.028 à NotchS downstroke 
V1/2
38(32)
QRSd indicates QRS duration. Variables are displayed as frequency(%) or mean±SD.







QRSd >155ms 3.7 (1.4–9.5) 0.006
Superior Axis 3.9 (1.1–14.0) 0.038
Transition >V4 24.4 (3.2–188.8) 0.006 22.0 (2.8–176.1) 0.004
QRS-S nadir V1 >90ms 6.4 (2.4–17.4) <0.001 4.6 (1.5–13.7) 0.007
QRS amplitude V2 >1.55 0.6 (0.2–1.5) 0.291
Notch S downstroke V1/2 3.9 (1.1–14.0) 0.038 3.0 (0.7–12.4) 0.122
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Figure	1.	Representative examples of the variables that were used in the algorithm. The first 3 
panels show scar-related VT morphologies, the most right panel shows a non scar-related VT.
Table	4.	Outcome of the algorithm in 179 validation VA
Transition	>V4 Notch	d	V1/2 QRS-Sd	V1	>90ms Algorithm
True Positive 83(46) 42(23) 86(48) 115(64)
False Positive 3(2) 5(3) 7(4) 10(6)
True Negative 56(31) 54(30) 52(29) 49(27)
False Negative 37(21) 78(44) 34(19) 5(3)
Sensitivity (%) 69(60-77) 35(27-44) 72(63-79) 96(90-98)
Specificity (%) 95(85-99) 92(81-97) 88(76-95) 83(71-91)
PPV (%) 97(89-99) 89(76-96) 93(85-97) 92(85-96)
NPV (%) 60(50-70) 41(33-50) 61(49-71) 91(79-97)
VA indicates ventricular arrhythmia; PPV, positive predictive value; NPV, negative predictive value. 
Values are displayed as frequency(%) or percentage(95% confidence interval).
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As most idiopathic VTs arise from the outflow tract region, the algorithm was separately 
evaluated for 105 VA with an inferior axis. Among these VA the algorithm correctly identi-
fied 46 out of 51 scar-related VA and 47 out of 54 non scar-related VA. This resulted in a 
sensitivity of 90%(78-96) and specificity of 87%(75-94). 
In patients with known heart disease, VA should be presumed to be related to the underly-
ing disease unless proven otherwise. We therefore assessed the algorithm excluding patients 
with ischemic heart disease or congenital heart disease, in whom prior knowledge of heart 
disease may be most likely. In the remaining 101 patients with 134 VA the sensitivity of the 
algorithm to predict scar was 93%(84-97) with a specificity of 83%(71-91).
Analysis	of	misclassified	VA	
Ten VA recorded in 9 patients were classified as scar-related based on the ECG algorithm 
without scar detection on ECG, imaging or EAM (table 5). Two VA were recorded in one 
patient in whom mapping revealed a focal endocardial exit of presystolic activity, but where 
ablation was unsuccessful; no epicardial mapping was performed. We can not exclude the 
possibility that epicardial EAM would have revealed scar, improving the algorithm perfor-
mance. Four VA were mapped to the aortic cusp or epicardial LVOT, two arose from the 
tricuspid annulus and two from the RVOT (figure 3). 
Five VA in 4 patients were misclassified as non scar-related. Three were related to a small 
epicardial scar area not detected by endocardial voltage mapping or imaging, one to a small 
Figure	2.	The step by step flow chart of the algorithm for the 179 validation VA. VA indicates 
ventricular arrhythmia; TP, true positive; FP, false positive; TN, true negative and FN, false negative.
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posterior RVOT scar detected by EAM and one to a basal septal scar in a patient with dilated 
cardiomyopathy. 
Interestingly in patients 4, 11 and 13 (table 5) ≥1 other VA were correctly classified as 
non scar or scar-related.
First	induced	VA
To adjust for the possible unequal representation of individual patients due to multiple 
inducible VA an additional analysis was performed testing the algorithm for only the first VA 
that was induced or recorded spontaneously in each of the 132 patients. When only these 
Table	5.	Misclassified VA according to the ECG algorithm








1 1 non-scar Inf 0 0 1
Endocardial 
RVOT
2 2 non-scar Sup 1 0 1
Tricuspid 
annulus
3 3 non-scar Sup 1 1 0
Tricuspid 
annulus
4 4 non-scar Inf 0 1 0 Aortic cusp
5 5 non-scar Inf 0 0 1
Likely 
epicardial VT
5 6 non-scar Sup 1 1 1
Likely 
epicardialVT
6 7 non-scar Inf 0 0 1
Aortic 
annulus
7 8 non-scar Inf 0 1 1 Aortic cusp
8 9 non-scar Inf 0 0 1
Endocardial 
RVOT













Inf 0 0 0
Epicardial 
RVOT








Epicardial scar RV 
inferior and RVOT
Inf 0 0 0
Epicardial 
RVOT
DCM indicates dilated cardiomyopathy; EAM, electroanatomical mapping; RV, right ventricle; RVOT, 
right ventricular outflowtract; VA, ventricular arrhythmia.
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VA were taken into consideration the algorithm correctly identified 73 of 76 scar-related 
and 49 of 56 non scar-related VA. This resulted in a similar sensitivity (96%(88-99)) and 
specificity of (88%(79-95)) as in the analysis of all VA. 
Amiodarone
In the algorithm validation group 22 patients with 34 VA were treated with amiodarone, the 
dosage was 324±247mg daily. The VA QRSd in patients on amiodarone was 218±50ms as 
compared to 170±121ms(p=0.03) in patients not on amiodarone. Since the use of amio-
darone may influence conduction properties an additional analysis excluding all patients 
Figure	3.	Examples of three QRS morphologies of false positive VA. These VA were originating 
from the epicardium, aortic cusp and tricuspid annulus (table 5 patient 2, 4 and 5) respectively. 
Notches in lead V1/2, a late transition and QRS S V1>90ms are indicated. 
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using amiodarone was performed to determine whether the use of amiodarone affected 
the outcome of the algorithm. In the remaining 145 VA the sensitivity of the algorithm was 
94%(86-98) and specificity 83%(71-91) to identify scar-related VA.
Mortality
Patients in whom the algorithm was developed were followed for 42±21months. During 
follow-up 13(16%) patients with scar-related VA classified by the ECG algorithm died and 
2(2%) patients underwent cardiac transplantation. In contrast, all patients who were clas-
sified as having non-scar VA survived. The follow-up duration in the prospective analysis 
group was 14±11 months (median 10, range 0-34 months). Eleven (6%) patients with 
algorithm based scar-related VA died whereas all patients who were classified as having non 
scar-related VA survived.  
Discussion
Scar-related reentry is the most common cause of sustained monomorphic VT in patients 
with structural heart disease, and usually warrants implantation of a defibrillator for pro-
tection from sudden cardiac death.7 In contrast, most idiopathic VA have a focal origin 
not associated with detectable scar, and a benign prognosis. Most have a LBBB pattern 
morphology and originate in the outflow tract of the RV or LV.5 LBBB pattern VA however 
can also be due to scar-related reentry, arising from RV and septal scars.1-4 A correct diag-
nosis of scar-related and idiopathic VA is important for long-term prognosis and therapeutic 
considerations. Diagnosis of idiopathic VA is still one of exclusion and may therefore require 
extensive non-invasive and invasive assessment.8 
The current study evaluated the affect of ventricular scar assessed by sinus rhythm ECG, 
cardiovascular imaging and electroanatomical voltage mapping on QRS morphology char-
acteristics of LBBB pattern VA on 12-lead ECG. 
A simple stepwise algorithm of 3 ECG criteria was developed based on 118 retrospec-
tively collected VA ECGs and prospectively tested in 179 LBBB pattern VA allowing for 
discrimination of VA originating from scarred or structurally normal myocardium with a high 
sensitivity and specificity. 
Ventricular	Scar	
In the current study only VA ECGs from patients referred for RFCA were included. These 
patients underwent extensive evaluation including evaluation of the baseline ECG for the 
presence of Q-waves, cardiac catherization and cardiovascular imaging. In addition, EAM 
was performed during RFCA in all patients to diagnose or confirm the presence of scar at of 
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the VT exit. The latter is of importance because EAM has been shown to be highly sensitive 
to detect scars that may escape detection by imaging.9 Accordingly, scar associated with 
VA was diagnosed only by EAM in 5(4%) VA evaluated retrospectively and in 22(12%) VA 
evaluated prospectively. In the latter group epicardial EAM was applied more frequently. 
Only patients in whom no scar was detected by any modality were considered to have idio-
pathic VA. That none of these patients died during follow-up, further suggests that important 
structural heart disease was unlikely to escape detection in our cohort. 
12-lead	ECG	of	the	VA	and	Site	of	Origin
ECG analysis of the VA included morphology characteristics related to the site of origin, QRS 
amplitude, duration and notching with special emphasis on the precordial leads V1 and V2. 
A superior axis is consistent with a more inferior and apical exit which is frequently 
observed in patients with ARVD/C but rare in idiopathic VA.10, 11 An inferior axis with a 
late transition beyond V4 is consistent with a more inferior and anterior exit below the 
pulmonary valve and is therefore also not frequently found in idiopathic VA.11, 12 However, 
a superior axis or inferior axis with a late precordial transition may occur in VA that arise 
from the tricuspid annulus region accounting for <5% of idiopathic VA.12, 13 Of interest, in 
one series patients with idiopathic VA arising from the tricuspid annulus were older and 
experienced more often ablation failure than patients with idiopathic VA originating from 
the RVOT. Although structural abnormalities were excluded by imaging perivalvular fibrosis 
as observed in other non-ischemic cardiomyopathies can not be fully excluded as a cause 
of this type of VA.14 Accordingly, the majority of idiopathic VA in the current study had a 
transition before or at V4. A transition beyond V4 was only observed in 4 of the VA that were 
classified as idiopathic. Two arose from the tricuspid annulus, both with a superior axis, one 
arose from the mid to apical septal region and one occurred in a patient with an epicardial 
circuit.
A broadly notched QRS(≥160ms) of PVCs has been associated with a dilated and 
hypokinetic left ventricle.15 In a study by Ainsworth the mean VA QRSd for all 12 leads 
was longer in ARVD/C patients (135.1±8.5ms) as compared to patients with idiopathic VA 
(126.5±13ms) measured on ECG paper copies recorded at 25mm/s. We found longer QRS 
durations in scar-related (184±43ms) and idiopathic (147±15ms) VA likely due to measure-
ment of QRS duration from simultaneous recordings of all leads, which likely avoids errors 
introduced due to isoelectric components in some leads.  
QRS duration was significantly longer in scar-related VT as compared to idiopathic VA 
and a QRSd>155ms argues for a scar-related VA. However, scar-related VA that arise from or 
near the septum might have a short QRS duration. In contrast, idiopathic VA that arise from 
the free wall of the RV may exhibit a longer QRS duration.16 
The presence of notches might reflect disturbed conduction and may therefore be a sign 
of scar tissue but has also been demonstrated in idiopathic VA that arise from the RV free 
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wall in up to 86% of patients.15 Although, we found a slightly higher number of total notches 
in the 12 leads, the difference as compared to idiopathic VA were not significant.
The QRS morphology of VA is determined by the location at which the activation wave-
front emerges to activate the ventricles. Areas of delayed conduction at this site, as typically 
found in scar-related reentry, may contribute to the QRS characteristics by prolongation 
and notching of its initial portion. In contrast in patients with structurally normal hearts, the 
spread of activation from the site of origin is rapid. The interval from the QRS onset in any 
lead to the nadir of the S in V1 was significantly prolonged in scar-related VA and notching 
of the S-downstroke in V1 or V2 was associated with the presence of ventricular scar. This is 
in line with the assumption that activation delay due to RV and septal fibrosis translates into 
a prolonged and notched initial portion of the VA QRS in lead V1 and V2.
Interestingly, longer QRS onset to S nadir in V1 (>60ms) and notching in the S-wave 
downstroke of V1 or V2 have previously been identified by Kindwell17 and used by Brugada18 
for the discrimination between supraventricular and ventricular origin of broad complex 
LBBB type tachycardias. Ninety-five percent of the VTs studied by Kindwell however were 
originating from structurally abnormal hearts, the majority being related to infarct scar.17 
Algorithm	development	and	validation
In multivariable analysis a late precordial R-wave transition, notching of the S downstroke in 
V1 or V2 and the QRS to S duration in V1 were shown to be independently associated with 
scar-related VA, but individually have a high specificity, but low sensitivity. Combining the 
three criteria improved sensitivity to 96% with a specificity of 83%. In subgroup analysis the 
algorithm was sensitive and specific to predict scar in patients with PVCs and with sustained 
VT. Furthermore if only VA with an inferior axis were taken into consideration, the most 
frequently observed axis in idiopathic VA, the sensitivity was still 90% and the specificity 
88%. Despite the high sensitivity in identifying scar-related VA the algorithm misclassified 
10 VA as scar-related. In half of those the origin of the VA was considered to be epicardial 
or found in the aortic cusps. 
Idiopathic VA with an epicardial or aortic cusp origin may have a prolonged QRS dura-
tion due to the time needed for the activation wavefront to traverse the myocardial wall and 
reach the endocardium19 and could be falsely classified as scar-related by our algorithm 
based on prolonged initial QRS duration. This QRS prolongation can be present or absent 
according to the epicardial location or origin of VA.20, 21 Similarly idiopathic LBBB type VA 
that originate from the TA may be misclassified due to the late precordial R-wave transi-
tion associated with this site of origin. Five VA were misclassified as idiopathic. In three 
patients small scar areas were only detected by epicardial voltage mapping and in one by 




In addition to the caveats discussed above there are other limitations to this study. As in 
previous studies the diagnosis of idiopathic VA was made when evaluation excluded the 
presence of scar. Even though the extensive evaluation including EAM is a strength of this 
study the lack of a currently available gold-standard for the diagnosis of idiopathic VA 
may allow misclassification of patients with a currently undetectable substrate for VA. The 
studied population did not include patients with known channelopathies, such as Brugada 
syndrome or long QT syndrome. Commenting on the VA QRS morphology in these patients 
who may be at risk for sudden death despite the absence of structural heart disease is there-
fore beyond the scope of this study. 
ECG measurements were performed during electrophysiological study at a sweep speed 
of 100mm/s, standard ECGs in clinical practice however are often printed at 25mm/s. It is 
possible that some of the observations, such as  the QRS-Sd in V1, may be more difficult in 
standard ECGs recorded at speed of 25mm/s.
Finally although the absence of mortality in the idiopathic group is reassuring and further 
supports the diagnosis of idiopathic VT, we can not exclude the possibility of small regions 
of ventricular scar that escape detection with present methods are present in some patients 
and that could lead to later development of other VA.
Clinical	implications
The proposed algorithm detects scar-related VA with high specificity. Although it is not a 
substitute for imaging to define ventricular function and structural disease, it does provide 
an immediate electrocardiographic indication of the likelihood of whether ventricular scar is 
likely to be present, that can inform further evaluation. Furthermore, patients with algorithm 
positive VA ECG who do not have evidence of structural heart disease on initial clinical 
assessment may be considered for more detailed imaging, such as MRI.
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Background: Radiofrequency catheter ablation (RFCA) for idiopathic right ventricular out-
flow tract (RVOT) arrhythmias is typically guided by local activation time (LAT) mapping 
and unipolar electrogram morphology (QS-configuration). However, LAT mapping is limited 
by the large variation among patients and the area demonstrating a QS-configuration of 
the unipolar electrogram may be larger than the focal source. Reversed polarity has been 
proposed as criterion to guide RFCA.
Objective: The aim of this study was to investigate the value of reversed polarity of adjacent 
bipolar electrograms to predict a successful ablation site in idiopathic RVOT arrhythmias. 
Methods: Twenty-five consecutive patients (12 male [48%], 43±15 years) undergoing 
RFCA for RVOT arrhythmia were studied. Electrograms of ablation sites and of points within 
a 15mm radius to the successful site were evaluated for LAT, unipolar electrogram morphol-
ogy and the presence of reversed polarity of adjacent bipolar electrograms. Electrogram 
characteristics of successful ablation sites were compared to non-successful ablation sites. 
The spatial distribution of each electrogram characteristic was studied.
Results: Successful ablation sites more often demonstrated reversed polarity and had an 
earlier LAT than non-successful sites. A wide spatial distribution was observed for unipolar 
electrograms with a QS-configuration around the successful ablation site. Mapping based 
on LAT and reversed polarity had a higher predictive value for a successful ablation site than 
mapping based on LAT and QS-configuration.
Conclusion: The presence of reversed polarity has a high predictive value for successful 
ablation sites in focal idiopathic RVOT arrhythmias and is likely to reduce the number of 
RFCA applications.
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Introduction
Ventricular arrhythmias (VA) in the absence of structural heart disease are a common entity. 
Patients presenting with idiopathic VA account for 10% of patients referred for evaluation and 
treatment of VA and more than 70-80% of  idiopathic VA originate from the right ventricular 
outflow tract (RVOT).1 Although idiopathic VAs are generally considered benign, they can 
cause severe symptoms and may be associated with a VA induced cardiomyopathy.2-6 
Current guidelines indicate anti-arrhythmic drugs as first choice therapy for symptomatic 
patients; however drugs are often ineffective or hampered by side effects.1,7,8 Radiofre-
quency catheter ablation (RFCA) is a reasonable alternative and acutely highly effective 
with procedural success rates of more than 80%.1,9-11 Although considered safe, serious 
complications may occur and the application of a limited number of radiofrequency lesions 
particular is preferred.1,12-15 
To guide RFCA, conventional strategies are based on bipolar local activation time (LAT) 
mapping and the presence of a QS-configuration of the unipolar electrogram to predict a 
successful ablation site.16-19 However, the use of LAT is limited by its large variation among 
patients and the area demonstrating a unipolar QS-configuration may be larger than the 
focal source.18,20 A more specific electrogram characteristic to predict a successful ablation 
site in RVOT arrhythmias is therefore desirable.
The feasibility of guiding ablation by reversed polarity of adjacent bipolar electrograms has 
been demonstrated in pulmonary vein isolation based on the hypothesis that the excitation 
wavefront propagates radially from the breakthrough site of the left atrium to the pulmonary 
vein.21 A similar reversal of the initial deflection of adjacent bipolar electrograms, indicative 
for wavefront propagation in opposite directions, has been demonstrated in patients with 
accessory pathways and focal atrial tachycardias.22 This phenomenon however, has not 
been well documented in focal RVOT arrhythmias. 
The aim of this study was to investigate the value of reversed polarity mapping to identify 




The patient population consisted of 25 consecutive patients undergoing RFCA of idiopathic 
focal VA originating from the RVOT. To rule out structural heart disease, a comprehensive 
clinical evaluation was performed including medical history, 12-lead electrocardiogram 
(ECG) and two-dimensional transthoracic echocardiography in all patients. If deemed nec-
essary to exclude structural heart disease, exercise testing, coronary angiography, cardiac 
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multi-detector computed tomography, magnetic resonance imaging and/or nuclear imaging 
were performed. Prior to RFCA, a 12-lead ECG recording of the VA and a 24-hour Holter 
registration were acquired in all patients. Ventricular arrhythmias consisting of more than 
three consecutive monomorphic beats were classified as ventricular tachycardia (VT) and 
VA ≤3 consecutive monomorphic beats were classified as premature ventricular contraction 
(PVC).
After RFCA, all patients were monitored for 24 hours to detect early VA recurrence. All 
patients were evaluated on a regular basis at the outpatient clinic 3 months after discharge. 
Each visit included a clinical history, 12-lead ECG and 24-hour Holter registration.
Electrophysiological	examination	and	catheter	ablation
After informed consent was obtained electrophysiological evaluation was performed 
comprising electrical programmed stimulation (EPS) and right ventricular electroanatomical 
activation mapping to identify the site of origin within the RVOT. During mapping and 
ablation, conscious sedation was avoided whenever possible. Anti-arrhythmic drugs were 
discontinued for at least 5 half-lives. None of the patients was using amiodarone prior to the 
procedure. Heparin was administered to maintain an activated clotting time of 250-300s. 
Catheters were placed through a right femoral vein approach. A quadripolar catheter was 
inserted in the right ventricle and used for EPS. In the presence of a spontaneous clinical 
VA, activation mapping was performed using the surface VA QRS as a temporal reference. If 
no spontaneous VA occurred EPS was performed before and after intravenous isoprotenerol 
(2-8 µg/min) infusion, if necessary. The EPS protocol consisted of 3 drive-cycle lengths (600, 
500 and 400 ms) with up to 3 ventricular extra stimuli and incremental burst pacing from 2 
different right ventricular sites.
A 3.5mm irrigated-tip quadripolar mapping catheter (2-5-2mm inter-electrode spacing, 
Navistar ThermoCool, Biosense Webster Inc, Diamond Bar, CA, USA) was used to create an 
electroanatomical activation map. Electroanatomical mapping was performed using a 3-D 
non-fluoroscopic mapping system (CARTO XPTM, Biosense Webster Inc, Diamond Bar, CA, 
USA). 
Bipolar electrograms recorded from the distal (M1-M2) and proximal (M3-M4) electrode 
pair of the mapping catheter (filtered at 30-400Hz), the unipolar electrogram recorded 
from the distal electrode (M1; filtered at 1-240Hz, Wilson central terminal) and the 12-lead 
surface ECG were displayed simultaneously and stored on an electrophysiological recording 
system (Prucka Cardiolab, GE Healthcare, Piscataway, NJ, USA) and on the 3-D mapping 
system for off line analysis. Bipolar electrograms recorded from the mid electrode pair (M2-
M3) were only displayed and stored on the electrophysiological recording system.
To guarantee accurate electroanatomical activation mapping and to avoid annotation 
of catheter induced PVCs, the VA QRS-morphology of each acquired mapping point was 
compared to a 12-lead QRS template of the clinical arrhythmia.
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Target sites for RFCA were selected based on 1) LAT, 2) the presence of a unipolar QS-
configuration and 3) the presence of reversed polarity. Local activation time was measured 
from the bipolar electrogram recorded from the distal electrode pair of the mapping catheter 
and was defined as the interval between the initial sharp peak of the electrogram and the 
onset of the VA QRS. Unipolar electrograms were recorded from the distal electrode of 
the mapping catheter. The presence of reversed polarity was evaluated from the bipolar 
electrograms recorded from the distal (M1-M2) and mid (M2-M3) electrode pairs of the 
mapping catheter and was defined as a rapid simultaneous deflection in opposite direction 
of the initial part of the bipolar electrograms occurring before the onset of the VA QRS. To 
record reversed polarity the mapping catheter was positioned parallel or in a shallow angel 
to the endocardial surface (Figure 1).
Radiofrequency energy was applied at 20-30W with a maximum temperature of 40°C 
and with external irrigation at 20ml/min to achieve an impedance-fall of 10ohm. If the VA 
was abolished within 30s, the energy application was continued for 60s. If the VA was not 
abolished within 30s, the energy application was terminated, the site was tagged as non-
successful ablation site on the map and mapping was continued. A successful ablation site 
was defined as the location where RFCA abolished the VA and was tagged on the map. The 
procedural endpoint was reached when the targeted VA did not occur spontaneously after a 
waiting period of 30min after the last application and could not be induced by EPS before 
and after isoprotenerol infusion. 
Electrogram	analysis
Electrogram characteristics at successful ablation sites, non-successful ablation sites and 
at mapping sites within the close vicinity of the successful ablation site (area points) were 
analyzed. Area points were defined as mapping points acquired within a radius of 15mm 
from the successful ablation site. The distance between area points and non-successful 
ablation sites to the VA termination site was measured using the software provided by the 
CARTO XP system. Area points were further categorized according to the distance to the 
successful ablation site (1-5mm; 6-10mm; 11-15mm) to study the spatial distribution of the 
different electrogram characteristics with regard to the successful ablation site. For each 
analyzed mapping point (1) LAT, (2) unipolar electrogram morphology and (3) the presence 
of reversed polarity were evaluated. Local activation time, a unipolar QS-configuration and 
the presence of reversed polarity were compared for successful and non-successful ablation 
sites.
To further determine the accuracy of LAT, unipolar QS-configuration and the presence 
of reversed polarity to predict a successful ablation site, electrogram characteristics of suc-
cessful sites were compared to the characteristics of area points. The cut-off value for LAT 
to predict a successful ablation site was determined based on the value with the highest 
combined sensitivity and specificity.
68
Figure	1.
Panel	A.	Schematic of an arrhythmogenic focal source within the RVOT (red) with radial wavefront 
propagation and the position of the quadripolar mapping catheter. The distal (M1-M2) and mid 
(M2-M3) electrode pairs are simultaneously activated showing a rapid simultaneous deflection in 
opposite direction of the initial part of the bipolar electrograms defined as reversed polarity. 
Panel	B.	Local bipolar electrograms recorded from the distal (M1-M2), mid (M2-M3) and proximal 
(M3-M4) electrode pairs of the ablation catheter and the12-lead surface ECG of idiopathic RVOT 
arrhythmias (sweep-speed 200mm/sec) in two patients. A single radiofrequency application at the 
recording site abolished the arrhythmia.
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To study the impact of reversed polarity on the accuracy to predict successful ablation 
sites, two different electrophysiological mapping strategies were compared: (1) a conven-
tional approach which was guided by LAT and unipolar QS-configuration and (2) a newly 
proposed approach guided by LAT and reversed polarity. Both approaches used LAT as a 
first selection criterion to delineate the area around the focal source within the RVOT. Next, 
within this area a unipolar QS-configuration or reversed polarity was used to identify the 
site of origin.
All electrograms were analyzed off-line by two independent observers blinded to the 
location of the mapping point and to the result of the ablation procedure. In case of discrep-
ancy between the two observers, agreement was reached by consensus. 
Statistical	analysis
Statistical analysis was performed using SPSS, version 16.0 (SPSS Inc, Chicago, IL, USA). A 
p-value of <0.05 was considered statistically significant. Normality of distribution was tested 
using the Kolmogorov-Smirnoff test. Continuous variables are expressed as mean±SD and 
were compared using the unpaired student’s t-test. Categorical variables are expressed as 
number (%) and were analyzed using the chi-square test. In order to correct for correlations 
due to multiple measurements within the same patient, robust standard errors were calcu-
lated using Sandwich estimators.23 Adjustment for multiple testing was performed using the 
Bonferroni correction. To determine the optimal cut-off value for LAT to predict a successful 
ablation site, a receiver operating characteristic curve was constructed. The cut-off value 
was based on the LAT value with the highest combined sensitivity and specificity. Finally, to 
test the clinical impact of electrophysiological mapping based on LAT and reversed polarity 
on the accuracy to identify a successful RFCA site, the net reclassification improvement 
compared to conventional mapping was calculated.24
Results
Twenty-five consecutive patients (12 male, 43±15 years) with a total of 26 registered VA 
(22 PVC (85%)) were included in the study. All patients had been symptomatic for 38±40 
months and were refractory to therapy with 1.3±1.3 anti-arrhythmic drugs. The VA bur-
den on 24-hour Holter monitoring was 22±17%. All patients had normal left and right 
ventricular function (mean left ventricular ejection fraction 58±5%) on echocardiography. 
To rule out structural heart disease additional diagnostic testing was performed and was 
normal in all patients. Twenty patients underwent exercise testing, coronary angiography 
was performed in 10 patients, cardiac multi-detector computed tomography in 1 patient, 
magnetic resonance imaging in 11 patients and nuclear imaging in 3 patients. 
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Electrophysiology	study	and	radiofrequency	catheter	ablation
During electrophysiological study, the clinical VA occurred spontaneously in 22/25 (88%) 
patients. In 3 patients isoprotenerol infusion was required to induce the clinical VA, addi-
tional burst pacing was required to initiate the clinical VA in 1 patient. One patient presented 
with 2 spontaneous VA morphologies (both were targeted).  
Electroanatomical activation mapping of the RVOT was performed prior to ablation in all 
patients (40±29 mapping points per VA). All VA were successfully abolished with a mean of 
2.3±1.8 RF applications. Procedural time was 76±24min (including a 30min waiting period 
after the last RF application) and a fluoroscopy time of 13±8min. Procedural success was 
achieved in all patients. No procedure related complications occurred and all patients were 
discharged without in hospital VA recurrence. 
After 8±7 months of follow-up all patients were free of symptoms without the use of anti-
arrhythmic drugs. Twenty patients had a VA burden of <1% on 24-hour Holter monitoring. 
In 2 patients the VA burden was 2 en 6%, respectively; however the VA QRS-morphology 
differed from the VA QRS-morphology targeted during the index procedure. In 3 asymptom-
atic patients, who had disabling symptoms before ablation, 24-hour Holter monitoring was 
not available.
None of the 4 patients with VT prior to ablation had VT recurrence.
Figure	2.	Frequency of local activation time (LAT) at successful ablation sites (black bars) versus 
non-successful ablation sites (grey bars). The dashed lines indicate the normal distribution of the 
LAT in the two groups. Please note the important overlap of LAT between successful and non-
successful ablation sites.
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Successful	versus	non-successful	ablation	sites
Electrogram characteristics from 26 successful and 33 non-successful ablation sites were 
compared. Local activation time was significantly earlier at successful ablation sites as 
compared to non-successful ablation sites (-28±7ms versus -22±8ms, p=0.002). However, 
there was a considerable overlap in LAT between both groups (Figure 2). Reversed polarity 
of adjacent bipolar electrograms was observed at 21 of 26 successful ablation sites (85%). 
In contrast, reversed polarity was absent at all non-successful ablation sites (p<0.001). The 
presence of a unipolar QS-configuration was similar between successful and non-successful 
ablation sites (22 (85%) versus 19 (83%), p=0.850). 
Spatial	distribution	of	electrogram	characteristics
Local activation time, unipolar QS-configuration and the presence of reversed polarity were 
compared between 26 successful ablation sites and 139 area points within three different 
categories (Table 1). Local activation time was significantly earlier at successful ablation 
sites as compared to area points. The best cut-off value to discriminate between a successful 
ablation site and an area point was a LAT of -23ms. In addition, area points beyond a 5mm 
radius from the successful ablation site demonstrated less often a unipolar QS-configuration 
when compared to the successful ablation sites. However, no differences in unipolar elec-
trogram morphology were found between successful ablation sites and area points within a 
5mm radius. Moreover, the prevalence of a unipolar QS-configuration at distances between 
6-10mm and 11-15mm remained high (63% and 53%, respectively) (Figure 3). Importantly, 
successful ablation sites showed significantly more often reversed polarity than area points 
across all categories. The sensitivity to discriminate between a successful ablation site and 
an area point was slightly higher for LAT (88%) as compared to a unipolar QS (85%) and the 
presence of reversed polarity (81%), however the specificity to identify a successful site was 




1 − 5mm 6 − 10mm 11 − 15mm
N 26 43 51 45
LAT (ms) -28±7 -21±8* -18±8* -18±8*
Unipolar QS-configuration, 
n (%)
22 (85) 37 (79) 32 (63) † 24 (53) ‡
Reversed polarity, n (%) 21 (81) 2 (5)* 3 (6)* 5 (11)*
LAT= Local activation time; * p<0.001 compared to successful ablation site; † p<0.05 compared 
to successful ablation site; ‡ p<0.02 compared to successful ablation site
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found to be significantly higher for reversed polarity (93%) as compared to LAT (71%) and a 
unipolar QS-configuration (35%) (Table 2).
Comparison	of	two	mapping	strategies	to	predict	a	successful	ablation	
site	
To study the clinical impact of reversed polarity on the accuracy of electrophysiological 
mapping of idiopathic RVOT arrhythmias, a comparison was made between a conventional 
mapping strategy and a newly proposed mapping strategy including reversed polarity. For 
both strategies, LAT>-23ms was applied as the first criterion. If LAT was >-23ms, this map-
ping site could be excluded as a successful ablation site with a 97% likelihood. However, 
if LAT at a certain location was ≤-23ms, the accuracy to positively predict a successful 
ablation site was only 36%. After excluding mapping sites with LAT>-23ms the conventional 
mapping strategy used the presence of a unipolar QS-configuration as the second criterion 
to identify a successful ablation site whereas the new mapping strategy used the presence 
of reversed polarity. The presence of a unipolar QS-configuration identified the successful 
Figure	3.	Electroanatomical activation map of a right ventricular outflow tract arrhythmia (posterior 
view). Local activation time (LAT) is color coded with isochronal steps of 5 ms according to the 
color bar. The white dotted line delineates the area around the successful ablation site (red tag) that 
demonstrated a unipolar QS-configuration. Black-with-green icons indicate areas demonstrating 
unipolar QS-configuration and white-with-red icons correspond to the area demonstrating a 
unipolar rS configuration. (for	figure	in	color	see	page:	254)
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ablation site with 40% accuracy. In contrast, application of reversed polarity as the second 
criterion led to the identification of the successful ablation site with 86% accuracy (Figure 
4). Moreover, mapping based on reversed polarity resulted in a net reclassification improve-
ment of 0.189 (p=0.028). This index of reclassification illustrated that mapping based on LAT 
and reversed polarity resulted in a significant ‘gain of certainty’ to identify a successful RFCA 
site compared to conventional mapping based on LAT and unipolar QS-configuration.24
Table	2.	Electrogram characteristics
Sensitivity Specificity NPV PPV
LAT ≤-23ms 88 71 0.97 0.36
Unipolar QS-configuration 85 35 0.92 0.20
Reversed polarity 81 93 0.96 0.68
LAT= Local activation time; NPV= negative predictive value; PPV = positive predictive value 
Figure	4.	The predictive value of a new mapping strategy guided by local activation time (LAT) and 
reversed polarity was compared to a conventional mapping strategy guided by LAT and unipolar 
electrogram morphology. Both approaches use LAT as the primary selection criterion. The new 
approach uses reversed polarity as the second selection criterion whereas the conventional 
approach uses the unipolar electrogram morphology (i.e. presence of unipolar QS-configuration). 
NPV=negative predictive value; PPV=positive predictive value.
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Discussion
Key findings of the present study are: (1) the presence of reversed polarity was associated 
with a high likelihood for a successful RF application; and (2) mapping of idiopathic RVOT 
arrhythmia based on LAT and reversed polarity resulted in a higher predictive value for 
a successful ablation, compared to a conventional mapping strategy based on LAT and 
unipolar electrogram morphology.
Conventional	mapping	strategies
Several electrophysiological strategies have been described to guide RFCA of focal RVOT 
arrhythmias. Typically, mapping procedures are guided by unipolar and bipolar electro-
grams. Unipolar electrograms provide information about the direction of the wavefront: 
an initial positive deflection of the unipolar electrogram indicates propagation towards the 
mapping catheter and has a high negative predictive value for a successful ablation site. As 
the wavefront reaches the electrode and propagates away, the deflection sweeps negative. 
When the electrode is located at the focal source the wavefront propagates away producing 
a monophasic QS complex. However, unipolar electrograms provide information about a 
large area and contain important far-filed signals. In contrast, in bipolar electrograms the far 
field signal is subtracted out thereby providing information about the local electrical activity, 
but do not contain information about the direction of the wavefront. Currently, most RFCA 
procedures for focal arrhythmias are guided by LAT defined by the initial peak of the bipolar 
electrogram and the rapid negative deflection of the unipolar electrogram, the unipolar elec-
trogram morphology and pace-mapping. Although these criteria have demonstrated their 
practical value, each technique is associated with its own inherited limitations.18,20,25,26 The 
spatial resolution of a good pace-map has been found to be 1.8±0.6cm2 and inferior to the 
spatial resolution of activation mapping. Based on this observation pace-mapping was not 
systematically investigated in our study.26 
In the current study, LAT was significant earlier at successful ablation sites (-28±7ms) 
as compared to ablation sites that did not abolish the VA (22±8ms), which is in line with 
prior studies reporting LAT at effective sites between -24±7 ms and -29±7ms.3,26 However, 
we could demonstrate a significant overlap in LAT between successful and non-successful 
ablation sites. Although the best cut-off value for LAT (-23ms) to discriminate between a suc-
cessful site and a site in a proximity of less than 15mm provided a high negative predictive 
value, only a minority of successful sites could be identified correctly. This finding suggests 
that a cut-off value for LAT can be used to delineate the area of interest, but is not accurate 
enough to identify a site where RF energy should be applied.  Furthermore, the current 
study confirms and extends prior observations that the area around a site of origin of a focal 
RVOT VA that exhibits a unipolar QS-configuration is considerably broad.27 The wide spatial 
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distribution of a unipolar QS is in line with the low additional value to predict a successful 
ablation site found in this study.
Reversed	polarity
Reversed polarity of bipolar electrograms to guide ablation of focal RVOT arrhythmia was 
first suggested in a case report by Fisher et al using a custom-built orthogonal electrode 
array.28 However, this method to target focal RVOT arrhythmias has not been applied in a 
large cohort of patients and using a standard quadripolar mapping catheter.
The use of reversed polarity to predict a successful ablation site is based on the hypoth-
esis that rapid radial propagation from a focal source results in simultaneous deflection in 
opposite direction of the initial part of the bipolar electrograms. Provided that the bipoles 
are positioned orthogonally to the activation wave front with the focal source ideally located 
between the bipoles. Due to the cylindrical anatomy of the RVOT it is possible to align a 
standard quadripolar mapping catheter orthogonally to the myocardial surface.
Indicating wavefront propagation in opposite direction, reversed polarity provides addi-
tional information to LAT. A focal source can be assumed if early local activation preceding 
the VA QRS is present and activation is observed in opposite directions. Combining these 
two electrogram characteristics is therefore likely to provide a reliable endpoint for catheter 
mapping. Accordingly, our suggested approach to map focal RVOT arrhythmias by combin-
ing LAT with reversed polarity resulted in a high negative predictive value but importantly 
also in a high positive predictive value to identify a successful ablation site. In contrast, 
conventional mapping based on LAT and a unipolar QS-configuration had comparable 
negative predictive but poor positive predictive value.
Procedural	aspects
Patients suffering from idiopathic focal RVOT arrhythmias are commonly young and 
healthy.29 Therefore important goals when targeting focal RVOT arrhythmias are reduction 
of radiation exposure and number of RFCA applications needed to terminate the VA. Prior 
studies reported on mean fluoroscopy time up to 54 minutes targeting RVOT arrhythmias 
whereas in the current study mean fluoroscopy time was only 13±8min.19,30 Moreover, 
the mean number of RFCA applications needed to terminate the VA ranged from 3 to 8 in 
previous studies but could be reduced to only 2.3±1.8 RFCA applications in the current 
study.19,26,30,31 These results indicate that implementation of reversed polarity is likely to 
reduce both radiation dose and number of RFCA applications. 
Limitations
The present study comprised a relatively small number of patients. Therefore the results 
should be confirmed in a larger population. Furthermore, for statistical purposes LAT was 
dichotomized according to the cut-off value provided by the ROC-curve analysis, although 
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this may not fully reflect clinical practice. In addition, during ablation target sites for 
RFCA were selected based on the combination of early LAT, the presence of a unipolar 
QS-configuration and the presence of reversed polarity. However, the decision to apply 
RF energy was made by the operator in a non-randomized fashion. The analyses of LAT, 
the presence of a unipolar QS-configuration and the presence of reversed polarity have 
been performed retrospectively. Ideally the newly proposed strategy, combining early LAT 
and reversed polarity presence, should have been validated prospectively. Finally, based 
on theoretical considerations the ablation catheter should be pulled back slightly when 
reversed polarity is recorded to ensure that the catheter tip is in the position of the second 
electrode. However, this was not systematically evaluated in the present study but seems to 
be unlikely to further reduce the number of RF applications needed.  
Clinical	implication
The presence of reversed polarity is easily to obtain and has a high predictive value to 
identify a successful ablation site in idiopathic focal RVOT arrhythmias. Combining LAT 
and reversed polarity can predict a successful ablation site with higher accuracy than con-
ventional mapping based on LAT and unipolar QS-configuration. Its clinical application is 
likely to reduce the number of RFCA applications and radiation exposure to both patient 
and operator.
Conclusion
The presence of reversed polarity has a high predictive value for a successful ablation site in 
focal idiopathic RVOT arrhythmias. Combining local activation time and reversed polarity 
improves the accuracy of identifying the site of origin compared to conventional mapping 
strategies.
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Background: Reperfusion therapy during acute myocardial infarction (AMI) results in 
myocardial salvage and improved ventricular function but may also influence the arrhyth-
mogenic substrate for ventricular tachycardia (VT). This study used electroanatomical (EA) 
mapping and infarct histology to assess the impact of reperfusion on the substrate and on VT 
characteristics late after AMI.
Methods and Results: The study population consisted of 36 patients (32 male, 63±15yr) 
referred for treatment of VT 13±9yrs after AMI. Fourteen patients with early reperfusion 
during AMI were compared with 22 non-reperfused patients. Spontaneous and induced 
VTs and the characteristics of EA voltagemaps were analyzed. Twenty-seven patients were 
treated by radiofrequency catheter ablation. Ten patients (non-reperfused 6) were treated by 
ventricular restoration with intraoperative cryoablation in 9. During surgery biopsies were 
obtained from the resected core of the infarct. VT cycle length of spontaneous and induced 
VTs was shorter in reperfused patients (reperfused 299±52/270±58ms, non-reperfused 
378±77/362±74ms, (p=0.01)). An EA patchy scar pattern was present in 71% of reperfused 
and in 14% of non-reperfused patients (p=0.004). The proportion of EA dense scar was 
smaller in reperfused patients (24±18% vs. 45±21%, p=0.02). Histological assessment in 10 
patients revealed thick layers of surviving myocardium in 75% of reperfused but in none of 
non-reperfused patients.
Conclusions: Scar size and pattern defined by EA mapping are different between VT 
patients with and without reperfusion during AMI. Less confluent EA scars match with thick 
layers of surviving myocardium on histology. Early reperfusion and less confluent electro-
anatomical scar are associated with faster VTs.
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Introduction
Catheter ablation is an important therapeutic option for controlling recurrent ventricular 
tachycardia (VT) late after acute myocardial infarction (AMI). Mapping studies have shown 
that reentry circuit locations and VT characteristics vary greatly among patients and are 
influenced by the 3-dimensional geometry of infarcted areas.1-3 In animal models, the dura-
tion of coronary artery occlusion determines size, transmurality and geometry of myocardial 
fibrosis after AMI.4, 5 Thus, it seems likely that early reperfusion, which has become the 
standard treatment of acute AMI will influence the nature of the VT substrate. Recently, 
methods have been developed to characterize the VT substrate based on bipolar electrogram 
characteristics during sinus or paced rhythm. These methods have been applied to abla-
tion of VTs that are not stable for mapping during VT, targeting the substrate with linear 
radiofrequency lesions at the electrophysiological scar borderzone.2, 3, 6 Animal studies to 
validate this substrate based ablation approach were performed in a chronically occluded 
infarct related artery (IRA) model resulting in a homogeneous dense scar surrounded by a 
small scar borderzone.7
We hypothesized that early reperfusion during AMI results in smaller and less homoge-
neous scars on electroanatomical voltage maps and faster spontaneous and inducible VT 
as compared to non-reperfused patients late after MI. To further evaluate the effect of early 
reperfusion on the VT substrate the results of electroanatomical voltage maps were com-




The population comprised of 36 consecutive patients late after AMI referred for catheter 
ablation or surgical treatment of sustained monomorphic VT without contraindications for 
LV mapping and without evidence of reversible ischemia. Clinical evaluation consisted 
of careful history taking regarding the reperfusion strategy during the index myocardial 
infarction and consecutive ischemic events, arrhythmias and symptoms of heart failure. All 
patients underwent echocardiography, coronary angiography and nuclear myocardial perfu-
sion imaging to detect ischemia. The results, including the functional status, the presence of 
a left ventricular (LV) aneurysm, concomitant valvular disease and residual coronary artery 
disease were evaluated by a team of cardiologists, electrophysiologists and cardiothoracic 
surgeons according to the institutional protocol. Patients with significant coronary artery ste-
nosis and reversible ischemia on nuclear perfusion imaging, or with a mobile LV thrombus 
or with NYHA heart failure class IV symptoms were excluded from the study.
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Patients presenting with symptoms of heart failure and a dilated or aneurysmatic LV after 
anterior AMI were considered candidates for a combined surgical approach of ventricular 
restoration comprising of an endoventricular circular patch plasty and intraoperative VT 
ablation.8 In the remaining patients radiofrequency catheter ablation (RFCA) was offered.
Coronary	Angiography
All available coronary angiograms obtained during and after the index AMI were reviewed 
by an interventional cardiologist to assess the effect of the early reperfusion strategy. Based 
on these results patients were classified as either acutely reperfused with documented open 
IRA or as not-reperfused. The TIMI (thrombolisis in myocardial infarction) scoring system was 
used to determine the patency of the infarct related artery (IRA).9 Patients were considered 
reperfused when TIMI 3 flow grade was present after reperfusion therapy.
Electrophysiological	evaluation
After informed consent all patients underwent electrophysiological evaluation including 
electrical programmed stimulation (EPS) and LV electroanatomical (EA) voltage mapping. 
Studies were performed in the post absorptive, non-sedated state. Antiarrhythmic drugs 
were discontinued for 5 half-lives, with the exception of amiodarone which was continued 
in 14 patients. The EPS-protocol consisted of 3 drive-cycle lengths (600, 500 and 400ms) 
and ≤3 ventricular extrastimuli from 2 right ventricular sites and burst pacing. 12-lead ECGs 
and intracardiac electrograms were recorded simultaneously with a 48-channel acquisition 
system (Cardio-Lab 4.1; Prucka Engineering, Houston, TX, USA). The positive endpoint of 
EPS was reproducible induction of a sustained monomorphic VT lasting ≥30s or requiring 
termination because of hemodynamic compromise. When catheter ablation was performed 
the entire protocol was repeated until all inducible VTs were eliminated or until the proce-
dure was classified as ablation failure in the judgment of the physician. Sinus rhythm (SR) 
EA voltage mapping (CARTO XP EP system Biosense Webster Inc, Diamond Bar, CA, USA) of 
the LV was performed with a 3.5mm tip quadripolar mapping catheter, interelectrode spac-
ing 2-5-2mm (NaviStar ThermoCooled, Biosense Webster Inc, Diamond Bar, CA, USA) by a 
retrograde aortic approach. Bipolar voltage maps with a spatial resolution of <15mm were 
created. Electrical scar in the IRA provided area was defined by voltage criteria. Electrogram 
amplitudes ≤0.5mV were defined as dense scar, voltages >0.5mV and ≤1.5mV2, 7 as scar 
borderzone and a ‘patchy pattern’ of EA scar as ≥2 low voltage areas separated by areas of 
preserved voltage (>1.5mV). For each map the surface of the total scar, the scar borderzone 
and the dense scar were measured using software provided with the CARTO system. 
VT was defined as IRA related if the reentry circuit isthmus site was located within the 
area supplied by the IRA. A reentry circuit isthmus site was defined by either activation and 
entrainment mapping for tolerated VT or by pace-mapping (≥11/12 lead match between 
VT QRS and paced QRS morphology and a Stimulus-to-QRS interval (S-QRS) >40ms) in 
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patients with poorly tolerated VTs or who were scheduled for operation. In the latter, the 
potential reentry circuit isthmus site was marked by a single RF application to facilitate 
ablation during surgery.
Ablation
RFCA was performed at isthmus sites during VT for stable VTs and during SR for unstable 
VTs with an open irrigated tip catheter. Radiofrequency power was applied to a maximum 
of 50W, provided that the temperature recorded from the electrode remained below 50°C 
for 60sec. All inducible monomorphic VTs were targeted and RF energy was applied, if a 
potential isthmus site could be identified.
Cryoablation concomitant to surgery was performed using a Surgifrost® cryoprobe 
(Cryocath, Montreal Canada). Overlapping applications, up to -150 °C during 90 sec, were 
applied to the endocardial scar border as identified by the surgeon. The epicardial surface 
was inspected for the extent of the scar, identified as a white discoloration of the muscular 
tissue. After opening of the left ventricle the endocardial surface was inspected for the extent 
of the scar. Next, the thickness of the left ventricular wall was assessed by palpation: a 
distinction between the normal thickness of the LV wall and the scar can be identified in 
every patient. In most patients the border at which the ventricular wall changes thickness 
coincides with the endocardial extention of the visible scar, except for the septal extension.
The area for endocardial cryoablation was based on visible extension of the scar tissue or, 
in rare cases where no visual identification was possible, on the change in wall thickness.10 
Care was taken that the VT reentry circuit isthmus site marked during catheter mapping was 
included in the ablation line. The encircling cryoablation line coincided with the suture line 
of encircling endoventricular patch plasty performed after ablation. VTs with a morphology 
corresponding to 12-lead surface ECG documentation of a spontaneous VT were considered 
clinical and VTs with a CL corresponding the CL of a VT documented in the ICD as presump-
tive clinical VT.11 Complete ablation success was defined as the absence of any inducible 
monomorphic VT after the ablation procedure. Partial success was defined as successful 
ablation of one or more clinical/presumptive clinical VT, but other VT remained inducible; 
and ablation failure was defined by continued inducibility of the clinical/presumptive clini-
cal VT. Acute success was tested immediately after RFCA in patients who underwent catheter 
ablation and during a second EPS before hospital discharge in patients who underwent 
surgery.
Histological	assessment
In patients treated with surgical ablation and/or ventricular restoration transmural biopsies 
were taken from the removed central part of the LV scar and were systematically assessed 
by a pathologist blinded to clinical history and mapping findings. Routine H&E stains were 
performed on 5 µm formalin-fixed paraffin embedded (FFPE) sections. All sections were 
86
analyzed for the presence and distribution of myocardial fibrosis. Assessment included 
visual scoring for density, location (predominance of subendocardial or subepicardial fibro-
sis) and extent of fibrosis and evaluation of the maximum percentage of transmurality. The 
identified area of most extensive fibrosis was further morphometrically analyzed for total 
wall thickness, thickness of the remaining viable myocardium and the ratio of remaining 
myocardium thickness to total wall thickness. In addition, the spatial relation between viable 
myocardium and fibrous tissue was assessed and scored for each section and compared to 
the EA mapping results of the core infarct region.
 
Statistical	Analysis
Continuous variables are expressed as mean±SD, and categorical variables as frequency(%). 
Mann Whitney U-test and Fishers Exact test were used to compare data when appropriate. 
Mean VTCL was compared after first averaging the VTCL of individual patients and subse-
quently perform analysis. All statistical analyses were performed with SPSS software (version 
16 SPSS Inc., Chicago, Illinois). For all tests a p-value ≤0.05 was considered significant.
Results
Baseline	criteria
The 36 patients (63±15yr, 32 male) were referred for treatment of VT 13±9 years after 
AMI. Fourteen (38%) patients had undergone acute reperfusion therapy. Reperfusion was 
achieved by PCI in 8 patients and thrombolysis in 5. In one patient with an occluded LAD 
collateral flow to the IRA (Rentrop grade 3) was present at the time of acute infarction. 
This was considered spontaneous reperfusion of the infarcted area. The time from onset of 
symptoms to presentation was available in 12 patients. All patients were admitted within 6 
hours after onset of symptoms. The median symptom-onset to presentation time was 2 hours 
and 45 minutes (interquartile range 1h – 5h40min). The median estimated time to needle 
or time to balloon was 45min (interquartile range 36min – 1h) and 1h (interquartile range 
30min – 2h), respectively resulting in a median symptom onset to balloon/needle time of 
3h30min (interquartile range 2h6min – 6h6min). Twenty-two patients did not undergo early 
reperfusion therapy. Twenty-two (60%) had anterior wall infarction, 11 (31%) inferior wall 
infarction, 2 (6%) posterior wall infarction and 3 (8%) had more than one infarct location. 
In these 3 patients the IRA were the left anterior descending (LAD) and right coronary artery 
(RCA); one patient underwent successful thrombolysis of the LAD and RCA subsequently 
and was classified as reperfused patient. The remaining two had chronic occlusion of the 
LAD and RCA and were classified as non-reperfused patients. At referral the IRA was patent 
in all patients who had undergone early reperfusion and occluded in 17 non-reperfused 
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patients. In 5 non-reperfused patients the IRA was patent due to late PCI in 4 and late 
spontaneous reperfusion in 1. 
After evaluation 9 (25%) patients were offered a combined approach of surgical ventricu-
lar restoration and intraoperative VT ablation. In one patient surgical ventricular restoration 
without cryoablation was performed after initial catheter ablation. The baseline characteris-










Male 32(89) 13(93) 19(86) 1.0
Age (year) 63±15 60±11 65±16 0.05
Diabetes 5(14) 1(7) 4(18) 0.6
Atrial Fibrillation 3(8) 2(14) 1(5) 0.3
Time after AMI (year) 13±9 8±5 16±10 0.01
Anterior AMI 22(60) 10(71) 11(50) 0.3
Inferior AMI 11(31) 3(21) 8(36) 0.5
Posterior AMI 2(6) 0 2(9) 0.5
Multiple AMI 3(8) 1(7) 2(9) 1.0
Late PCI of IRA 8(22) 4(29) 5(23) 0.7
Late CABG of IRA 9(25) 1(7) 8(36) 0.06
NYHA class
   1 21(58) 9(64) 12(55) 0.8
   2 9(25) 3(21) 6(27) 0.8
   3 6(17) 2(14) 4(18) 0.8
Echocardiography
LVEF (%) 30±13 33±16 28±11 0.5
Anterior aneurysm 18(40) 7(50) 11(50) 1.0
LV hypertrophy 3(8) 0 3(14) 0.3
Failed AAD
   Amiodarone 16(44) 4(29) 12(55) 0.2
   Sotalol 10(28) 4(29) 6(27) 1.0
   Class I 4(11) 1(7) 3(14) 1.0
   B-Blocker 29(81) 11(79) 18(82) 1.0
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Spontaneous	VT
Fifty-five different spontaneous VT were registered during 4.7±5 months preceding referral. 
The number of different VT did not differ between reperfused and non-reperfused patients 
(1.4±1.3 versus 1.7±1.1, p=0.4). Twenty VTs were documented on 12-lead surface ECGs and 
35 on local electrograms stored in the ICD. In the latter group a difference in VTCL of >30ms 
was considered as different VT. The VTCL was significantly shorter in reperfused patients as 
compared to non-reperfused patients (299±52ms vs. 378±77ms, p=0.01) (figure 1). To cor-
rect for the effect of antiarrhythmic drugs and specifically of amiodarone on VTCL, the mean 
CL of VTs registered without any AAD and without amiodarone were compared. There was 
a non-significant tendency to a shorter VTCL without AAD and a significant shorter VTCL 
without amiodarone in reperfused compared to non-reperfused patients (table 1).
Electrophysiological	evaluation
VT was inducible in all patients with a total of 80 different induced VTs. The CL of the first 
induced VT (the positive endpoint of EPS) was significantly shorter in reperfused patients 
(278±80ms versus 391±109ms, p=0.002). A similar difference was found for the mean VTCL 
(270±58 vs. 362±74, p=0.001) (figure 1).
Medication at referral
   Amiodarone 14(38) 4(29) 10(45) 0.5
   Sotalol 6(17) 4(29) 2(9) 0.1
   Class I 2(6) 2(14) 0 0.2
   B-Blocker 24(67) 10(71) 14(64) 0.7
   ACE-I/ATII antagonist 35(97) 14(100) 20(91) 0.5
   Diuretics 23(64) 7(50) 16(73) 0.3
Spontaneous VT
   Number distinct VT 1.6±1.7 1.4±1.3 1.7±1.1 0.4
   Mean CL (ms) 353±78 299±52 378±77 0.01
   Shortest CL (ms) 328±74 279±55 352±72 0.01
   Longest CL (ms) 381±94 316±62 411±92 0.01
   Mean CL without AAD (ms) 337±65 297±51 351±66 0.07
    Mean CL without amiodarone 
(ms)  
334±65 302±53 355±65 0.05 
   ICD 18(50) 5(36) 13(59) 0.3
AMI indicates acute myocardial infarction; PCI, percutaneous coronary intervention; IRA, infarct 
related artery; CABG, coronary artery bypass graft; NYHA, New York heart association; LVEF, left 
ventricular ejection fraction; VT ventricular tachycardia; CL, cycle length; ICD, internal cardiac 
defibrillator; AAD, anti arrhythmic drugs; ACE-I ACE inhibitor; ATII, angiotensin II. Data are displayed 
as mean±SD or frequency(%).
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In 71% of reperfused patients fast VTs with a CL<250ms were inducible compared to 
23% non-reperfused patients (p=0.003). After exclusion of patients on amiodarone during 
EPS the induced VTCL remained significantly shorter in reperfused patients (254±51ms vs. 
334±65ms, p=0.006). 
Electroanatomical	mapping
LV voltage mapping was performed with a mean number of 214±43 mapping points. The 
total scar surface area (bipolar voltage<1.5mV) was comparable in reperfused and non-
reperfused patients (65±48cm2 vs. 85±46cm2). However, the surface area of dense scar 
(bipolar voltage<0.5mV) and the percentage of dense scar in relation to total scar was 
significantly smaller in the reperfused group (reperfused 21±25 cm2 and 24±18% vs. non-
reperfused 42±32 cm2 and 45±21%, p=0.02 and p=0.002 respectively). 
A patchy scar pattern in the IRA related area was found in 13(36%) patients. Ten of 14 
reperfused patients (71%) had a patchy pattern but only 3 (14%) non-reperfused (p=0.001) 
(figure 2). 
In patients who underwent primary PCI the differences as compared to non-reperfused 
patients were even more pronounced. In these patients the average CL of clinical and 
induced VTs was 270±23ms and 239±24ms, respectively (figure 1). The average absolute 
surface area of dense scar was 11±12cm2, the mean percentage of dense scar was 14±12% 
and 7(88%) had a patchy scar pattern. 
Figure	1.	The median and interquartile range for spontaneous (panel A) and induced (panel B) 
VTCL are displayed for reperfused vs. non-reperfused patients vs. patients after PCI, for patients 
with a patchy vs. patients without a patchy pattern of electroanatomical scar and for patients with 
and without amiodarone treatment. CL indicates cycle length; EP electrophysiological study; PCI, 
percutaneous coronary intervention; VT, ventricular tachycardia. 
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Figure	2.	Left ventricular electroanatomical voltagemaps of six patients. Bipolar voltages are color 
coded according to the colorbar. Voltages <1.5mV were considered abnormal. The 3 maps on the 
left hand side are obtained in reperfused patients and the 3 on the right in non-reperfused patients. 
The scar pattern is patchy in reperfused and homogeneous in non-reperfused patients. (for	figure	
in	color	see	page:	255)
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The targeted reentry circuit sites of VT were located within the scar area supplied by the IRA 
in 33 patients. In 3 patients no reentry circuit isthmus side could be identified based on the 
above defined criteria. However, the VT QRS morphology was compatible with an exit site 
located in the area supplied by the IRA. 
The results of the electrophysiological evaluation are summarized in table 2.
Ablation
Catheter ablation was performed in 24/27 patients. In 3 patients, all after early reperfusion 
with non-tolerated VT (average CL 227±7ms) and a patchy scar pattern no potential VT 
isthmus site could be identified. In 2 non-reperfused patients epicardial catheter ablation 
was performed after endocardial ablation failure, which was successful in one. In none of 
the reperfused patients an epicardial ablation approach was considered appropriate.  No 
procedure related complications were observed.
Ten patients were treated by surgery after electrophysiological evaluation. Nine patients 
(reperfused 3 (21%), non-reperfused 6 (27%)) were treated by surgical cryoablation and 
surgical ventricular restoration. One patient underwent surgical ventricular restoration 
without cryoablation after catheter ablation. There was one peri-operative death due to 









Induced VT at EPS
   Number distinct VT 2.3±1.6 2.1±1.7 2.5±1.6 0.5
   CL first induced VT (ms) 347±112 278±80 391±109 0.002
   Mean CL (ms) 326±81 270±58 362±74 0.001
   Shortest CL (ms) 290±62 251±37 314±63 0.001
   Longest CL (ms) 363±117 292±90 409±112 0.002
   Mean CL without AAD (ms) 297±70 254±51 334±65 0.006
Points voltagemap 214±43 220±44 211±56 0.6
Surface area map (cm2) 244±55 249±55 242±55 0.7
Surface area scar (cm2) 77±47 65±48 85±46 0.2
Surface area dense scar (cm2) 35±32 21±25 42±21 0.02
Surface area borderzone (cm2) 43±24 44±29 42±21 0.8
Borderzone % of scar 62±22 76±17 54±21 0.002
Patchy pattern of scar 13(36) 10(71) 3(14) 0.001
CL indicates cycle length; EPS, electrical programmed stimulation; VT, ventricular tachycardia; AAD, 
antiarrhythmic drugs. Data are expressed as frequency (%) or mean±SD.
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heart failure. One patient refused post-operative EPS. Outcome after ablation did not differ 
between reperfused and non-reperfused patients (table 3). 
Histological	assessment
Histological assessment was performed in the subpopulation of 10 patients undergoing a 
surgical intervention (reperfused 4, non-reperfused 6). In all non-reperfused patients focal, 
transmural fibrosis was found; in contrast 3/4 patients with early reperfusion had only 
non-transmural fibrosis (Figure 3A+B). The average wall thickness of the infarcted area was 
1.4±0.7mm. In reperfused patients the average wall thickness was significantly thicker than 
in non-reperfused patients (2.0±0.6 mm versus 1.0±0.5mm, p=0.03, Figure 3C). The average 
thickness of viable myocardium even in the most severely fibrotic area was 1.0±0.8 mm 
in reperfused patients, translating to a ratio of viable myocardium to total wall thickness 
of 0.5±0.3. In the patients (4 reperfused, 1 non-reperfused) with a patchy pattern of EA 
scar the average wall thickness was thicker than in patients with a homogeneous EA scar 
(1.9±0.5mm vs. 0.8±0.2mm, p=0.01). The extent to which viable myocytes were interspersed 
with fibrosis was categorized (figure 4). Five dominant histological patterns were identified: 
(A) Contiguous areas of viable myocardium, (B) small confluent areas of fibrosis surrounded 
by viable myocardium, (C) confluent areas of fibrosis containing only strands of viable 
cardiomyocytes, (D) confluent areas of fibrosis containing solitary viable cardiomyocytes 
and (E) transmural confluent fibrosis. The first two patterns were only found in 3 patients 










RFCA 27(75) 11(79) 16(73) 1.0
   Complete 14(52) 5(45) 9(56) 0.3
   Partial 9(33) 3(27) 6(38) 0.3
   Failure 4(15) 3(27) 1(5) 0.3
Intraoperative EC 9(25) 3(21) 6(27) 1.0
  Complete 4(44) 1(33) 3(50) 0.5
  Partial 0 0 0 0.5
  Failure 3(33) 2(67) 1(17) 0.5
Overall Result
  Complete 18(50) 6(43) 12(55) 0.2
  Partial 9(25) 3(21) 6(27) 0.2
  No 7(20) 5(36) 2(10) 0.2
Two patients who underwent intraoperative EC did not undergo post-operative EPS, RFCA 
indicates radiofrequency ablation; EC, encircling cryoablation. Data are expressed as frequency(%).
Chapter 4
Early Reperfusion and Late Ventricular Tachycardiagical Substrate
93
2 patients with a patchy EA pattern of scar (one reperfused, one non-reperfused) transmural 
fibrosis with solitary viable cardiomyocytes was found at histological assessment. However, 
in these two patients the core infarct region which was resected consisted of dense scar at 
mapping (patient 5 in figure 4). In the 5 non-reperfused patients with a homogeneous scar 
on mapping no contiguous areas of viable myocardium were found. Three representative 
examples of EA maps (patient 1, 5 and 6) were incorporated in the figure. The assumed area 
that was resected by the surgeon is indicated on the maps.
Discussion
The current study evaluates the effect of early reperfusion of the infarct related artery on VT 
characteristics and the VT substrate by EPS, 3-D electroanatomical voltage mapping and 
histology in patients, who present with VT late after AMI.
Figure	3.	Representative slides of transmural biopsies from the core infarct zone in 2 patients 
(H&E stain). Panel A: small mid wall fibrosis surrounded by thick viable myocytes bundles in a 
patient after early reperfusion and with a patchy pattern of EA scar. Panel B: mural thinning with 
dense transmural fibrosis in a non-reperfused patient with a homogeneous pattern of EA scar with 
only interspersed cardiomyocytes. Panel C: average wall thickness of the area of most extensive 
fibrosis in myocardial biopsies of reperfused (n=4; 2.0±0.6 mm) and non-reperfused (n=6; 1.0±0.5 
mm) patients. (for	figure	in	color	see	page:	256)
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The main finding of the study is that characteristics of low voltage scars after AMI are 
different in patients with and without reperfusion therapy. Early reperfusion is associated 
with less dense and less confluent electroanatomical scars that appear to give rise to faster 
spontaneous and inducible VTs. The electrophysiological findings match with the histologi-
cal assessment demonstrating that the LV core infarct area consists of at least 50% viable 
myocardium in reperfused patients.
To the best of our knowledge this is the first study to report on differences in EA ventricu-
lar voltage maps between post-AMI patients with and without successfully reperfused IRA 
and their potential impact on clinical arrhythmias.
Figure	4	The relation between viable myocytes and fibrosis was characterized. Five patterns of 
local histological scar were identified (A-E). The presence of any of these types in the assessed 
core infarct region was scored and compared to the presence of reperfusion and the pattern of 
electroanatomical scar in the 10 patients in whom histological assessment was performed. Three 
representative examples of EA maps (patient 1, 5 and 6) are shown, the assumed area that was 
resected by the surgeon is indicated. (for	figure	in	color	see	page:	257)
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Reperfusion	and	myocardial	scar
Early reperfusion during AMI results in myocardial salvage and reduced mortality during 
follow-up.12 Animal studies showed that the duration of coronary artery occlusion is related 
to infarct size and extend of transmural necrosis.4, 5 Early reperfusion resulted in necrosis 
of the inner third of the wall extending towards the midmyocardium, whereas late reperfu-
sion or permanent occlusion resulted in an uniform transmural necrosis.5 Similar findings 
were made in human autopsied hearts with acute myocardial infarction after treatment with 
thrombolysis.13 These findings from the acute phase of AMI are supported and extended 
by our data as biopsies were taken in the chronic healing phase 13±9 years after the index 
MI in 10(28%) of the studied patients. Likely as a result of transmural necrosis the core 
infarct consisted of transmural fibrosis in non-reperfused patients whereas the majority of 
early reperfused patients showed no transmural fibrosis at all with thick layers of viable 
myocardium even in the core infarct region.
The current gold-standard in electrophysiology to define scars after MI is based on elec-
troanatomical voltage criteria. Mapping studies in a porcine model of healed myocardial 
infarction after chronic occlusion of the IRA revealed large, homogeneous areas of very 
low voltages surrounded by only a small scar borderzone.7 These very low voltage areas, 
arbitrarily defined as <0.5mV, are likely to reflect dense, transmural scar typical for chronic 
occlusion of the IRA without collateral circulation, whereas the surrounding borderzone 
may reflect non-transmural scar areas which are partly supplied by non IRAs. A similar 
pattern of a central homogeneous dense scar area surrounded by the EA borderzone was 
found in the majority of non-reperfused patients in this study.
Total infarct size defined as areas of electrograms <1.5mV was similar in reperfused and 
non-reperfused patients. However, acute reperfusion with a median symptom onset to bal-
loon/needle time of 3h30min does not completely abort myocardial infarction but resulted 
in non-transmural scars as confirmed by histology in a subgroup of patients and contributed 
to total infarct size using an EA cut-off value of <1.5mV.
Of importance, the total area of electrograms <0.5mV was significantly smaller and the 
scar borderzone defined by electrograms between 0.5 and 1.5mV significantly larger in 
reperfused patients which is in line with the histological findings demonstrating only non-
transmural scar in the majority of reperfused patients. 
In addition, reperfused patients had less confluent EA scar in which areas of lower volt-
age were frequently interspersed by areas that show relatively preserved or normal bipolar 
electrograms. These electrograms do not exclude intramural fibrosis as demonstrated by 
histology. The EA findings likely reflect an inhomogeneous distribution of viable myocar-
dium and fibrosis. Preserved voltage areas are more likely to contain predominantly viable 
myocardium interspersed by fibrous tissue whereas dense  EA scar likely reflects confluent 
areas of fibrosis containing only strands of viable cardiomyocytes (figure 3). 
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Arrhythmia	and	EA	scar
Precondition for scar related VT is slow conduction through narrow bundles of surviving 
myocytes bounded by fibrous tissue.14
VTCL is determined by circuit path length and conduction velocity. Increasing isthmus 
length contributes to circuit path length with consecutive longer VTCL.15 In a canine infarct 
model zones of slow conduction and lines of block, bordering the protected isthmus coin-
cided with areas where the borderzone of viable myocardium was thinnest and where the 
local gradient in borderzone thickness was maximal. In contrast, regions of fast conduction 
coincided with areas of thicker borderzones with minimal gradients.1, 16 
Tachycardia related slow conducting channels have been identified within dense EA scar 
areas in the majority of patients with monomorphic VT after AMI. The mean length of these 
channels was 23±11mm and the mean CL of the channel related VT was 365±77ms, similar 
to VLCL found in non-reperfused patients in our study.17 
The larger and confluent dense scar areas found in patients without reperfusion are 
more likely to contain longer protected slow conducting channels which may explain the 
observed longer arrhythmia CL.15 In contrast, in reperfused patients small areas of dense 
scars are interspersed with areas of preserved voltages and likely preserved conduction 
velocity referred to as patchy pattern. Small areas of dense scar and thicker infarct border-
zones may result in shorter isthmus length, faster conduction and therefore shorter VTCL. 
(example provided as online supplement)
Clinical	implications
The current study has demonstrated significant differences in the electroanatomical and 
histological substrate between early reperfused patients and patients with a chronically 
occluded infarct related artery. In addition, among post-AMI patients who underwent early 
reperfusion a shift seems to occur towards faster arrhythmias likely because of the reperfu-
sion induced change of the substrate. Previous studies providing insights into the underlying 
substrate of reentry circuits of VT and the importance of the scar borderzone were performed 
in patients with a chronically occluded IRA.
Currently RFCA of fast and unstable VT requires a substrate based approach that targets 
the borderzone of scar relying on voltage mapping and pace-mapping. This substrate based 
approach was validated in an animal model of chronic occluded IRA with large homoge-
neous electroanatomical scars surrounded by a small borderzone. The larger border zone in 
reperfused patients with only small areas of dense scar on mapping and histology, however 
may require a different mapping approach. Pace-mapping to define VT exit sites, might 
be less reliable or not applicable if pacing is performed within short protected isthmuses. 
Whether a ‘patchy pattern’ of EA scar after reperfusion will pose a challenge in substrate 
based mapping and ablation needs further evaluation. Studies in animal models that reflect 
the anatomical substrate in the reperfusion era are warranted to reevaluate the relationship 
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of the VT circuit and the architecture of the scar which might influence the concept of 
substrate based ablation.
Limitations
Reperfused patients accounted for one third of the studied population. These patients 
presented on average 7.7 years earlier than non-reperfused patients. There might be an 
ascertainment bias such as that the non-reperfused patients represent a subgroup of long 
term survivors. In addition, alterations in the anatomy of the VT substrate over time that may 
occur due to increased wall stress, ischemia, hypertension or medication, or due to gradual 
changes after infarct healing can not be excluded as potential confounders to the presented 
results. However, the difference in presentation time might reflect advances in recognition 
and reperfusion strategies of ST-segment elevation AMI in our patient population. The obser-
vational nature and relatively small sample size of the study limits the further identification 
of possible confounders. Since all patients in the current study were referred for ablation 
of VT, larger studies in a general population of patients after MI are warranted to further 
elucidate the effect of early reperfusion on arrhythmogenisis and characteristics of VTs.
All biopsies were taken from the central part of the infarcted area as identified by the 
surgeon. The scar areas were not resected completely, therefore small areas of transmural 
fibrosis in the core infarcted area in reperfused patients might be missed. In addition, trans-
mural biopsies were only available from the small subgroup of patients who underwent 
surgery. 
Conclusions
There are marked differences in EA scar size and pattern between patients with and without 
successful reperfusion at the time of myocardial infarction. Less confluent EA scars match 
with layer of surviving myocyte bundles on biopsy. Early reperfusion and less confluent 
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Aims: Substrate based ablation of ventricular tachycardia (VT) relies on electroanatomical 
voltage mapping (EAVM). Integration of scar information from contrast-enhanced magnetic 
resonance imaging (CE-MRI) with EAVM may provide supplementary information. This 
study assessed the relation between electrogram voltages and CE-MRI scar characteristics 
using real-time integration and reversed registration.
Methods and results: 15 patients without implantable cardiac defibrillator (14 male, 
64±9yr) referred for VT ablation after myocardial infarction underwent CE-MRI. Contours of 
the CE-MRI were used to create 3-dimensional surface meshes of the left ventricle (LV), aor-
tic root and left main stem (LM). Real-time integration of CE-MRI derived scar meshes with 
EAVM of the LV and aortic root was performed using the LM and the CARTO surface registra-
tion algorithm. Merging of CE-MRI meshes with EAVM was successful with a registration 
error of 3.8±0.6mm. After the procedure voltage amplitudes of each mapping point were 
superimposed on the corresponding CE-MRI location using the reversed registration matrix. 
Infarcts on CE-MRI were categorized by transmurality and signal intensity. Local bipolar and 
unipolar voltages decreased with increasing scar transmurality and were influenced by scar 
heterogeneity. VT reentry circuit isthmus sites were correlated to CE-MRI scar location. In 3 
patients VT isthmus sites were located in scar areas not identified by EAVM.
Conclusions: Integration of MRI derived scar maps with EAVM during VT ablation is 
feasible and accurate. CE-MRI identifies non-transmural scars and infarct gray zones not 
detected by EAVM according to currently used voltage criteria and may provide important 
supplementary substrate information in selected patients. 
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Catheter ablation is an important therapeutic option for recurrent ventricular tachycardia 
(VT) in patients late after myocardial infarction (MI).1 The majority of these patients are 
inducible for VTs not suitable for mapping during tachycardia.2, 3 Substrate based methods 
have been developed to identify ablation target sites during sinus rhythm.2, 4 These methods 
rely on the delineation of myocardial scar by electroanatomical voltage mapping (EAVM).
Contrast enhanced magnetic resonance imaging (CE-MRI) can be used to visualize the 
3-dimensional (3-D) geometry of myocardial fibrosis and is the gold-standard for detection 
of non-transmural scar.5, 6 Scar heterogeneity on CE-MRI based on signal intensity (SI) has 
been associated with spontaneous and inducible VT.7, 8 Furthermore, animal studies showed 
that CE-MRI defined scar geometry can predict the location of VT reentry circuits.9 Thus the 
integration of CE-MRI derived scar information with EAVM may provide important additional 
information to facilitate VT ablation procedures. Recently post MI scar areas delineated by 
CE-MRI have been shown to correspond with scar areas defined by EAVM. In two studies 
different voltage cut-off values were reported to discriminate between the presence and 
absence of scar based on a post-procedural image comparison.10, 11 However, a single volt-
age cut-off value for the presence of scar may not reflect the complex scar architecture and 
its use may not result in accurate delineation of non-transmural scar and infarct gray-zones. 
The purpose of the present study was (1) to show the feasibility and accuracy of real-
time integration of CE-MRI derived scar maps and EAVM in post MI patients. Mapping was 
performed with emphasis on scar borderzone, non-transmural infarcts and gray-zones as 
assessed by CE-MRI. Then (2), using a post-procedural process bipolar and unipolar voltages 
of each mapping point were compared to scar transmurality and SI of the corresponding 
CE-MRI segment. Finally (3) the correlation between VT reentry circuit isthmus sites and 
CE-MRI scar locations was determined.  
Methods	
Fifteen consecutive patients referred for catheter ablation of sustained monomorphic VT 
late after MI without contra-indication for MRI were studied. In 3 patients the indication for 
ablation was VT that could not be controlled by antiarrhythmic drugs. In 12 patients with 
a reasonably preserved ejection fraction RF ablation procedure was offered as an alterna-
tive for amiodarone therapy or ICD implantation. Informed consent was obtained from all 
patients. No ethical committee approval was obtained as all performed procedures were 
part of the routine clinical protocol applied at the Leiden University Medical Center. 
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MRI	acquisition	and	processing
MRI was performed on a 1.5 T Gyroscan ACS-NT/Intera MR system (Philips Medical Systems, 
Best, The Netherlands) with patients positioned in the supine position. A standardized clini-
cal cardiac MRI protocol was followed, including cine MR imaging in long-axis (2-chamber 
and 4-chamber view) and short-axis orientation covering the complete left ventricle. In 
addition, the proximal aorta including the ostium of the left main coronary artery (LM) 
and the right coronary artery was imaged in a stack of cross-sectional slices using a black 
blood TSE sequence. Contrast-enhanced (CE) images were acquired 15 minutes after bolus 
injection of gadolinium using an imaging protocol as described previously.8 The heart was 
imaged in one breath-hold with 20-24 imaging levels (dependent on heart-size) in short-axis 
and long-axis views. Images were acquired 600-700ms after the R-wave on surface ECG. 
Image analysis was performed using in-house developed software (Mass research soft-
ware, V2008-EXP). In the aorta image series contours were traced describing the lumen 
of the aorta and the centerline of the LM and the proximal right coronary artery. In the CE 
short-axis image series, LV endocardial, LV epicardial and right ventricular (RV) endocardial 
contours were manually traced (figure 1, A). Myocardial tissue with a signal intensity (SI) 
value ≥35% of the maximum SI within the infarct region was considered scar. The infarct 
core was defined as myocardium with a SI≥50 and infarct gray zone as myocardium with 
SI≥35% but SI<50% of the maximum SI (figure 1B).8 Transmurality of scar was computed for 
every location for different layers within the LV myocardium. Subsequently, the LV anatomy 
as described by the endocardial and epicardial contours was converted into 3D mesh 
files that could be imported into the CARTO system (Biosense Webster, Cordis-Webster, 
Johnson&Johnson, Diamond Bar, California). 3D meshes were constructed by converting 
the traced myocardial and aorta contours into 3D coordinates, based on the 3D spatial loca-
tion and pixel size of the MR images. Assuming minimal patient motion between the various 
MR sequences, the generated meshes are spatially aligned in the same coordinate system of 
the MR scanner. A triangularization approach was followed to obtain a surface description 
of the myocardial walls and the luminal surfaces of the aorta and coronary arteries suitable 
for importing and visualization with the mapping system.
 The vertices of the endocardial and epicardial surface mesh were color coded with the 
degree of transmurality for the inner and outer half of the LV wall, respectively. Meshes 
without color-coding were generated of the anatomy of the RV endocardial surface, the 
proximal aorta and the proximal segments of the left main and right coronary artery (figure 
1).
Prior to the ablation procedure all meshes were imported into the CARTO system using 
pre-commercial CARTO-Merge (IPE) software enabling the registration and fusion of mul-
tiple, separate datasets. 
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All patients underwent electrical programmed stimulation and EAVM in the post absorptive, 
non-sedated state. Antiarrhythmic drugs were discontinued for 5 half-lives. The protocol 
consisted of 3 drive-cycle lengths and up to 3 extrastimuli from 2 RV sites and burst pacing. 
The positive endpoint of stimulation was induction of a sustained monomorphic VT lasting 
for >30s or requiring termination because of hemodynamic compromise. 
Figure	1.	Preprocedural processing consisted of drawing endo- and epicardial ventricular contours 
using the short axis CE-MRI slices (panel A), defining intensity and transmurality of scar  (yellow= 
gray-zone, red= core infarction, panel B) and creating color coded endocardial (panel C&E) and 
epicardial (panel D&F) surface meshes. Panels C&D show coding for percentage of transmurality 




EAVM (CARTO XP) was performed during sinus- or paced rhythm. Using a 3.5mm tip, irri-
gated mapping catheter (NaviStar ThermoCooled, Biosense Webster Inc, Diamond Bar, CA, 
USA) and a retrograde approach a voltage map of the aortic root was created. Electrograms 
were filtered at 30-400Hz(bipolar) and 1-240Hz(unipolar). The catheter was positioned in 
the left coronary cusp and carefully advanced towards the LM. The position at the ostium 
was confirmed by undiluted contrast injection through the mapping catheter. The mapping 
catheter was flushed with saline directly after contrast injection. Secondly a voltage map 
was created of the LV. Bipolar voltages <1.5mV were considered abnormal and bipolar 
voltages <0.5mV dense scar.4, 12 The pre-acquired MRI derived meshes were integrated with 
the EAVM. A landmark was set at the ostium of the LM on EAVM and MRI mesh. The maps 
were visually aligned using the location of the LM to overcome rotation errors. Subsequently 
the surface of the Aortic and LV maps were automatically aligned with the meshes using 
CartoMERGE software (figure 2). Distances between EAVM and MRI derived maps includ-
ing the LM ostium were calculated to evaluate the registration accuracy. After registration 
additional mapping points were acquired in areas with a mismatch between EAVM and 
MRI derived mesh at the EA scar borderzone and at areas with non-transmural scar and 
gray-zones as assessed by CE-MRI. The location and extent of scar surface on EAVM using 
a cut-off value of 1.5mV was measured using the software provided with the system and 
compared with the scar distribution on MRI derived maps. 
Figure	2.	During the procedure 3-D CE-MRI derived meshes (purple represents scar, green 
represents normal myocardium) were integrated with the electroanatomical voltage maps (color-
coding as in the colorbar). After the procedure color-coded mapping points were superimposed on 








A VT reentry circuit isthmus site was defined by activation and entrainment mapping for 
tolerated VT or by pace-mapping (≥11/12 lead match between VT-QRS and paced-QRS 
morphology and stimulus-to-QRS interval >40ms) for poorly tolerated VTs.1 All isthmus 
sites were tagged on the EAVM and evaluated with respect to scar distribution as assessed 
by CE-MRI. All inducible monomorphic VTs were targeted and radiofrequency energy was 
applied if a potential isthmus site could be identified. 
Comparison	of	electroanatomical	voltagemaps	and	contrast	enhanced	
MRI
Post-procedural processing was performed in all cases. The registration matrix, mapping 
point coordinates and bipolar and unipolar voltages were exported from the CARTO system. 
Using the reverse registration matrix and point coordinates voltage data were superimposed 
on the corresponding CE-MRI slice (Mass research software, V2008-EXP) (figure 2). 
To enable the assessment of voltages corresponding to different types of CE areas each 
short-axis MRI slice was divided into 20 segments. Segments were subdivided into four 
layers (0-25%, 25-50%, 50-75% and 75-100% transmurality). Each layer was automatically 
coded as core infarct, infarct gray-zone or normal myocardium based on the mean SI. Based 
on the characteristics of the 4 layers each segment was assigned to one of 13 subcategories 
discriminating between location (sub-endocardial, sub-epicardial or mid-wall), transmural-
ity (0%, 25%, 50%, 75% or 100%) and SI (normal, gray-zone or core infarct) of CE scar 
Figure	3.	Schematic of the categorization of short axis CE-MRI segments. Panel A shows potential 
contrast enhancement patterns with regard to transmurality and signal intensity (SI) in different 
segments. Panel B shows the corresponding coding according to transmurality and SI (yellow= 
gray-zone, red= core infarction). 
108
(figure 3). The bipolar and unipolar voltages of each mapping point were combined with the 
scar code of the CE-MRI segment at the corresponding location for analysis. 
Statistical	Analysis
Continuous variables are expressed as mean±SD or median(interquartile range) when 
appropriate, and categorical variables as frequency(%). Statistical analysis was performed 
using SPSS, version 16.0(SPSS, Inc., Chicago). Mann Whitney U-test was used to compare 
voltages between different CE-MRI segment categories. All tests were two-tailed and a 
p-value ≤0.05 was considered significant.
RESULTS
Patient	Population
Fifteen patients (14 male, 64±9 years) were studied. Patient characteristics are summarized 
in table 1.
Delayed	Enhancement	MRI
MRI findings are listed in table 2. The mean LV ejection fraction was 44±10%. All patients 
had evidence of scar tissue on CE-MRI. The infarct was located at the anterior wall in 3(20%), 
the inferior wall in 9(60%) and the lateral wall in 3(20%) patients. The endocardial surface 
of segments with transmural infarction (core infarct and infarct gray-zones) was 12±13cm2 
(7.7±7.3% of the total surface) and of sub-endocardial and transmural infarctions 33±20cm2 
Table	1.	Patient characteristics at the time of referral for radiofrequency catheter ablation
Age 64±9
Male gender (%) 14 (93)
Time after myocardial infarction (year) 14±12
VT cycle length (ms) 341±76
Drugs
   Amiodarone  (%) 0
   Sotalol (%) 1 (7)
   Beta-Blocker (%) 14 (93)
   Class I antiarrhythmic drugs (%) 1 (7)
   ACE-I/AT-2 antagonist (%) 13 (87)
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(23±11% of the total surface). Segments with intramural or sub-epicardial scar accounted 
for 1.0±0.91cm2 (0.74±0.63%) of the total surface. 
3-D	electroanatomical	voltage	mapping	and	image	integration
Determination of the location of the LM ostium was uncomplicated in all patients. After 
contrast injection no dysfunction or obstruction of the mapping catheter was observed. 
Endocardial voltage maps of the aortic cusps and LV were obtained in all patients. The mean 
number of LV points was 255±43. The imported MRI meshes were successfully merged with 
the aortic and LV maps with a mean surface registration error of 3.83±0.57mm. After registra-
tion the position error between the LM on EAVM and MRI derived mesh was 4.64±3.58mm. 
EAVM findings and registration data are summarized in table 3.
Electrical infarct localization (bipolar electrograms <1.5mV) corresponded to infarct 
localization on CE-MRI (≥25% transmurality) in all patients. The mean endocardial surface 
area of scar was 30±21cm2 as determined by EAVM (<1.5mV) and 33±20cm2 as determined 
by CE-MRI (correlation R=0.91). 
However, despite this correlation visual analysis showed a clear mismatch between 
EAVM scar areas and MRI maps in particular in 5(33%) patients with inferior MI. In these 
patients scar areas on MRI were larger than scar areas delineated by EAVM. Of importance, 
all scar areas not detected by EAVM were non-transmural on CE-MRI (transmurality <75%). 
Examples are provided in figure 4.
Table	2.	Results of MRI studies
LV ejectionfraction (%) 44±10
LV end diastolic volume (ml) 232±71
LV end systolic volume (ml) 133±59
LV Mass (g) 140±43
Contrast enhanced mass (g) 26±20
Endocardial surface (cm2) 134±29
Transmural scar (% of surface) 7.7±7.3
Subendocardial and transmural scar (% of surface) 23.0±11.0
Subepicardial and midwall scar (% of surface) 0.7±0.6
Localization contrast enhancement
   Anterior wall 3 (20)
   Inferior wall 9 (60)
   Lateral wall 3 (20)
LV indicates left ventricle; CE, contrast enhancement. Data are expressed as mean±SD.
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Mapping	and	ablation	of	VTs		
A total of 26 sustained monomorphic VTs with a cycle length of 305±85ms was induced in 
13 patients (1.9±1.0 VTs/patient). In 2 patients no sustained VT was inducible. A VT isthmus 
site could be identified and successfully targeted within an endocardial low voltage area 
corresponding with scar on MRI for 16 VTs in 9 patients. In the remaining 4 patients no 
endocardial ablation target site could be identified. In 3 the earliest activation during VT 
or best matching pacemap was at a normal voltage site (>1.5mV). However, at these sites 
CE-MRI identified sub-endocardial septal scar in 1 and intramural inferoseptal scar in 2 
pts. Based on the mapping and CE-MRI findings epicardial mapping was performed in the 
latter with successful identification of an epicardial ablation target site. In one patient with 
a poorly tolerated VT no endocardial pace match could be obtained, a mid septal area of 
CE identified in this patient aswell. RFCA abolished all inducible VTs in 9, the clinical docu-
mented VT in 1 and none of the clinical VTs in 3 patients. In 2 patients ablation failed likely 
to the fact that there was an intramural septal reentrant circuit which was consistent with 
the finding of contrast enhancement at this location. In one epicardially mapped patient no 
ablation was performed since the ablation target site was mapped to the close vicinity of the 
epicardial right coronary artery. 
Ten patients received an internal cardiac defibrillator including those in whom ablation 
failed to abolish all VTs. The median follow-up after ablation was 19 (3 –27) months during 
which 5 patients experienced recurrent VT. 
Table	3.		3-D Electroanatomical mapping and image integration 
Mean points Aorta map 25±11
Mean points LV map 255±43
Total points LV maps 3023
Points with bipolar voltage<1.5mV  1180(39)
Localization low voltage area
   Anterior 3 (20)
   Inferior 9 (60)
   Lateral 3 (20)
Distance EAVM points to MRI mesh surface
   Mean (mm) 3.83 ±0.57
   Standard Deviation (mm) 2.61±0.49
   Minimum (mm) 0.04±0.04
   Maximum (mm) 14.2±3.36
Distance LM EAVM to MRI mesh (mm) 4.64±3.58
LV indicates left ventricle; EAVM, electroanatomical mapping; MRI, magnetic resonance imaging. 
LM, left main coronary artery. Data are expressed as mean±SD or frequency(%)
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Voltages of each mapping point were compared to the CE characteristics of the corre-
sponding segment. 1533(51%) of mapping points were allocated at a segment without CE, 
1343(44%) mapping points at a segment with sub-endocardial (684(23%)) or transmural 
(657(22%)) CE and 112(4%) of mapping points at a segment with mid-wall or sub-epicardial 
Figure	4.	Representative examples of a patient in whom CE-MRI derived mesh matched the EAVM 
(panel A, B) and of a patient with additional scar-areas identified by CE-MRI not detected by EAVM 
(panel C, D). Panels A and C show the bipolar voltage maps (color-coding as in the colorbar) and 
corresponding endo- and epicardial MRI derived surface meshes coded for transmurality (purple 
represents scar, green represents normal myocardium). Panels B and D show a representative long 
axis CE-MRI slice with superimposed mapping point locations (mapping point bipolar amplitudes 
are color coded as in voltage maps). 
112
Figure	5.	Panel A: median bipolar voltage of points located at short axis CE-MRI segments coded 
for transmurality and SI of scar. The number of mapping points allocated at each of the 9 segment 
categories is provided under the X-axis. The p-value of differences (Mann Whitney U-test) between 
bipolar voltages of each category is displayed. Panel B displays the distribution of points for each 
segment category according to the current used cut-off values in bipolar voltage mapping (≤0.5mV, 
>0,5mV - ≤1.5mV and >1.5mV). Panel C displays the mean bipolar voltage and distribution of points 
at segments with epicardial and mid-wall scar. 
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CE. The median bipolar voltage at segments with normal myocardium was 3.2mV(1.8-
5.1mV). Endocardial bipolar electrogram amplitudes for the core infarct and infarct gray-
zone decreased significantly with increasing scar transmurality. The median bipolar voltages 
for segments with a sub-endocardial to transmural core infarct were 2.2mV(1.1-2.5mV), 
1.5mV(0.9-2.2mV), 1.1mV(0.6-1.7mV) and 0.8mV(0.4-1.3mV) for 25%, 50%, 75% and 
100% scar transmurality, respectively. For infarct gray-zones median bipolar voltages were 
2.2mV(1.3-3.3mV), 1.7mV(0.8-2.4mV), 1.5mV(0.7-2.5mV) and 1.0mV(0.6-2.1mV) for 25%, 
50%, 75% and 100% scar transmurality, respectively (figure 5). The mean unipolar voltage 
was 11.5mV(8.0-15.1mV) at normal segments and decreased significantly with increasing 
scar transmurality for core infarct and infarct gray-zone. Segments with sub-epicardial and 
midwall scars between 25% and 75% transmurality showed reduced bipolar and unipolar 
electrogram voltage (figure 5, 6).
Although bipolar and unipolar electrogram amplitudes were an effective parameter to 
differentiate between segments of different scar transmurality there was an important over-
lap between groups. A median bipolar voltage <1.5mV was only found in segments with 
≥75% core infarct transmurality and transmural gray-zone infarction.
Figure	6.	Panel A: median unipolar voltage of points located at short axis CE-MRI segments coded 
for transmurality and SI of scar. The number of mapping points allocated at each of the 9 segment 
categories is provided under the X-axis. The p-value of differences (Mann Whitney U-test) between 
mean unipolar voltages of each category are displayed. Panel B: median unipolar voltage of points 
at segments with epicardial and mid-wall scar.
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Discussion
The current study is the first to evaluate the relation between the 3-D geometry of scar and 
local electrogram voltages using real-time integration and reversed registration of EAVM and 
CE-MRI in humans. The main findings of this study are: (1) Real-time registration of CE-MRI 
derived scar information including scar transmurality and heterogeneity and EAVM data 
during catheter ablation of post-MI VTs is feasible and accurate; (2) Endocardial bipolar 
and unipolar electrogram amplitudes decrease with increasing scar transmurality and are 
also influenced by scar heterogeneity as quantified by signal intensity; (3) The current used 
bipolar electrogram cut-off value of 1.5mV can not fully delineate non-transmural scar, 
small sub-epicardial scar and infarct gray-zones as identified by CE-MRI. 
Imaging	derived	scar	information	and	EAVM
Surviving myocyte bundles embedded in fibrous tissue are the substrate for reentrant VT 
in patients after MI. Identification of scar is of importance in substrate based ablation 
approaches for unstable VT.2, 4 CE-MRI allows detection of small scars and characterization 
of infarcts by differentiating the core infarct and infarct gray-zones which extend has been 
associated with inducible and spontaneous VT.6-8 
Scar geometry is also an important determinant for conduction properties. The infarct 
borderzone thickness and the local thickness gradient could predict the location of VT 
reentry circuit isthmuses in a canine model.9 Thus, scar information derived from CE-MRI 
has the potential to improve substrate based ablation.
The currently used gold-standard in electrophysiology to define scar relies on EAVM. 
Two prior studies have compared CE-MRI data with EAVM in post MI patients. In a post 
hoc analysis, a good correlation between scar areas on CE-MRI and EAVM was reported 
using cutoff values of 1.3mV and 1.54mV for bipolar and 5.5mV and 6.52mV for unipolar 
voltages, respectively.10, 11 Mismatches between the presence of scar defined by EAVM and 
CE-MRI found in both studies were thought to be due to the lack of high density mapping at 
the scar borderzone and poor catheter contact.
Real-time	integration
Real-time integration of CE-MRI derived scar information achieved in the current study 
facilitated high density mapping at the EA scar borderzone and at areas with a mismatch 
between scar areas on EAVM and CE-MRI. The good registration accuracy prevented delin-
eation of false positive low voltage areas due to poor catheter contact. 
Integration of CE-MRI derived data with EAVM was automatically performed with a mean 
position error of <4mm. This accuracy is in line with studies using CT imaging.13, 14 In 
contrast to prior studies in which the position of LV apex, mitral annulus and aorta were used 
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for registration we tagged the position of the LM ostium. The advantage of using the LM and 
endocardial surface registration is that it precludes rotation errors.15
After image integration and delineation of the EA borderzone we found a good correla-
tion between the surface of scar measured by EAVM using a cutoff value of 1.5mV and 
scar surface area derived from CE-MRI. However, visual analysis showed a clear mismatch 
between scar areas defined by EAVM and the area of scar coded on the CE-MRI meshes. 
CE-MRI scar areas were larger in 33% of the patients. Insufficient mapping density was 
excluded as a cause of the mismatch by acquiring additional mapping points in these areas 
after image integration. 
The surface of low voltage areas was measured using the CARTO software. This software 
sums the surface of all individual triangles between mapping points. Therefore the total 
surface increases with the number of mapping points that are not located in the same plane. 
Comparing the absolute endocardial scar surface calculated by using the CARTO system 
with the scar surface measured by the endocardial contours on CE-MRI might therefore be 
inaccurate. 
Reversed	registration
The newly proposed technique of reversed registration allowed a head-to-head comparison 
of voltage data and CE-MRI characteristics independent of surface measurements.
Bipolar and unipolar electrogram amplitudes significantly decreased with increasing 
scar transmurality for core infarct and infarct gray-zones. A similar correlation between 
decreasing bipolar voltages and increasing scar transmurality assessed by histology was 
demonstrated in a dog model of MI.16 For segments with ≥75% scar transmurality bipolar 
electrograms were also significantly influenced by scar density defined by SI. Interestingly, 
the only segments with a median bipolar voltage <1.5mV were segments coded as ≥75% 
transmural core and completely transmural gray-zone infarction (figure 5). 
This finding is in line with prior animal studies as transmural scars are the prevailing 
type of scar found in pigs after MI in which the cut-off value of 1.5mV was validated.12 In 
the current study performed in patients with a relatively preserved LV function, however 
transmural scars accounted for only 7.7% of the total endocardial surface. Forty-four per-
cent of all mapping points located at a scar area were allocated to a segment with <75% 
transmural core or infarct gray-zone. The variation in number, size and geometry of surviving 
myocyte bundles in non-transmural and inhomogeneous scar are likely to influence local 
electrogram amplitudes.
Accordingly, non-transmural and inhomogeneous scars showed significant higher bipo-
lar and unipolar voltages contributing to the mismatch between EAVM and CE-MRI derived 
scar maps after image integration and visual comparison.
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The total sub-endocardial surface of segments with only mid-wall or sub-epicardial scar 
was small, which might be expected in a post-MI population. 
Defining a voltage cut-off value for the presence of scar, based on real-time image inte-
gration like suggested by others10, 11, 13 is appealing. However, due to the demonstrated 
complex relation between local electrogram amplitudes and scar characteristics a single 
cut-off value can not discriminate between the presence or absence of infarct scar at a 
particular location, because voltage is dependent on infarct transmurality and heterogeneity.
Reentry	circuit	isthmus	sites	and	scar	characteristics
It has been demonstrated that in patients with hemodynamically tolerated VT the majority 
of successful ablation sites was located in the EA scar borderzone using a cut-off value of 
1.5mV. However, some ablation sites were located within normal myocardium as defined 
by EAVM.17
More recently, Desjardins reported that VT isthmus sites, the majority identified by 
pace-mapping, had a mean bipolar voltage of 0.6±0.9mV and corresponded to core infarct 
regions or transmural gray-zones on CE-MRI using post-procedure image integration. Of 
importance, for one third of the induced VT no isthmus could be identified.10 
In the current study we were unable to identify a VT reentry isthmus site within a low 
voltage area in 4 patients. However, in 3 patients successful identification of an ablation 
target site was guided by CE-MRI derived scar information showing non-transmural scar 
leading to pace-mapping in a normal voltage area in one and an epicardial ablation attempt 
in 2 patients.
Clinical	implications
Real-time integration of CE-MRI derived scar maps and EAVM is feasible and accurate. Of 
importance, all CE-MRI information including the location of intramural and non-transmural 
scar and of the core infarct and infarct gray-zone not detectable by EAVM can be visualized 
during the ablation procedures. This might have important implications for substrate based 
ablation procedures in particular in patients, in whom variation in collateral circulation and 
early reperfusion strategies have resulted in inhomogeneous and non-transmural infarction. 
The technique of reversed registration as described in this study may also provide more 
insights into the spatial relationship between VT reentry circuit sites and scar characteristics 
on CE-MRI as successful ablation sites can be superimposed on the CE-MRI. 
Limitations
The studied population consisted of post MI patients without contraindications for MRI 
study. The routine use of MRI in implantable cardioverter defibrillator (ICD) carriers is not 
considered safe and currently limits the application of the described methods. The increas-
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ing availability of ‘MRI-safe’ implantable defibrillators in the near future may however make 
the use of MRI derived information during RFCA applicable to a larger population. 
The sample size of the patient population included in this study was relatively small. 
Further studies in larger groups of patients are warranted to further study the supplemental 
value of the integration of MRI derived scar information during VT ablation.
Conclusions
Real-time integration of CE-MRI derived scar information including scar transmurality and 
heterogeneity and EAVM data during catheter ablation of post-MI VTs is feasible and accu-
rate. 
Electrogram voltages decrease with increasing scar transmurality and are also influenced 
by scar heterogeneity. The current used bipolar voltage cut-off value of 1.5mV seems to 
be appropriate to delineate transmural scar. However, local bipolar and unipolar voltages 
alone are not sufficient to characterize the complex 3-D scar geometry. Merging CE-MRI 
derived information with EAVM provides supplementary substrate information in particular 
for non-transmural and heterogeneous infarction.
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Background: Epicardial catheter ablation (CA) for ventricular arrhythmias (VA) is limited 
by the presence of coronary arteries and epicardial fat. This study aimed to evaluate the 
feasibility and accuracy of real-time integration of multi-detector computed tomography 
(MDCT) derived coronary anatomy and fat distribution and its impact on electroanatomical 
mapping (EAM) and ablation. 
Methods and Results: Twenty-eight patients (21 male, 59±16yr) underwent combined 
endo-epicardial EAM. Prior to the procedure, MDCT derived coronary anatomy and epi-
cardial fat meshes were loaded into the EAM system (CARTO™). Real-time registration of 
MDCT data was performed after endocardial EAM. The distance between epicardial abla-
tion target sites and coronary arteries was assessed by registered MDCT and angiography. 
After the procedure, mapping and ablation points were superimposed on the MDCT using 
a reversed registration matrix for head-to-head comparison of mapping data and local fat 
thickness. Image registration was successful and accurate (surface error 2.8±1.3mm). Forty-
six VA were targeted; 25(54%) were abolished by CA, in 21(46%) ablation failed. In 5 VA 
no target site was identified and in 3 adhesions prevented mapping. In 2 VA ablation was 
withheld due to His-bundle vicinity and in 7 due to proximity of coronary arteries. In 4 
VA CA was ineffective. At ineffective ablation sites epicardial fat was significantly thicker 
compared to successful sites (16.9±6.8mm [range 7.3-22.2mm] and 1.5±2.1mm [range 
0-6.1mm], p<0.001). 
Conclusion: Real-time image integration of pre-acquired MDCT information is feasible 
and accurate. Epicardial fat of >7mm and the presence of coronary arteries are important 









Epicardial electroanatomical mapping (EAM) followed by radiofrequency catheter ablation 
(RFCA) for ventricular arrhythmia (VA) is an important therapeutic option in patients after 
endocardial ablation failure. Despite the presence of a subepicardial substrate epicardial 
EAM and ablation may have important limitations. Bipolar voltage mapping might not be 
accurate to delineate subepicardial scar and is likely to overestimate its extent as even thin 
layers of epicardial fat attenuate bipolar electrogram amplitudes.1-3 
Once a potential ablation target site (TS) has been identified, delivery of RF energy needs 
to be withheld in the vicinity of coronary arteries, usually visualized by repeated coronary 
injections, or may be ineffective due to the thickness of epicardial fat which presence 
can only be assumed when irrigated tip ablation is ineffective.1,4 Cardiac multi-detector 
computed tomography (MDCT) can reliably visualize both coronary arteries and epicardial 
fat.5,6 Accurate real-time integration of MDCT derived coronary anatomy and fat distribution 
during the ablation procedure is therefore desirable.
The purpose of this study was (1) to evaluate the extent and distribution of epicardial fat 
in patients undergoing combined endo-epicardial mapping and ablation, (2) to assess the 
feasibility and accuracy of real-time integration of MDCT derived coronary anatomy and 
epicardial fat distribution with EAM, (3) to determine the influence of epicardial fat thickness 
on bipolar and unipolar voltage and ablation outcome and (4) to evaluate the potential use 
of the integrated MDCT to identify inappropriate ablation sites. 
Methods
Patients	and	baseline	evaluation
The study population consisted of 28 consecutive patients (21 male, 59±16 years) scheduled 
for combined endo-epicardial EAM and RFCA for drug refractory VA because of previous 
endocardial ablation failure (n=24) or a high suspicion for an epicardial substrate based 
on ECG criteria (n=4).7-9 No ethics committee approval was necessary as all performed 
procedures were part of routine clinical protocol. Informed consent was obtained from 
all patients. Prior to the procedure all patients underwent transthoracic echocardiography. 
When considered necessary, magnetic resonance imaging and/or nuclear imaging were 
performed to assess the presence of structural heart disease. 
Pre-procedural	MDCT	acquisition	and	processing
Patients underwent cardiac MDCT prior to EAM. The MDCT data were analyzed using MASS 
software (V2009-EXP LKEB, Leiden, The Netherlands). The aortic, endocardial, pericardial 
and epicardial contours and proximal coronary arteries were manually traced (Figure 1A). 
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The distance between the epicardial and pericardial contours was computed to assess fat 
thickness. A bull’s eye reconstruction of the epicardial surface was created and divided 
into 8 equal short-axis and 3 long-axis segments (Figure 1B).5 For each segment the mean 
epicardial fat thickness was calculated. 
Contours were converted into 3D meshes and imported into the EAM system (CARTO-
XPtm, Biosense Webster Inc, Diamond Bar, CA, USA). The epicardial surface meshes were 
color coded according to fat thickness (Figure 1C). In addition, the original MDCT data 
were loaded into the CARTO system and cardiac structures were segmented (Figure 1D). All 
meshes and segmented images were merged to a final fusion image (FFI) using CARTOMerge 
(IPE) software (Figure 1E). 
Figure	1.	Panel A: Multi-detector computed tomography (MDCT) short axis slice with 
pericardial (green) and epicardial (red) contours divided into 8 segments A-H. Panel B: Bull’s eye 
reconstruction (8 equal short axis segments A-H and 3 equal long axis segments) of the epicardial 
surface color coded for fat thickness according to the color bar. Panel C: 3D epicardial surface 
mesh color coded for fat thickness according to the color bar. Panel D: MDCT derived anatomical 
structures segmented using the CARTO system. Panel E: Final fusion image. The epicardial fat 
meshes (color coded for fat thickness as indicated) merged with the segmented MDCT images. 
Cx=circumflex coronary artery, D1=first diagonal coronary artery, LAD=left anterior descending 









Electrophysiological evaluation included programmed electrical stimulation and endo-
epicardial EAM. The stimulation protocol consisted of 3 drive-cycle lengths (600, 500 and 
400ms) with up to 3 ventricular extra stimuli at 2 RV sites and burst pacing, with and without 
isoproterenol (2-10µg/min). Positive endpoint for stimulation was induction of a sustained 
monomorphic VA lasting for >30s or requiring termination because of hemodynamic 
compromise. Anti-arrhythmic drugs were discontinued for at least 5 half-lives except for 
amiodarone (n=7).
Electroanatomical	mapping	and	real-time	image	integration
Pericardial access was established through a subxiphoid puncture (n=26) or by a surgical 
subxiphoidal window in case of pericardial adhesions (n=2).10 Limited EAM of the aortic 
root was performed with a 3.5mm, irrigated-tip catheter (NaviStar ThermoCooled, Biosense 
Webster Inc, Diamond Bar, CA, USA) using the CARTO system. The mapping catheter was 
positioned in the ostium of the left main artery (LM) confirmed by undiluted contrast injec-
tion through the mapping catheter and the position was tagged on the map.11 Secondly, an 
endocardial EAM of the LV and/or RV was created. Electrograms were filtered at 30-400Hz 
(bipolar) and 1-240Hz (unipolar). Bipolar voltages <1.5mV were considered abnormal and 
bipolar voltages <0.5mV dense scar.12 Next, the MDCT-derived images were integrated with 
the EAM.	The images were visually aligned using the location of the LM as a landmark for 
registration. Subsequently, the surfaces of the LV or RV were automatically aligned using 
CARTOMerge software. After surface registration the position of the LM was used to assess 
rotation errors.11,13 Distances between the EAM and the FFI including the LM were calcu-
lated to evaluate registration accuracy. 
Identification	of	ablation	target	sites
In idiopathic VA LV, RV, aortic sinus and/or coronary venous system activation mapping was 
performed. If no TS could be identified, the potential epicardial TS was predicted based on 
the spatial distribution of earliest local activation time.14 The local epicardial fat thickness 
and vicinity of coronary arteries was assessed prior to epicardial mapping (Figure 2A).
For scar-related VA TS were selected based on activation and entrainment mapping for 
tolerated VA. For non-tolerated VA, TS were identified guided by pace-mapping (≥11/12 
lead match between VA-QRS, stimulus-to-QRS interval >40ms) and/or the presence of late 
potentials (potentials separated by an isoelectric segment >20ms and inscribing after QRS).
Epicardial	mapping	and	ablation
For idiopathic VA limited epicardial voltage mapping was performed, followed by detailed 
activation mapping of the predicted TS. In scar related VA, a regional epicardial voltage map 
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was created of the target area. Ablation TS were defined as for the endocardium and tagged 
on the epicardial map. 
Before epicardial ablation, the vicinity of major coronary arteries branches was estimated 
on the FFI and categorized into 3 categories (<5mm, 5-15mm, >15mm). Subsequently, coro-
nary angiography (LAO45°, RAO30°) was performed and the distance between catheter tip 
and coronary artery was evaluated on fluoroscopy using the length of the distal electrode 
pair (6.7mm) and tip-proximal-electrode distance (14.9mm) as a visual reference (Figure 3).	
The distance between the catheter tip and major coronary artery branches on the FFI and on 
fluoroscopy were compared to further evaluate the registration accuracy. If TS were in close 
proximity to a major branch additional injections were performed to confirm the accuracy 
of spatial relation as measured on the FFI.	 Ablation was usually withheld at TS with an 
estimated distance <5mm. High out put pacing (10mA, 2ms) was performed to determine 
the location of the phrenic nerve, if appropriate. 
Radiofrequency energy was applied at 30-45W (maximum temperature 45ºC, flow 
20-30ml/min, 60s) for endocardial sites and up to 50W (flow 20ml/min) for epicardial sites. 
A successful ablation site was defined as the site where RF energy abolished the VA. In case 
the VA remained inducible after RF energy was applied, the ablation site was considered 
non-successful. The endpoint of the procedure was non-inducibility of any VA, inability to 
identify TS or TS locations that prevented or did not allow effective RF delivery.
Figure	2.	Electroanatomical activation map (EAAM) of an idiopathic ventricular arrhythmia and 
image integration. Panel A: Endocardial EAAM of the left ventricle (LV), right ventricle outflow tract 
(RVOT), aorta (Ao) and great cardiac vein (GCV). Similar activation time of the LV, RVOT and GCV 
was observed. The final fusion image (FFI) was registered with the endocardial EAAM, using the 
left main artery (LM) (right). The white triangle demonstrates the predicted epicardial target site 
in the vicinity of the left anterior descending artery (LAD), covered by >4mm fat. Panel B: Limited 
epicardial EAAM confirmed the earliest activation within the predicted site not suitable for ablation. 









After the procedure, epicardial mapping points and the registration matrix were exported 
from the CARTO system and superimposed on the original MDCT (Figure 4A). Bipolar and 
unipolar voltages were correlated to epicardial fat thickness using only mapping points 
at sites with no evidence for scar on imaging. Mapping points were grouped into three 
predefined categories according to epicardial fat thickness (0mm, >0≤4mm and >4mm fat).4 
To investigate the impact of epicardial fat on ablation outcome, fat thickness at successful 
and non-successful ablation sites was compared. In case of linear lesions, the average fat 
thickness was used.
Figure	3.	Registration accuracy in 2 patients comparing the distance between the catheter tip and 
coronary arteries on integrated multi-detector computed tomography (MDCT) images and coronary 
angiography in a right (RAO) and left (LAO) anterior oblique view. Upper panel: limited activation 
mapping identified a target site located on the left anterior descending artery (LAD) on both MDCT 
and angiography. Lower panel: the target site (based on pace-mapping) was located <7mm from 
the right coronary artery (RCA) confirmed by angiography. (for	figure	in	color	see	page:	260)
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Figure	4.	Panel A: Reversed registration of epicardial mapping points projected on the 
corresponding multi-detector computed tomography (MDCT) location of three sequential short axis 
images. Points are color coded for bipolar voltage (color bar). Panel B: Median bipolar voltage of 
epicardial mapping points according to the 3 predefined epicardial fat thickness categories. Panel 
C: Distribution of epicardial mapping points for each epicardial fat thickness category according to 
the currently used cut-off values for bipolar voltage mapping. Panel D: Median unipolar voltage of 









After discharge, patients were followed regularly at our outpatient clinic. Implantable car-
dioverter defibrillator interrogation was performed every 6 months. Therapy was regarded 
appropriate when delivered in response to any VA. 
Statistical	analysis
Statistical analysis was performed using SPSS, version 18.0 (SPSS, Inc., Chicago, IL, USA). 
Continuous variables are expressed as mean±SD or median (interquartile range) when 
appropriate, and categorical variables as frequency (%). The Mann-Withney U-test or stu-
dent’s T-test were used to compare variables, as appropriate. All tests were two-tailed and a 
p-value <0.05 was considered statistically significant.
Results
Patient	characteristics	and	pre-procedural	MDCT	processing
Baseline patient characteristics are summarized in Table 1. The ventricular epicardial surface 
covered by fat was 65±16%; 25±15% was covered by >4mm fat. Body mass index and age 
showed a strong association with the percentage of the epicardial surface covered by >4mm 
fat (p<0.001 and p=0.008, respectively). The basal and apical anterior RV wall and the basal 
superior LV wall showed the thickest epicardial fat layer (5-6±3mm) (Figure 5).
Table	1.	Patient	characteristics	
Male gender (%) 21 (75)
Age, years 59±16
Body mass index, kg/m² 25±6
Diabetes mellitus (%) 5(18)
LV ejection fraction,% 46±12
Etiology
Idiopathic (%) 7 (25)
Ischemic (%) 2 (7)
ARVD/C (%) 3 (11)
LV-cardiomyopathy (%) 10 (36)
Biventricular-cardiomyopathy (%) 6 (21)
ARVD/C=Arrhythmogenic right ventricle dysplasia/cardiomyopathy; LV=left ventricle
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Real-time	image	integration	and	registration	accuracy
Endocardial voltage maps of the LV were obtained in 25 patients (structural heart disease 
105±65 points, idiopathic VA 50±25 points) with an additional endocardial RV map in 
9. In 3 patients only RV mapping was performed (67±23 points). Epicardial mapping was 
performed in all patients (structural heart disease 150±74 points, idiopathic 87±50 points). 
The MDCT derived images were successfully merged to the FFI and integrated with the 
aortic and LV and/or RV EAM with a mean surface registration error of 2.8±1.3mm. After 
registration, the position error between the LM on the EAM and the FFI was 5.5±2.8mm. 
Ablation	target	sites	and	procedural	outcome
In 22 patients 41 VA (cycle length 382±98ms) could be induced; in 5 patients the clinical 
VA (idiopathic premature ventricular complexes) was present at baseline; in one patient no 
VA could be induced. All 46 VA were targeted (Table 2). Seven VA (15%) in 5 patients were 
successfully ablated from the endocardium and 18 (39%) VA in 13 patients were success-
fully targeted from the epicardium (7.7±4.3 RF applications/VA). 
Ablation of 21 (46%) VA in 13 patients was non-successful. Two VA in 1 LV-cardiomy-
opathy patient were not targeted due to proximity of the His bundle. For 5 hemodynamic 
non-tolerated VA in 3 patients (2 LV-cardiomyopathy, 1 arrhythmogenic right ventricular 
dysplasia/cardiomyopathy) no appropriate TS could be identified. In 1 patient epicardial 
Figure	5.	The 24 segments bull’s eye reconstruction with 8 short axis segments and 3 long axis 
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mapping for 3 VA was compromised due to pericardial adhesions. Ablation at the TS of the 
remaining 11 VA in 8 of 13 patients was either ineffective (4 VA in 4 patients) or withheld 
because of close proximity of a coronary artery (7 VA in 4 patients).  
Of interest, all ineffective ablation sites were located at the LV superior wall (2 idiopathic 
and 1 LV-cardiomyopathy VA) and RV anterior superior wall (1 biventricular-cardiomyopathy 
VA). These sites were covered by >4mm fat as delineated by the fat meshes.
MDCT-derived	coronary	anatomy	
To further evaluate the registration accuracy, the distance between 28 TS and coronary arter-
ies on the FFI and coronary angiography were compared. Based on the integrated FFI, in 
7 patients the TS for 11 VA were located >15mm from a coronary artery, in 8 patients the 
TS for 8 VA were located 5-15mm and in 6 patients the TS for 9 VA were located <5mm 
from a coronary artery. In all cases the distance was confirmed by angiography (Figure 3, 
Table 2). In 4 patients (7 VA) ablation was withheld because of proximity of a coronary 
artery accounting for ablation failure. In 2 patients ablation was successfully performed 
without acute complications despite the vicinity of coronary arteries; 1 patient had a TS 
near a functional occluded coronary artery, the other patient who was in cardiogenic shock 
because of incessant VA had a TS close to the circumflex artery (distance<5mm) and RF was 
successfully applied. This patient died 4 weeks later due to progressive heart failure. No 
coronary artery lesion could be detected at autopsy (Figure 6).
Procedural	complications	
In 1 patient a major epicardial bleeding (>80cm3) occurred. Of importance, there was no 
damage of the LM evaluated by angiography and no procedure related death. Procedural 
time was 253±89 minutes and fluoroscopy time was 43±15 minutes. 
Post-procedural	evaluation	of	the	impact	of	epicardial	fat
A total of 1046 epicardial mapping points were located at the epicardium without evidence 
for scar on imaging. Twenty-two percent of these mapping points (n=232) were located at 
epicardium not covered by fat with a median bipolar voltage of 2.5mV (1.4-4.6mV) and a 
median unipolar voltage of 7.5mV (5.4-12.0mV). Bipolar voltages decreased significantly 
with increasing epicardial fat thickness according to the predefined categories (p<0.001). 
However, using the previously suggested cut-off value of 2.8mm, 37% of mapping points 
comprised bipolar voltage of >1.5mV. Unipolar voltage was not influenced by epicardial 
fat (Figure 4B-D).  Epicardial fat thickness was 16.9±6.8mm (range 7.3-22.2mm) at 4 non-





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In the subgroup of 7 patients without evidence of structural heart disease the earliest local 
activation time was similar over a broad endocardial area (Δ local activation time ≤10ms at 
≥3 endocardial points >1.5cm apart) (n=2), at two remote endocardial sites (Δ local activa-
tion time ≤10ms at 2 endocardial points >1.5cm apart) (n=1) or at both an endocardial and 
an aortic sinus/cardiac venous site (n=4) strongly suggesting an epicardial TS.	The predicted 
epicardial TS and its distance to the coronary arteries and the expected fat layer was con-
firmed after epicardial EAM and reversed registration in all patients. The area was located 
near (<5mm) the left anterior descending artery in 2 patients (no ablation performed) (Figure 
2B). In 2 other patients, the TS was covered by 22.2mm and 21.0mm fat and ablation at 
Figure	6.	Panel A: Gross pathology of the heart of the patient who died 4 weeks after ablation. 
Panel B: Final fusion image. Panel C: Fusion of the multi-detector computed tomography (MDCT) 
anatomy with the epicardial electroanatomical voltage map in a modified anterolateral (top) and 
posterolateral (bottom) view. The ablation site in the vicinity of the circumflex coronary artery 
is indicated. Comparison of panel A and B shows a good correlation between epicardial fat 
distribution by pathology and the MDCT derived epicardial fat mesh (white dotted lines). The 
black line indicates the atrioventricular groove; the anterolateral low voltage area (color coded as 
indicated) is compatible with subepicardial scar in the absence of epicardial fat. 
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these sites was ineffective. In 3 patients the TS was located remote (range 7.3-11.5mm) from 
a coronary artery and covered by 3.8±2.3mm fat. Ablation at these sites abolished the VA.
Follow-up
During a mean follow-up of 27±15 months 5 patients died (4 heart failure; 1 cancer) and 
1 patient underwent heart transplantation because of terminal heart failure. Of the remain-
ing 22 patients, 11 patients experienced VA recurrence; all 7 patients with ablation failure 
(100%) and 4 (27%) who were non-inducible for any VA.
Discussion
The distribution of epicardial fat and coronary arteries varies between patients. Both are of 
key relevance during epicardial mapping and ablation. This study is the first to demonstrate 
the feasibility and accuracy of real-time integration of MDCT derived images to visualize 
both the coronary artery anatomy and the distribution and thickness of epicardial fat before	
epicardial mapping. In 62% of patients with epicardial ablation failure lack of success was 
related to the proximity of a coronary artery or a thick epicardial fat layer both correctly 
identified using image integration.
Accuracy	of	real-time	image	integration	
Image integration was performed using the ostium of the LM as a single landmark and by 
the surface registration tool provided by CARTO after limited endocardial mapping. This 
approach resulted in highly accurate integration of EAM and MDCT data. In all patients 
accuracy was verified with surface registration statistics (surface error 2.8±1.3mm) and the 
position error between the LM landmark on the EAM and the FFI images (5.5±2.8mm). The 
registration accuracy of the LM was used to assess rotation errors. The relatively large posi-
tion error of this landmark is likely due to the fact that the LM is located outside the surface 
of the LV and RV. The absolute value of the LM position error underestimates the registration 
accuracy as position errors due to rotation are expected to be larger with increasing distance 
from the surface. For all points the mean surface registration error was only 2.8mm which 
is clinically acceptable keeping in mind that the used mapping catheter had a 3.5mm tip.
In contrast to all prior studies, registration accuracy was not only evaluated by the surface 
registration statistic. We also assessed accuracy by comparing the distance between catheter 
position and coronary arteries on integrated maps and coronary angiograms. The clinically 
relevant distance of <5mm, 5-15mm or >15mm was correctly estimated in all 14 patients 
in whom the TS was located in the proximity of a coronary artery. Others have used the 
epicardial apex and the most lateral tricuspid and mitral annular points as landmarks for 
image integration of MDCT derived data after epicardial EAM.1 However, this strategy may 
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be prone to rotational errors which do not necessarily result in poor surface registration sta-
tistics and in addition this strategy requires extensive epicardial mapping. By using the LM 
as a landmark, rotational errors can be excluded and epicardial mapping can be restricted 
to the area of interest.
The demonstrated correspondence of the distance between mapping catheter position 
and coronary arteries on integrated MDCT image and fluoroscopy has important practical 
implications. After confirmation of the registration accuracy by a single coronary injection, 
the distance between further TS and major coronary arteries may be evaluated by integrated 
MDCT only. In case of close proximity to a major coronary artery or when small coronary 
arteries, such as diagonal and obtuse marginal branches are present and not accurately 
visualized on MDCT, additional limited contrast injection may still be necessary. However, 
in most cases image integration is likely to prevent multiple coronary injections in different 
angulations. It may even enable more accurate assessment of the proximity of a coronary 
artery if angiography in caudal angulations is limited by the location triangle of the EAM 
system.
Although MDCT derived epicardial fat distribution cannot directly be verified using fluo-
roscopy, the 3D coordinates for epicardial fat meshes and coronary anatomy were derived 
from the same MDCT suggesting an identical accuracy to delineate fat thickness.
Epicardial	fat	and	voltage	mapping
Up to 64% of the epicardial surface was covered with fat; a quarter with a fat layer of >4mm. 
Of importance, epicardial fat was not restricted to the atrio- and interventricular groove 
as suggested by others.1-3 Epicardial fat can attenuate bipolar voltages thereby preventing 
accurate delineation of subepicardial scar by bipolar voltage mapping. A fat layer ≥2.8mm 
was found to best separate low voltage (<1.5mV) from normal voltage in a prior study.1 
However, our newly proposed technique of reversed registration allowed a head-to-head 
comparison of voltage data and local fat thickness. Although we could confirm a decrease in 
bipolar voltages with increasing fat thickness, nearly 60% of all mapping points acquired in 
areas with fat and >37% of points acquired in areas with ≥2.8mm fat showed normal bipolar 
voltages. These findings underline the importance of accurate MDCT derived fat information 
to avoid overestimation of subepicardial scar and underestimation of epicardial fat.
In contrast to prior observations, this study demonstrates that unipolar voltages are not 
influenced by epicardial fat which may be caused by the larger field of view.15,16 Therefore, 
unipolar voltage mapping may be of value to indicate subepicardial or intramural scar even 
when a significant epicardial fat layer is present. 
Epicardial	fat	and	impact	on	ablation
Epicardial fat was thickest at the LV superior and RV anterior wall, which is in line with prior 





age Integration during Epicardial A
blation
139
Little is known about the effect of epicardial fat on the efficacy of RF applications. In a prior 
study, epicardial cooled tip ablation was unable to produce epicardial lesions applied at 
sites covered by a fat layer >3.5mm.4 However, this was tested for only 3 applications in an 
animal model of myocardial infarction. In humans, Desjardins et al. compared epicardial 
fat thickness of 12 effective and 4 ineffective epicardial cooled-tip ablation sites; all ineffec-
tive ablation sites were covered by 10.8-14.6mm fat while effective ablation sites were all 
located at sites covered by <1.8mm fat.1 Therefore, a cut-off value for epicardial fat thickness 
precluding effective epicardial ablation remained undetermined. 
In the current study, ablation was performed at 21 sites covered by 0-22.2mm of epicar-
dial fat, including 6 sites covered by 3.0-10.0mm epicardial fat. The epicardial fat thickness 
at ineffective ablation sites ranged from 7.3-22.2mm. In contrast, all effective ablation sites 
were covered by 0-6.1mm fat. These findings suggest that an epicardial fat layer <7mm 
allows for effective irrigated tip ablation in humans.
Predicted	epicardial	target	sites	in	idiopathic	VA	
Real-time visualization of the coronary anatomy and fat distribution before epicardial 
access might be particularly important in patients with a focal arrhythmogenic source typi-
cal for idiopathic VA. Based on local activation times we could not only correctly predict 
the epicardial TS but also, using the pre-acquired and integrated MDCT, the proximity of 
coronary arteries and local fat thickness at these TS before epicardial access. Consequently, 
image integration may predict potential ablation failure and may thereby prevent unneces-
sary epicardial access in selected patients in the future.
Limitations
The comparison of successful and non-successful TS was performed retrospectively. The 
validation of a cut-off value of >7mm for epicardial fat preventing effective RFCA should be 
performed in a prospective manner in a larger group of patients.
In addition, the bull’s eye reconstruction of epicardial fat reflects a simplified contour of 
the heart. Consequently, interpretation of the bull’s eye should be performed with vigilance 
and is merely designed to provide a schematic overview of epicardial fat thickness and 
distribution.
The value of electrogram characteristics for delineation of scar was not analyzed, since 
the current gold standard to delineate scar (contrast-enhanced magnetic resonance imaging) 
was not available during the procedure in all patients. However, the objective of this study 
was to demonstrate the clinical value of real-time image integration of MDCT derived data 
and to determine the influence of epicardial fat thickness on bipolar and unipolar electro-
gram voltages. Therefore, only areas without evidence for scar were evaluated.
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Conclusion
Real-time image integration of pre-acquired MDCT data on coronary anatomy and fat 
distribution using the ostium of the LM as a single landmark with EAM is safe, accurate 
and feasible and available before epicardial access. One fourth of the ventricular epicardial 
surface is covered by >4mm fat which is predominantly present at the LV superior wall and 
RV anterior wall. Although bipolar voltages decrease with increasing fat thickness the exact 
delineation of fat based on bipolar voltage mapping is poor and may be even worse if sub-
epicardial scar is present. In contrast, unipolar voltages are not influenced by fat thickness 
and might therefore be superior for identification of scar covered by epicardial fat.
Epicardial fat layers of >7mm and the presence of coronary arteries are important reasons 
for epicardial ablation failure. Visualization of the MDCT derived coronary anatomy and 
epicardial fat thickness prior to epicardial mapping is therefore of importance for the correct 
interpretation of local bipolar electrograms and the identification of potential harmful and 
ineffective ablation sites. In addition, accurate image integration after endocardial ablation 
failure for focal VA may even prevent unnecessary pericardial access and thereby potential 
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Objective: Improvement of left ventricular (LV) ejectionfraction (EF) after radiofrequency 
catheter ablation (RFCA) of frequent premature ventricular contractions (PVCs) has been 
reported. However, most patients with frequent PVCs have normal LVEF. In these patients 
subtle and early forms of PVC induced left and right ventricular (RV) impairment may not be 
detected by standard echocardiographic techniques. This study aimed to assess the effect of 
frequent PVCs on ventricular function in patients with preserved LVEF.
Methods: Forty-nine patients (30male, 49±16years) with recent onset (median 1.2years), 
frequent PVCs (burden 26±13%) and 25 healthy controls were studied. Thirty-four patients 
with PVCs underwent successful RFCA. Two-dimensional echocardiography was performed 
at baseline and follow-up. LV volumes and LVEF were calculated by Simpson’s rule. Tricus-
pid annulus plane systolic excursion and fractional area change were calculated to assess 
RV function. Multidirectional LV strain (radial, circumferential, longitudinal) and RV free 
wall longitudinal strain were calculated by two-dimensional speckle tracking imaging. At 
baseline LVEF, volumes and RV dimensions were normal in patients and controls. 
Results: Speckle tracking imaging demonstrated reduced LV and RV strain in PVC patients 
as compared to controls. At follow-up there were no changes in LVEF, LV volumes and RV 
dimensions and function in successfully treated by RFCA and untreated patients. However, 
radial, circumferential and longitudinal strain improved significantly in patients after RFCA 
but remained unchanged in untreated patients. 
Conclusions: Frequent PVCs can induce subtle cardiac dysfunction detected by speckle 
tracking imaging analysis in patients without apparent cardiomyopathy. RFCA can success-
fully eliminate PVCs and improve cardiac function. 
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Introduction
Symptomatic ventricular ectopy is frequently encountered in clinical practice. The arrhyth-
mia occurs commonly in patients without structural heart disease and is considered to be 
without prognostic significance.1 
In some patients, frequent idiopathic premature ventricular contractions (PVCs) can 
cause moderate to severe left ventricular (LV) dysfunction.2-4 Elimination of these PVCs by 
radiofrequency catheter ablation (RFCA) may result in improved LV ejection fraction (EF).2-4 
The majority of patients presenting with frequent symptomatic PVCs has normal LV volumes 
and LVEF. It has however been shown that impairment of LV function may evolve after 
several years of follow-up.5 Small series demonstrated a reduction of LV dimension after 
successful RFCA in patients with normal LV function using conventional echocardiography 
assessment.6, 7 This finding suggests that frequent PVCs may already have an early sub-
clinical detrimental effect on LV function which may not be unmasked with conventional 
echocardiography. Whether frequent PVCs have an adverse effect on right ventricular (RV) 
function is unknown.
Recently, two-dimensional (2D) speckle tracking strain imaging has been introduced.8, 
9 This novel technique enables accurate detection of subtle abnormalities in ventricular 
function that are not revealed by conventional echocardiographic parameters such as LVEF 
and RV fractional area change.10 In addition, 2D speckle tracking strain imaging allows 
angle-independent evaluation of multidirectional LV strain in radial, circumferential, and 
longitudinal directions and RV longitudinal strain.11 
The purpose of this study was to assess the effect of recent-onset, frequent PVCs on RV 
and LV function in patients with preserved LVEF using 2D speckle tracking strain imaging. 




Forty-nine consecutive patients with symptomatic, frequent PVCs (>5% PVC on 24h Holter 
monitoring) were included. All patients underwent extensive baseline evaluation to rule out 
structural heart disease including a clinical history with regard to the onset of symptoms, 
12-lead electrocardiogram (ECG), exercise testing, 24-hour Holter monitoring and 2D 
transthoracic echocardiography. 
The 12-lead ECG QRS duration, morphology and PVC coupling interval were evaluated. 
The PVC burden was calculated by dividing the number of PVCs by the total number of 
beats on Holter recording.
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Echocardiographic reference values	were obtained from a group of 25 individuals with 
structural normal hearts. The controls were frequency matched to patients by age, gender, 
body surface area and LV function. The control group included individuals who were 
referred for evaluation of chest pain and who had normal echocardiograms. Those indi-
viduals referred for echocardiographic evaluation of known valvular heart disease, murmur, 
syncope, arrhythmias, congestive heart failure or cardiac transplantation were excluded.
Radiofrequency	catheter	ablation
After informed consent catheter mapping and ablation was performed in the post-absorptive, 
non-sedated state. Antiarrhythmic drugs were discontinued for 5 half-lives, with the excep-
tion of amiodarone. 
Mapping was facilitated by an electroanatomical mapping system (CARTO) using a trans-
venous or retrograde aortic approach. At the site of earliest activation based on the onset 
of bipolar electrograms with a local unipolar QS-pattern pace-mapping was performed to 
confirm a ≥11/12 lead QRS pace-match. 
Radiofrequency energy was delivered at the site of earliest activation and best pace-map 
with the target temperature set at 60°C and maximum power output of 50W. After ablation 
programmed electrical stimulation was performed before and during the administration of 
isoproterenol (2-10µ/min) to confirm that PVCs were not inducible by adrenergic stimula-
tion. Complete procedural success was defined as the absence of spontaneous or inducible 
PVC for at least 45 minutes after ablation. 
Echocardiography
Two-dimensional echocardiography was performed using a commercially available system 
(Vivid-Seven, General Electric Vingmed, Horten, Norway) equipped with a 3.5-MHz trans-
ducer. Data acquisition was performed in the left lateral decubitus position  at a depth of 
16cm in the parasternal and apical views. Standard M-mode, grey-scale 2D and color-
Doppler images, triggered to the QRS complex, were acquired and saved in cine-loop 
format for off-line analysis (EchoPAC 7.0.0., GE Medical Systems, Horten, Norway). All 
echocardiographic measurements were performed on sinus beats, avoiding the first postex-
trasystolic beat if feasible.
Left ventricular end-diastolic and end-systolic volumes were measured at the apical 2- 
and 4-chamber views by modified Simpson’s rule and LVEF was derived.12 RV dimensions 
were measured according to current guidelines.12 From the apical 4-chamber view, the 
mid-cavity and basal RV diameters as well as RV longitudinal diameter were measured 
at end-diastole. From the parasternal short-axis images, the end-diastolic RV outflow tract 
diameter was measured proximal to the pulmonary valve. RV systolic function was evalu-
ated by calculating the fractional area change and measuring the tricuspid annular plane 
systolic excursion (TAPSE) index from the apical 4-chamber view.12  
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Two-dimensional	speckle	tracking	imaging	analysis
Multidirectional analysis of LV strain (radial, circumferential and longitudinal directions) 
was performed using 2D speckle tracking imaging. Standard grey-scale 2D images were 
acquired at a high frame rate to assure adequate tracking of the speckles equally distributed 
within the myocardium. Myocardial strain can be calculated by measuring the change of the 
position of the speckles within a myocardial segment along the cardiac cycle.13, 14
Applied to the short-axis of the LV, radial strain assesses the thickening and thinning of the 
myocardial wall whereas circumferential strain assesses the shortening and lengthening of 
the myocardium along the curvature of the LV wall. The mid-ventricular short-axis of the LV 
is divided in 6 segments and the values of radial or circumferential strain are derived from 
the average of the 6 segmental peak systolic strain values (Figure 1A and B). 
Applied to LV apical images (2-, 4-chamber and long-axis views), longitudinal strain 
assesses the shortening of the LV resulting from the excursion of the mitral annulus plane 
towards the LV apex. Each LV apical view is divided in 6 segments and the global longitu-
dinal strain value is derived from the average of the 18 segmental peak systolic strain values 
(Figure 1C).  
Myocardial deformation of the RV was assessed in the longitudinal direction.15 From a 
modified apical 4-chamber view, focused on the RV, longitudinal strain of the free-wall was 
evaluated. The RV free-wall is divided in 3 segments and the global longitudinal strain value 
is obtained from the average of the 3 segmental peak systolic strain values (Figure 1D).
All echocardiographic analyses were performed by an independent observer blinded to 
the clinical history and the treatment. The inter-observer agreement for 2D speckle tracking 
strain measurements have been previously reported16, 17, being 6.5±5.4 for radial strain, 
2.3±2.4 for circumferential strain, 0.9±1.0 for longitudinal strain and 0.16±3.6% for RV 
longitudinal strain. 
Statistical	analysis
Continuous variables are expressed as mean±SD. Categorical variables are expressed as 
frequencies(%). Comparisons between controls and patients were performed by Student 
t-test for unpaired data. Patients treated with RFCA and patients who were not treated with 
RFCA were compared by using Mann-Whitney U-test for unpaired data. Changes in LV and 
RV dimensions and function at follow-up were compared with Student t-test and Wilcoxon 
Signed Ranks test for paired data, as appropriate. A p-value <0.05 was considered statisti-
cally significant. All statistical analyses were performed with SPSS software (version 16.0, 
SPSS Inc., Chicago, Illinois). 
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Figure	1.	Multidirectional strain analysis with 2-dimensional speckle tracking imaging. In the LV, 
myocardial strain can be measured in the 3 directions with 2-dimensional speckle tracking imaging. 
Radial (panel A) and circumferential (panel B) strain are calculated at the mid-ventricular short axis 
view of the LV. The LV is divided in 6 segments and the segmental peak systolic strain values with 
the corresponding time-strain curves along the cardiac cycle are obtained. Longitudinal strain of 
the LV is calculated at the 4-chamber, 2-chamber and long-axis apical views (panel C). In each apical 
view, the LV is divided in 6 segments, obtaining the segmental peak systolic strain values and the 
corresponding time-strain curves. Longitudinal strain of the RV free wall (panel D) is measured at 
modified 4-chamber view, focused on the RV. The free wall is divided in 3 segments, providing the 
segmental peak systolic strain value and the time-strain curves along the cardiac cycle.
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Baseline characteristics of the 49 patients (30 men, mean age 49±16 years) are summarized 
in Table 1. The median duration of symptoms before the first evaluation was 1.2 years (inter-
quartile range 0.4–3 years). In patients who underwent RFCA the 24-hour Holter monitoring 
was performed 3.0 months (interquartile range 1.0-5.6) prior to the RFCA procedure.  
The burden of PVCs was 26±13% of total beats. The PVCs had one dominant morphology 
in all patients. The mean QRS duration of PVC was 175±24ms. The frontal plane axis was 
left inferior in 24(49%), left superior in 1(2%), right inferior in 23(47%) and right superior 
in 1(2%) patient. The average coupling interval was 498±115 ms. No evidence of ischemia 
was found on exercise testing in any of the patients.
The control group included 25 individuals with normal echocardiograms. By definition, 
controls were comparable to patients in terms of gender (14(56%) men, p=0.665), age (46±9 
years, p=0.333), body surface area (1.8±0.1m2, p=0.080) and LVEF (58±5%, p=0.201). 
Mapping	and	Radiofrequency	catheter	ablation
Forty patients were scheduled for mapping and ablation; in nine no RFCA was attempted 
due to patients’ preference. Thirty-four patients could successfully be ablated with a median 
of 3 RF applications (range 1–14). The PVCs originated from the RV in 24(71%) and the LV 
Table	1.	Baseline characteristics
n = 49
Age (years) 49 ± 16
Gender (M/F) 30 (61%) / 19 (39%)
Body surface area (m2) 1.9 ± 0.2
PVC-burden (%) 26 ± 13
Cardiovascular risk factors
           Hypertension 10 (20%)
           Hypercholesterolemia 10 (20%)
           Family history CAD 13 (27%)














ACEI = angiotensin-converting enzyme inhibitors, PVC = premature ventricular contraction, CAD = 
coronary artery disease
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in 10(29%) patients. The site of successful RF application was the RV outflow tract in 23, the 
pulmonary artery in 1, the LV outflow tract in 2, the mitral annulus in 1, the anterior cardiac 
vein in 3, the aortic cusps in 3 and the Purkinje system in 1 patient. In 2 of these patients 2 
different morphologies could be successfully targeted in adjacent areas (RVOT in 1 and Aortic 
cusps in 1). In 5/6 patients with ablation failure the site of origin could not be determined by 
an endocardial approach including mapping within the cardiac veins (>1 PVC morphology 
in 2) and in 1 patient no ablation attempt was made due to the proximity of the His bundle. 
Procedure and fluoroscopy times were 150±60 min and 17±15 min respectively. In the suc-
cessfully ablated patients the burden of PVCs was reduced to 0.2±0.8% confirming freedom 
of PVCs at repeated Holter monitoring 4.1 months (interquartile range 1.4-9.2 months) after 
RFCA. In contrast, in the 15 patients in whom no mapping and/or ablation attempt was 
made the PVC burden was stable at follow-up. No complications were observed. 
Baseline	echocardiography	and	2D	speckle	tracking	strain	analysis
At baseline, all patients had a non-dilated LV with preserved LVEF (56±7%) and no differ-
ences were observed as compared to controls (Table 2). In addition, patients had comparable 






Heart rate (bpm) 68 ± 10 67 ± 10 0.588
LV end-diastolic volume (ml) 117 ± 29 123 ± 35 0.391
LV end-systolic volume (ml) 49 ± 13 55 ± 19 0.102
LV ejection fraction (%) 58 ± 5 56 ± 7 0.201
RV outflow tract diameter (mm) 29 ± 3 29 ± 4 0.973
RV basal diameter (mm) 31 ± 3 30 ± 4 0.439
RV mid-level diameter (mm) 30 ± 6 29 ± 5 0.421
RV longitudinal diameter (mm) 70 ± 10 71 ± 10 0.481
RV fractional area change (%) 41 ± 9 42 ± 8 0.628
TAPSE (mm) 2.4 ± 0.3 2.4 ± 0.5 0.867
LV Radial strain (%) 43.3 ± 12.7 30.5 ± 12.9 <0.0001
LV Circumferential strain (%) -20.2 ± 3.1 -15.8 ± 4.0 <0.0001
LV Longitudinal strain (%) -20.1 ± 1.0 -17.4 ± 3.0 <0.0001
RV Longitudinal strain (%) -30.1 ± 4.4 -23.8 ± 6.7 <0.0001
LV = left ventricular; PVC = premature ventricular complex; RV = right ventricular; TAPSE = tricuspid 
annular plane systolic excursion.
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RV dimensions and function to controls (fractional area change 42±8% and TAPSE index 
2.4±0.5mm) (Table 2).
Multidirectional 2D speckle tracking assessment of the LV demonstrated that patients 
had significantly impaired LV strain in all the 3 directions (radial, circumferential and lon-
gitudinal). Furthermore, patients had lower values of RV longitudinal strain as compared to 
controls (Table 2). In 7 patients, 2D speckle tracking analysis was performed during sinusal 
post-extrasystolic beat. However, this had not significant impact on the values of multidirec-
tional strain of the overall population.
Effects	of	PVC	origin
To evaluate the impact of PVC origin on RV and LV function, patients with PVCs originat-
ing from the RV confirmed by successful RFCA (n=24) were compared to patients with LV 
origin (n=10). No differences were observed in LVEF, LV end systolic and diastolic function, 
RV fractional area change and TAPSE. Myocardial strain was decreased in all the direc-
tions to a similar extend in patients with LV and RV site of origin: LV circumferential strain 
(-16.3±4.0% vs. -15.6±3.3%, p=0.5), LV longitudinal strain (-18.3±3.1% vs. -17.1±2.3%, 
p=0.7), LV radial strain (30.1±13.8% vs. 33.1±15.6%, p=0.2) and RV longitudinal strain 
(-25.8±8.4% vs. -22.1±2.3%, p=0.07). 
PVC	burden	and	echocardiographic	findings
To account for the effect of PVC burden the 30(61%) patients with a PVC burden of >20% 
(34±9.7%) were compared to 19(39%) patients with a PVC burden <20% (13.3±4.7%). 
Patients with a high PVC burden tended to have lower LVEF (55±8% vs. 58±6%, p=0.07) 
and larger LV end-diastolic volume (130±37ml vs. 113±31ml, p=0.13) and LV end-systolic 
volume (59±20ml vs. 49±17ml, p=0.09) as compared to patients with a moderate PVC bur-
den, however these differences were not significant. Both groups showed comparable values 
of LV circumferential strain (-16.3±4.4% vs. -15.8±4.0%, p=0.9), radial strain (-31.9±14.2% 
vs. -32.1±16.0%, p=1.0), longitudinal strain (-17.1±3.5% vs. -17.9±2.2%, p=0.9) and RV 
longitudinal strain (-23.3±6.0% vs. -25.2±8.3, p=0.3).
Effect	of	RFCA	on	LV	and	RV	function	
After a median follow up of 13 months (interquartile range 5–22 months) a second echocar-
diogram was obtained in all patients. The follow-up, the 34 patients successfully treated with 
RFCA showed a significant decrease in LV end-systolic volume (from 56±21ml to 49±15ml, 
p=0.018). Changes in LV end-diastolic volumes and LVEF (from 57±8 ml to 59±5%, 
p=0.245) were not significant. However, with 2D speckle tracking imaging, a significant 
improvement of strain values was observed in all the 3 directions, with normalization of LV 
multidirectional myocardial strain. In addition, although there were no significant changes 
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in RV dimensions and function, RV longitudinal strain also improved at follow-up, with 
normalization of the longitudinal strain values in successfully treated patients. (Table 3)
In contrast, the group of 15 patients in whom RFCA could not successfully be performed 
or no RFCA attempt was made the PVC burden was stable and no changes in LV dimensions 
and function, assessed either by LVEF or multidirectional strain were found. Furthermore, 
no changes in RV dimensions, function and deformation properties were observed (Table 3). 
Discussion
The major finding of the present study is that patients with frequent PVCs of recent onset 
and normal LV volumes, LVEF and RV dimensions show subtle LV and RV dysfunction. This 
cardiac impairment normalized after successful ablation of PVCs but remained unchanged 
in non-treated patients and in patients after unsuccessful RFCA. These findings suggest that 
recent onset, frequent PVCs can result in reversible biventricular dysfunction not detected 
by conventional echocardiographic parameters. 
Effect	of	frequent	PVCs	on	ventricular	performance
Frequent PVCs are generally considered a benign condition when found in patients without 
structural heart disease. Small series have demonstrated a link between frequent PVCs and 
increased LV dimensions and impaired LVEF which improved or normalized after abolishing 
PVCs by pharmacological treatment or RFCA. However, the majority of patients presenting 
with frequent PVCs has a preserved LVEF.1-5  This does not exclude a negative effect of PVCs 
on systolic function as subtle or early impairment may not be detected by conventional 
parameters. 
Niwano prospectively followed 239 patients with frequent PVCs and only 13, the major-
ity with a high PVC burden, developed a small but significant decline in LVEF after 4 years, 
suggesting that impaired LV function may develop only over long periods.5 However, 42 
patients with significant symptoms and/or LV dysfunction at baseline were excluded. These 
patients might represent a subgroup of patients in whom LV dysfunction occurs earlier.5 
In the present study the median duration of symptoms was 13 months. Despite the short 
period, these patients had already decreased multidirectional strain as compared to controls, 
whereas LV volumes, RV dimensions and LV and RV function measured by conventional 
echocardiographic techniques were normal. This indicates that PVCs may induce early LV 
and RV dysfunction not detected by conventional 2D echocardiography measurements. The 
evaluation of multidirectional strain with 2D speckle tracking imaging enables the detection 
of functional abnormalities by exploring the mechanical properties of the myocardium.10 
2D speckle tracking imaging may constitute a more sensitive tool to detect subtle ventricular 
dysfunction, in particular for RV function assessment since quantification of RV volumes 
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and function with conventional echocardiography remains problematic due to the complex 
geometry of the RV. However, the present results do not allow to define robust baseline 
cut-off values of multidirectional myocardial strain to identify and predict which patients 
will develop cardiomyopathy if RFCA is not applied. Additional studies including larger 
populations and longer follow-up are warranted to elucidate this aspect.
An inverse relationship between PVC burden and cardiac function has been described and 
PVC frequency has also been suggested as risk factor for PVC induced cardiomyopathy.4, 6, 7 
Table	3.	Follow-up echocardiography study and 2-dimensional speckle tracking strain analysis 
PVC-RFCA (n = 34) Non-RFCA PVC (n = 15)
Baseline Follow-up p-value Baseline Follow-up p-value
Heart rate (bpm) 69 ± 11 68 ± 11 0.790 64 ± 8 68 ± 11 0.670
LV end-diastolic volume 
(ml)
127 ± 39 120 ± 34 0.077 116 ± 22 114 ± 23 0.551
LV end-systolic volume 
(ml)
56 ± 21 49 ± 15 0.018 52 ± 14 49 ± 12 0.073
LV ejection fraction (%) 57 ± 8 59 ± 5 0.245 55 ± 5 57 ± 8 0.244
RV outflow tract diameter 
(mm)
29 ± 4 30 ± 4 0.362 30 ± 4 31 ± 2 0.207
RV basal diameter (mm) 30 ± 4 29 ± 3 0.535 32 ± 4 31 ± 3 0.153
RV mid-level diameter 
(mm)
29 ± 6 28 ± 5 0.186 28 ± 4 28 ± 5 0.689
RV longitudinal diameter 
(mm)
73 ± 10 74 ± 10 0.632 68 ± 11 72 ± 11 0.091
RV fractional area change 
(%)
43 ± 9 45 ± 10 0.261 41 ± 5 40 ± 8 0.783
TAPSE (mm) 2.5 ± 0.5 2.4 ± 0.4 0.327 2.4 ± 0.3 2.2 ± 0.3 0.073





<0.0001 28.5 ± 9.7 32.0 ± 9.6 0.272















0.007 -16.4 ± 3.2 -17.1 ± 2.5 0.638









*p<0.01 vs. non-RFCA at follow-up; †p = 0.014 vs. non-RFCA at follow-up.
LV = left ventricular; PVC = premature ventricular complex; RFCA = radiofrequency catheter ablation; 
RV = right ventricular; TAPSE = tricuspid annular plane systolic excursion.
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In the current study, patients with a PVC burden of >20% were compared to patients 
with a PVC burden <20%. Although we did not observe significant differences in LVEF 
and volumes, there was a tendency to larger LV volumes in patients with a higher PVC 
burden, still within normal range. LV and RV strain were decreased to a similar extend in 
patients with a high and moderate PVC burden indicating that even a moderate burden of 
PVCs (mean 13.3%) can induce subclinical cardiac dysfunction. However, the proportion 
of patients with a moderate PVC burden was relatively small. 
Previous studies reporting on a reversal of cardiomyopathy after RFCA only included 
patients with PVCs from the RV outflow tract.3, 7 More recently it was demonstrated that a 
reversible reduced EF was equally prevalent among patients who had PVCs with a right or 
left bundle branch block configuration.4, 18 This was confirmed by our study demonstrating 
that subtle and reversible LV and RV dysfunction can be induced by PVCs regardless of the 
site of origin. 
RFCA	and	improvement	of	LV	and	RV	strain
This study extends the finding of prior reports, that RFCA for PVCs can reverse cardiac 
functional abnormalities induced by PVCs.3, 4, 6, 7 While Yarlagadda3 and Bogun4 observed 
reversal of mild to severe dilated cardiomyopathy after ablation of PVCs, Takemoto7 and 
Sekiguchi6 studied patients with normal LVEF detecting no functional abnormalities before 
RFCA, and demonstrating improvement of LV EF and diameters within the normal range dur-
ing follow-up. The present study, however, shows that PVC induced LV and RV dysfunction 
detected at baseline by strain analysis in patients with normal ventricular dimensions and 
LVEF can be reversed after successful RFCA. In contrast, in the PVC RFCA -control group 
decreased strain at baseline did not change during short term follow-up. Additional stud-
ies with longer follow-up will be warranted to elucidate whether ventricular strain further 
impairs in patients with frequent PVC non-treated with RFCA. 
Clinical	implications
Two-dimensional speckle tracking strain imaging detects cardiac functional abnormali-
ties in symptomatic patients with PVCs not detected by conventional echocardiographic 
measurements. This relatively novel imaging technique has been validated against sonomi-
crometry and tagged magnetic resonance imaging and several studies have demonstrated its 
accuracy to measure myocardial strain.13, 14 By measuring the mechanical properties of the 
myocardium with this technique, subtle myocardial dysfunction can be detected. Indeed, 
despite preserved LV or RV functions as assessed with conventional echocardiography, 
2D speckle tracking can demonstrate subtle myocardial dysfunction in different clinical 
conditions (i.e. aortic stenosis, diabetic cardiomyopathy, coronary artery disease).16, 19, 20 In 
addition, subtle myocardial dysfunction as detected with 2D speckle tracking has important 
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prognostic implications.21-23 As demonstrated in previous studies, LV longitudinal strain 
showed superior prognostic value than baseline clinical characteristics, LV ejection fraction 
or wall motion score index measured with conventional echocardiography.23 Therefore, 2D 
speckle tracking may constitute a valuable imaging tool to improve the risk stratification 
of patients with different clinical conditions, including those that potentially can cause 
cardiomyopathy at long-term follow-up if not treated.
RFCA for PVCs is associated with a high success rate and few complications.3, 4, 6, 7, 24 
Beside its value in relieving patients symptoms, RFCA can play an important role in the 
management of patients with PVC induced ventricular dysfunction. 
Since it has been suggested that advanced PVC induced ventricular dysfunction may lead 
to irreversible cardiomyopathy in individual patients, the early detection of PVC induced 
dysfunction might be of clinical relevance.25 Although there seems to be an association 
between PVC frequency, duration and decline in LV function some patients with low PVC 
burden and/or short duration of symptoms have already deterioration of LV function. There-
fore PVC burden and duration alone may not identify patients at risk.2, 4, 5 Until additional 
risk factors are identified, 2D speckle tracking strain imaging may constitute a valuable test 
to identify patients that need to be re-assessed during long term follow-up. Whether 
Conclusions
Frequent PVCs can induce subtle LV and RV dysfunction in patients without apparent 
cardiomyopathy. PVCs originating from the LV and RV have similar detrimental effects on 
ventricular function. RFCA can successfully eliminate PVCs and improve cardiac function. 
These changes can be evaluated by using 2D speckle tracking imaging. 
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Introduction: Patients with established ARVC/D based on task force (TF) criteria and ven-
tricular tachycardia (VT) are at risk of VT recurrence and sudden death. Data on patients 
with VT due to right ventricular (RV) scar not fulfilling TF criteria are lacking. The purpose of 
this study was to assess the long-term arrhythmia recurrence rate and outcome in patients 
with scar-related right VT with and without a diagnosis of arrhythmogenic right ventricular 
cardiomyopathy (ARVC/D).
Methods: Sixty-four patients (age 43.5±15yr, 49 male) presenting with non ischemic scar-
related VT of RV origin were studied. Scar was identified by electroanatomical mapping, 
contrast-echocardiography and/or MRI. Patients were evaluated and treated according to a 
standard institute protocol. 
Results: Twenty-nine (45%) patients were diagnosed with ARVC/D according to TF cri-
teria (TF+) and 35 (55%) with RV scar of undetermined origin (TF-) at the end of follow-up 
(64±42 months). Patients were treated with anti-arrhythmic drugs, Radiofrequency catheter 
ablation and/or ICD implantation. VT recurrence-free survival for TF+ and TF- was 76% vs. 
74% at 1yr and 45% vs. 50% at 4yr (p=ns). Patients with fast index VT (CL≤250ms, n=31) 
were more likely to experience a fast VT during follow-up than patients with a slow index 
VT (CL>250ms, n=33) (61% vs. 3%, p<0.001). 
Conclusions: Scar-related RV VTs have a high recurrence rate in TF+ and TF- patients. 
Patients presenting with a fast index VT are at high risk for fast VT recurrence and may 
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Introduction
Patients with scar-related ventricular tachycardia (VT) of right ventricular (RV) origin are at 
risk for VT recurrence and sudden cardiac death. RV scar can be due to various diseases, 
such as ischemic heart disease, viral myocarditis, sarcoidosis, and genetically determined 
diseases. Subtle forms of RV involvement may not always be detected and classified by clini-
cal evaluation including echocardiography, heart catherization, MRI and endomyocardial 
biopsy which may have important diagnostic and therapeutic implications. An important 
cause of RV scar is arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), 
a progressive and most likely genetic disease. In more than 50% of affected patients no 
familial occurrence1 or disease specific genetic mutations2 are found, therefore diagnosis 
of ARVC/D is based on criteria proposed by a generally accepted consensus report by an 
international task force (TF).3 
Prognosis and risk factors for arrhythmia recurrence and sudden cardiac death in patients 
with ARVC/D have been studied. Class III antiarrhythmic drugs may be effective to control 
arrhythmia4. Radiofrequency catheter ablation (RFCA) is acutely effective in selected patients 
but hampered by a high recurrence rate during follow-up perhaps due to progression of the 
disease or subepicardial substrate.5, 6 ICD implantation for secondary prevention has shown 
a high incidence of appropriate ICD therapy of 70% to 74%.7, 8 
Data on patients presenting with scar-related left bundle branch block (LBBB) type VT 
without an established diagnosis of ARVC/D according to TF criteria are lacking. 
The purpose of this study is to compare the clinical presentation, arrhythmia recurrence 
and outcome in patients with ARVC/D versus TF negative patients with scar-related LBBB 
type VT’s during long term follow-up.
Methods
Patient	population
Data from 64 patients referred to the Leiden University Medical Center with non-ischemic 
scar-related LBBB type VT, defined as predominant S-wave in precordial lead V1 were 
studied. 
Patients had to meet the following criteria for inclusion in the study: documentation of 
sustained LBBB type VT and evidence of RV scar. RV scar was defined as (1) akinetic or 
dyskinetic wall motion abnormalities and/or severe right ventricular dilatation with dysfunc-
tion3 on echocardiography9, 10 or MRI 11-14 and/or (2) as regions of adjacent, fragmented, 
prolonged (≥3 positive deflections, ≥40ms signal duration) and low amplitude bipolar 
electrograms (≤1.5 mV) 15, 16 on catheter mapping. Patients with (1) idiopathic LBBB VT 
without evidence of RV scar, (2) with extensive left ventricular (LV) scar or dysfunction 
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(LV ejectionfraction <45%) and (3) with significant symptomatic coronary artery disease 
(defined as positive exercise test and >50% diameter stenosis in one or more coronary 
arteries) were excluded. 
Diagnostic	Evaluation
All patients underwent standard invasive and non-invasive testing for ARVC/D according to 
the criteria defined by the Task Force (TF) of the Working Group Myocardial and Pericardial 
Disease of the European Society of Cardiology and of the Scientific Council on Cardio-
myopathies of the International Society and Federation of Cardiology3. In these guidelines 
major and minor TF criteria have been established encompassing structural, histological, 
electrocardiographical, clinical and familial aspects of ARVC/D (Table 1). 
A 12-lead surface electrocardiogram (ECG) was obtained to determine the presence of 
T-wave inversion beyond lead V2, a QRS duration ≥110ms in leads V1-V3, the presence of an 
epsilon wave3 and terminal activation delay (TAD) >55ms17. QRS durations were measured 
at 100mm/s. Two-dimensional echocardiography with emphasis on wall motion abnormali-
ties and function of the RV and LV with and without intravenous contrast was performed. 
Images were obtained using a 3.5 MHz transducer, at a depth of 16 cm in the parasternal 
and apical views (standard long-axis, two-chamber and four-chamber images). 
MRI studies were obtained using a 1.5 T MRI system (Philips Medical Systems, Best, The 
Netherlands). To evaluate regional cardiac function, ECG- triggered multislice, multi-phase 
gradient-echo MR imaging of the heart was performed encompassing both ventricles with 
10-12 imaging planes. MRI studies were evaluated by an experienced cardiac radiologist. 
Evaluation by signal-averaged electrocardiography was not performed. Endomyocardial 
biopsies were not obtained routinely because of the well-known sampling error caused by 
the segmental nature of ARVC/D and the possible risk of perforating the thin walled RV in 
patients with ARVC/D.18 All patients were classified according to TF criteria. The diagnosis of 
ARVC/D was established when at least 2 major criteria or 1 major plus 2 minor criteria or 4 
minor criteria were fulfilled. TF negative patients who fulfilled 1 major and 1 minor criterion 
or 3 minor criteria were classified as ‘probable’ ARVC/D. In a second analysis the recently 
proposed TAD was included and considered as diagnostic class IV major criterion.
Arrhythmias
The cycle length (CL) of the index LBBB like VT was measured. In patients presenting with 
syncope or resuscitation the induced LBBB like VT was considered as index VT.  Fast VT was 
defined as a VT with a CL≤250ms. Syncope without ECG documentation was considered as 
VT with hemodynamic compromise and registered as fast VT for analysis purpose. Slow VT 
was defined as VT with a CL>250ms. Electrical programmed stimulation was performed in 
all patients. The induction protocol consisted of 3 drive-cycle lengths (600, 500 and 400ms) 











Class	I Dysfunction and structural 
alterations
   Major Severe dilatation and reduction of 
RV ejection fraction with no (or mild) 
LV impairment and/or localized RV 
aneurysms (akinetic or dyskinetic 
areas with diastolic bulging)
25(86) 6(17)
   Minor Mild global RV dilatation and/or 
ejection fraction reduction with 
normal LV and/or mild segmental 
dilatation of the RV and/or regional 
RV hypokinesia
3(10) 14(40)
Class	II Tissue characterization of 
walls
			Major Fibrofatty replacement of 





   Minor Inverted T waves in right precordial 
leads (V2 and V3) (age> 12 yr; in 




   Major Epsilon waves or localized 
prolongation (>110 ms) of the QRS 
complex in right precordial leads 
(V1-V3)
17(58) 1(3)
Terminal activation duration (TAD) 
≥55ms*
17(58) 6(17)
   Minor Late potentials (signal-averaged ECG) - -
Class	V Arrhythmias
   Minor Left bundle branch block type 




   Major Familial disease confirmed at 
necropsy or surgery
0(0) 0(0)
   Minor Familial history of premature 
sudden death due to suspected right 
ventricular dysplasia and/or familial 
history (clinical diagnosis based on 
present criteria)
0(0) 1(3)
Diagnostic criteria for ARVC/D as defined by McKenna et al.(3) The number (%) of patients fulfilling 
each criterion is given for patients with (TF+) and without (TF-) diagnosis of ARVC/D. *Recently 
proposed diagnostic criteria for ECG depolarisation abnormalities17, not included to classify patients 
into TF+ and TF-. 
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Treatment
Patients were treated according to the routine clinical protocol. The protocol included class 
III antiarrhythmic drugs (preferably sotalol) in all patients and RFCA if feasible. Patients who 
were not inducible after RFCA and/or on class III antiarrhythmic drugs were discharged 
without ICD and antiarrhythmic drug therapy was maintained. Patients who were resusci-
tated and patients who remained inducible despite AAD received an ICD. In the later course 
of the study also patients who present with spontaneous or inducible fast VT received an ICD 
regardless of the results of electrical programmed stimulation and an established diagnosis 
of ARVC/D.
Hemodynamically tolerated VT were mapped and ablated during VT. Target sites for abla-
tion were sites with an isolated middiastolic potential, and/or sites where pacing entrained 
the VT with concealed fusion and a postpacing interval within 30ms of the VT cycle length. 
For fast and hemodynamically untolerated VT the mapping approach was based on the 
presence of electrograms with low amplitude fragmented signals, double potentials and/
or isolated late potentials during sinus rhythm. At these sites pace-mapping was performed. 
A paced QRS morphology similar to the VT QRS morphology and stimulus to QRS delay 
>40ms was used to identify target sites for ablation. Ablation for slow and fast VT’s was 
initially performed using roving catheter techniques and later facilitated by electroanatomi-
cal mapping (EAM) (CARTO XP EP system, Biosense Webster Inc, Diamond Bar, CA, USA or 
RPM™ system, Boston Scientific, Natick, MA, USA).
Complete procedural success was defined as the absence of any inducible monomorphic 
VT at the end of the ablation procedure. Partial success was defined as successful ablation 
of the clinical tachycardia and ablation failure if the clinical VT could not be successfully 
ablated. 
Follow-up
All patients were followed routinely at our clinic. During visits a detailed history with regard 
to arrhythmia recurrence was taken. Progression of disease was defined as progressive de- or 
repolarization abnormalities on ECG, progression of RV dilatation and new a- and dyskinetic 
areas on echocardiography and/or MRI.  
Arrhythmia recurrence was defined as not-otherwise explained syncope or documented 
VT on 12-lead ECG, 24-hour holter registration, event monitor and/or ICD. 
All patients were reevaluated and classified according to TF criteria at last visit. 
Statistical	Analysis
Continuous variables are expressed as mean±SD, and categorical variables as frequency(%). 
Comparison of data was performed using the Student’s t-test. The probability of remaining 
event free was analyzed by the Kaplan-Meier method, and differences in event-free survival 
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Cox regression analysis and variables that were found statistically significant in univariate 
analysis. 
Twenty-one out of 49 patients in the study population underwent more than one ablation 
procedure because of VT recurrence. In order to judge the long-term effect of RFCA, sub-
sequent procedures were included in the survival analysis using a delayed entry approach, 
with time from inclusion as analysis time scale. Individuals who had more than one proce-
dure reentered the survival analysis after their initial recurrence. Since multiple occurrences 
of the same patient are based on disjoint time intervals, correction for dependence is not 
needed in this approach. For all tests a p-value <0.05 was considered significant.
Results
Study	population
The studied population consisted of 49 males and 15 females. Median age at referral was 
39yr (range 15–79yr). Thirty-three (52%) patients were younger than 40yr. At presentation 
25 patients were diagnosed with ARVC/D according to TF criteria. At the end of follow-up 
29 patients fulfilled TF criteria for ARVC/D (TF+) and 35 patients did not fulfill TF criteria 
(TF-). Nine of the 35 TF- patients were classified as probable ARVC/D.  The diagnosis of 
ARVC/D was based on at least 2 major TF criteria in 11 and at least 1 major and 2 minor TF 
criteria in 18 patients. In TF- group 14 patients fulfilled only 1 minor, 12 patients fulfilled 2 
minor, 2 patients fulfilled 3 minor and 7 patients fulfilled 1 major and 1 minor TF criterion 
(Table 1). If the newly proposted TAD criterion was applied only one additional patient 
would have been classified TF+.  
RV scar was detected by imaging techniques in 44(69%) patients (TF+ 28 (97%) vs. 
TF- 16 (46%, p<0.001), in 20 (31%) TF- patients scar was only identified by EAM. 
Severe RV dysfunction was present in 7 patients (TF+ 6 vs. TF- 1, p=0.02) and mild left 
ventricular (LV) involvement in 8 (TF+ 5 vs. TF- 3, p=0.29). In patients with severe RV dilata-
tion and dysfunction the QRS duration was significantly longer as compared to patients with 
mild RV involvement (149±28ms vs. 110±24 respectively, p<0.001).
 Low amplitude, fragmented electrograms were found in 42/49 patients (TF+ 81% vs. 
TF- 89%, p=0.28) who underwent RFCA. Patient characteristics are summarized in Table 2.
Presentation	and	treatment
Nine patients (14%) had been resuscitated and 12(19%) had experienced syncope, all of 
these patients were inducible for LBBB type VT at electrical programmed stimulation. A fast 
VT (CL ≤250 ms ) was documented in 10 (17%) patients and a slow VT (CL>250 ms) in 33 
(52%) patients at initial presentation. Forty-nine (72%) patients were treated with Class III 
antiarrhythmic drugs and 49 (72%) underwent at least one RFCA procedure. A total of 97 
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RFCA were performed with complete success in 17 (45%) of the procedures in TF+ patients 
and in 33 (56%) in TF- patients (p=0.25). Antiarrhythmic drug therapy was continued after 
RFCA in all patients. 3-Dimensional EAM of the RV was used to facilitate RFCA in 58(59%) 
procedures in 33 patients (CARTO system in 25 patients, RPM system in 8 patients).  RFCA 
Table	2.		Patient Characteristics
TF+ TF- P=
 n=29  n=35
Sex M/F 26/3 23/12 0.02
Age 41±13 46±18 0.21
Imaging
   Mild TVR 14(48) 16(46) 0.90
   Moderate TVR 5 (17) 5(14) 0.77
   Mild PVR 11(38) 19(54) 0.12
   Moderate PVR 0(0) 2(6) 0.19
   Mild RV dilatation 9(31) 3(11) 0.06
   Severe RV dilatation 10	(34) 3(9) 0.011
   Mild RV dysfunction 7(24) 2(6) 0.04
   Severe RV dysfunction 6(21) 1(3) 0.02
   LV involvement 5(19) 3(9) 0.27
Catheter	mapping
 Low voltage fragmented electrograms 17(59) 25(71) 0.28
 Located at 1 RV area
   RV outflow tract 4(24) 11(44) 0.22
   RV apex 1(6) 3(12) 0.48
   RV free wall 0 2(8) 0.24
   Adjacent to Tricuspid Annulus  2(12) 1(4) 0.33
Located at ≥2 RV areas 10(59) 8(32) 0.07
Presentation
   Resuscitation 4(14) 5(14) 0.96
   Syncope 8(28) 4(11) 0.09
   Fast VT  (CL≤250ms) 6(21) 4(11) 0.31
   Slow VT (CL>250ms) 11(38) 22(63) 0.05
   CL VT at baseline (ms) 260±55 286±67 0.10
    Superior axis VT* 14(48) 10(29) 0.15
   Multiple VT morphologies* 9(34) 5(14) 0.14
CL indicates cycle length; EPS, programmed extrastimulation;TVR, tricuspid valve regurgitation; 
PVR, pulmonary valve regurgitation; TF+, taskforce positive; TF-, taskforce negative, RV, right 
ventricular; LV, left ventricular; VT, ventricular tachycardia. * VT’s Spontaneous at presentation or at 
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success was not influenced by the use of 3-D EAM systems or the site of origin (RVOT vs. 
none RVOT) of the VT. 
An ICD was implanted in 26 patients (41%), 66% of patients in group TF+ and in 20% of 
patients in TF- (p<0.001) (Table 3).  
Patient	follow-up			
The mean follow-up until last evaluation for VT recurrence was 64±42 months, range 1 
to 166 months (TF+ 68±43 months vs. TF- 61±42 months, p=0.51). Follow-up between 
inclusion and last evaluation for the presence of TF criteria was 57±42 months. During 
follow-up VT recurrence occurred in 41 patients, (TF+ 20 (72%) and TF- 21 (60%) p=0.21). 
The cumulative VT recurrence-free survival after the index event was 76% and 74% at 1 
year, 59% and 61% at 2 years and 45% and 50% at 4 years, for TF+ and TF- respectively. 
There was no significant difference in the VT recurrence-free interval between both groups 
(Figure 1). Within the TF- group (n=35) the VT recurrence free survival was comparable 
between patients with a probable ARVC/D (n=9) and patients with less than 1 major + 1 
minor or 3 minor TF criteria (n=26) (respectively 53% and 49% at 4 years, p=0.54). Three 
patients died during follow-up (3 TF+).Two deaths were sudden, both occurred in patients 
without ICD during the early phase of the study when ICD’s were not implanted routinely 








   Class III 22(76) 27(77) 0.68
   Other 5(17) 8(23) 0.68
RFCA
   Patients 21(72) 28(80) 0.48
   Number RFCA procedures 38 59
   Mean no RFCA 1.31±1.13 1.69±1.99 0.37
   Complete success 17(45) 33(56) 0.25
   Partial/No success 21(55) 26(44) 0.25
   3-D EA mapping (% of patients) 13(62) 20(71) 0.22
ICD 19(66) 7(20) <0.001
RFCA indicates radiofrequency catheter ablation; ICD, implantable cardioverter defibrillator; TF+, 
taskforce positive; TF-, taskforce negative; 3-D EA, 3 dimensional electroanatomical. Data are 
expressed as absolute number (%) or mean±SD.
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Cycle	length	of	the	index	VT
Patients with documented fast VT or syncope at inclusion had a significant lower cumulative 
recurrence-free interval (35% at 4 years) than patients with documented slow VT (60% at 
4 years) (Figure 2). Except for one patient (TF+, index VT CL 260ms), no patient with slow 
VT at presentation experienced fast VT during follow-up. Figure 3 illustrates the shortest 
documented VTCL at inclusion and the shortest documented VTCL during follow-up for 
each individual patient. 
Predictors	of	VT	recurrence
Fast VT and/or resuscitation and/or syncope at inclusion and age≤40yr at referral were 
significant predictors for recurrence after univariate Cox regression analysis of the baseline 
characteristics. Diagnosis of ARVC/D (hazard ratio TF+ vs. TF- 1.41 (95% CI 0.77-2.62) 
and severe RV dilatation and RV dysfunction were not predictive for VT recurrence. After 
multivariate analysis fast VT and/or resuscitation and/or syncope were the only significant 
predictors for VT recurrence (Hazard Ratio 1.98, 95% CI 1.03-3.81, p=0.04). 
Figure	1.	Survival analysis showing the cumulative event free survival for patients with (TF+) and 
without (TF-) diagnosis of ARVC/D after initial presentation. The table below the graph indicates the 
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Outcome	after	RFCA
In the subgroup of patients who underwent RFCA the cumulative VT recurrence free survival 
after a single RFCA procedure was 48% and 58% at 1 year, 31% and 36% at 2 years and 
14% and 26% at 4 years, for group TF+ and group TF- respectively. The recurrence free 
survival was longer after complete success as compared to partial or no success of RFCA 
(Figure 4). In patients with a fast index VT complete success of RFCA was less likely (32%) 
than in patients presenting with a slow VT (71%) (p=<0.001). After multivariate analysis fast 
VT (Hazard Ratio 2.14, 95% CI 1.24-3.69) and incomplete or no success of RFCA were 
independent predictors of VT recurrence after a single RFCA procedure (Hazard Ratio 2.15, 
95% CI 1.24-3.72). 
Figure	2.	Survival analysis showing the cumulative recurrence free survival for patients presenting 
with fast VT (cycle length≤250ms) or resuscitation or syncope and patients presenting with a slow 
VT (cycle length>250ms). The table below the graph indicates the numbers of patients at risk. 
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Discussion
The present study compares the long term clinical outcome of 64 patients presenting 
with scar-related LBBB type VT. The major finding is that the recurrence rate of ventricular 
arrhythmias is high in patients with an established diagnosis of ARVC/D and in patients with 
RV scar of undetermined origin. Patients presenting with a fast VT are at high risk for fast VT 
recurrence.
RV	scar	and	TF	criteria
ARVC/D is a progressive, often inherited cardiomyopathy, but to date molecular diagnosis is 
not feasible in the majority of cases. The clinical diagnosis is based on the Task Force criteria, 
however, patients with a confirmed ARVC/D causing mutation may remain TF negative and 
disease causing mutations are found in less than 50% of TF positive patients.19-22 
EAM is a sensitive diagnostic modality capable of identifying RV involvement in con-
cealed forms of ARVC/D that are not  identified by imaging modalities.23 In a small series of 
patients presenting with RVOT VT in the absence of RV dilatation or dysfunction on imaging 
low voltage areas on EAM correlated with fibrofatty myocardial replacement at biopsy.23 
However, different pathologies such as myocarditis or sarcoidosis may mimic ARVC/D.24-26 
Analysis of endomyocardial biopsies in ARVC/D TF positive patients with LBBB type VT 
identified myocarditis as underlying cause of RV scar in some of these patients.25 Despite 
Figure	3.	Chart showing the cycle length (CL) of VT at presentation and the shortest documented 
CL of recurrent VT during follow-up for each individual. Patients who presented with a slow VT 
(CL>250ms) are shown in the left panel, patients who presented with a fast VT (CL≤250/syncope) 
are shown in the right panel. Except for 1 patient none of those presenting with a slow VT 
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the clinical importance of the TF criteria these findings highlight their limitations for iden-
tification of patients with scar related VT due to mild or early form of ARVC/D and for 
distinguishing ARVC/D from other potential arrhythmogenic diseases. To date, most avail-
able data on outcome and recurrence of scar-related RV VT are derived from TF positive 
patients or their relatives. 
To our best knowledge this is the largest study reporting on long-term arrhythmia recur-
rence and treatment efficacy in patients with scar-related LBBB type VT of undetermined 
origin. Of importance, we included bipolar electrogram criteria to define scar and in 54% 
of the TF- patients scar was only detected by EAM implicating that some of these VT’s may 
have been otherwise classified as idiopathic VT (Figure 5). 
Long-term	arrhythmia	follow-up
ARVC/D is associated with a ventricular arrhythmia recurrence rate of 48 – 74%. 7, 8, 27 The 
results of the present study confirm the high VT recurrence rate in these patients despite 
drug therapy and RFCA. However, a remarkable finding is the high VT recurrence rate in 
patients with RV scar of undetermined origin of whom the majority had no or mild structural 
alterations of the RV on MRI and/or contrast echocardiography. This finding extends prior 
observations that localized RV scar, even if detected only by EAM, predispose to VT recur-
rence, and of importance, to a similar extend as in TF+ ARVC/D patients with obvious 
structural and functional alterations of the RV. These localized scars may be due to an early/
mild form of ARVC/D. Since endomyocardial biopsy was not performed systematically in 
Figure	4.	Survival analysis showing the cumulative recurrence free survival for patients with 
(TF+) and without (TF-) diagnosis of ARVC/D after the first RFCA procedure (left panel) and the 
cumulative recurrence free survival for patients with acute complete and partial/no success of 
RFCA (right panel). The table below the graph indicates the numbers of patients at risk.
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our patient population because of the predominant non-septal location of the scar areas 
other causes of RV scars can not be excluded. 
Risk	stratification
A fast index VT or syncope as presenting symptom, most likely due to a VT with hemody-
namic compromise was the only independent predictor for VT recurrence in both groups. 
The event free survival in these patients was significantly shorter than in patients presenting 
with slow VT. Of importance, patients who presented with a fast index VT were also more 
likely to experience recurrence of fast and potentially fatal ventricular arrhythmias during 
follow-up perhaps identifying a subgroup of patients who benefit most from ICD therapy. 
This is in line with previous data demonstrating fast VT/VF at presentation as a predictor for 
potentially fatal VT recurrence in ARVC/D patients.7, 27 
Several studies seeking risk factors for VT in patients with TF positive ARVC/D have identi-
fied younger age, severity of RV failure and LV involvement as factors with predictive value 
for arrhythmia recurrence. 7, 8, 27 In contrast to these studies severe RV enlargement and LV 
involvement was not found to be an independent predictor of VT recurrence, however this is 
likely due to the smaller number of ARVC/D patients with RV enlargement and the exclusion 
of patients with significant functional LV impairment. 
Figure	5.	Right ventricular 3-D electroanatomical bipolar voltage maps of a TF- (left) and a TF+ 
(right) patient. Voltages are color-coded according to the corresponding color bar. Normal voltage 
is defined as electrogram amplitude >1.5mV displayed in purple. The TF- patient had recurrent VT’s 
with different morphologies originating from a single small RV free wall scar area. Scar was only 
identified by voltage mapping. The TF+ patient had multiple low voltage areas. VT was successfully 
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Treatment	
Treatment to prevent VT recurrence was similar in both groups. RFCA was offered to all 
patients and attempted in 49. There was no difference in acute procedural success between 
both groups. The low acute success rate of RFCA may be at least partly due to a subepicardial 
substrate typical for patients with ARVD/C, which may not be reachable by an endocardial 
approach. The recently introduced technique of epicardial mapping and ablation in patients 
with scar-related RVVT was applied in 4 patients with an unsuccessful endocardial ablation 
approach leading to complete ablation success in 2 patients. The acute success rate was 
lower in patients presenting with a fast VT compared to patients in whom a slow VT was 
targeted. In the latter mapping could be performed during VT which may explain the favour-
able result. The concept of substrate mapping and ablation during stable rhythm to target 
unstable VT’s based on electrogram characteristics and pace-mapping has evolved during 
the course of the study. In addition the application of linear lesion to encircle low voltage 
areas and connect scars was only introduced recently6. This approach and the introduction 
of epicardial ablation is likely to further improve the acute results of RFCA for fast VT.
However, after adjustment fast VT and procedural failure remained independent predic-
tors for VT recurrence. After RFCA the recurrence-free interval was remarkable short for both 
groups. The high VT recurrence rate in patients with ARVC/D in the first 4 years after ablation 
is in line with previous studies by Verma et al6 and Dalal et al5 and may be due to disease 
progression. Marchlinski  et al.28 reported a distinctly higher long-term procedural success 
of RFCA facilitated by EAM in ARVC/D patients. These findings seem to contradict the pre-
sented results. However, the current study reported the outcome of all RFCA procedures. In 
contrast,  68% of the patients reported by Marchlinski et al.28 underwent a repeated ablation 
procedure suggesting a lower single procedure success rate. The high VT recurrence after 
RFCA in patients with RV scar of undetermined origin found in this study may indicate that 
the arrhythmogenic substrate in these patients is similar to that in patients with established 
ARVC/D and may be consistent with an early form of ARVC/D. 
However, despite the long term follow-up RV involvement remained concealed in the 
majority of the patients if routine imaging modalities are applied. 
In the current study TF+ ARVC/D patients were more likely to receive an ICD than 
TF- patients. Similar to the strategy that has been adopted for VT treatment and sudden 
death prevention in patients after myocardial infarction patients with scar related VT and a 
preserved RV function who did not meet diagnostic criteria for ARVC/D were considered to 
be at low risk for sudden cardiac death and VT recurrence after drug treatment and RFCA. 
Although no sudden death occurred in the TF- group during the follow-up period, the high 
recurrence rate of fast and therefore potential fatal VT’s gives cause for concern.
The results of this study indicate that the diagnosis of ARVC/D based on TF criteria does 
not identify patients at risk for recurrence of RV scar-related VT. Careful decision making 
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for ICD implantation should include the type of the presenting arrhythmia rather than the 
definite diagnosis of ARVC/D. 
Study	Limitations	
Our study has several limitations. Not all arrhythmia episodes necessitate hospitalization 
and episodes may have been missed particularly in patients without ICD. 
Due to advances in catheter mapping and the introduction of endo- and epicardial high 
density 3-dimensional electroanatomical mapping during the course of the study, we can 
only provide data on the distribution of low voltage areas and not on the scar burden. The 
extend of the subendocardial and particular the subepicardial scar is likely underestimated 
in both groups and small low voltage areas may  be missed due to the initially performed 
restricted EAM.
No signal averaged ECG were obtained in our patient population. Therefore a TF class 
IV minor criterion can be missed which is relevant for the TF- group. If hypothetically the 
SAECG in all TF- patients had shown late potentials 9 patients in this group would be 
diagnosed with ARVC/D according to TF criteria resulting in a TF+ group of 38 patients. 
Repeated analysis of these groups did not result in a significant difference in recurrence free 
survival between TF+(+9) and TF-(-9) patients. Furthermore univariate Cox regression did 
not identify a diagnosis of TF+(+9) as predictor for recurrence. 
The majority of patients in this study was not evaluated for genetic mutations causing 
ARVC/D. Genotyping both TF+ and TF- patients is of the greatest relevance and would 
provide valuable information regarding the underlying cause of RV scar. 
Conclusion
Scar-related RV VT are associated with high recurrence rates regardless if the patient was 
considered TF+ or TF-. In the majority of TF- patients RV scar was only identified by volt-
age mapping, which might be a diagnostic tool with important prognostic and therapeutic 
implications.  Patients who present with fast VT are at high risk for fast VT recurrence despite 
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Background: This study aimed to evaluate the impact of early reperfusion during acute 
myocardial infarction (MI) on ventricular tachycardia (VT) inducibility, inducible VT cycle 
length (CL) and occurrence of spontaneous VT late after MI.
Methods and results: Five-hundred-six patients (440 male, 63±11yr) with prior MI who 
underwent electrophysiology study before implantation of an implantable cardioverter 
defibrillator for primary or secondary prevention were assessed. Patients were classified 
according to the reperfusion strategy {reperfusion (thrombolysis (n=44) or percutaneous 
coronary intervention (n=65)) vs. no reperfusion (n=397)} during acute MI.
Monomorphic sustained VT was inducible in 351 (69%) patients. Inducibility in reper-
fused and non-reperfused patients was similar in primary prevention patients (56% vs.58%) 
but significantly higher for non-reperfused patients in secondary prevention patients (56% 
vs.79%, p=0.001). Induced VTCL was shorter (247±40 vs.287±63, p<0.001) and very fast 
VT (CL≤250 ms) was more often induced in reperfused patients (71% vs.47%, p=0.001). 
In primary prevention patients, non-reperfusion was associated with a doubled risk for first 
spontaneous VT during follow-up. 
Conclusion: There are important differences in VT inducibility, induced VTCL and occur-
rence of spontaneous VT in the chronic infarct healing phase between patients with and 
without successful reperfusion during acute MI. These findings suggest differences in the 
chronic arrhythmogenic substrate.
Chapter 9
Early Reperfusion and VT Characteristics
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Introduction
Survivors of acute myocardial infarction (MI) may be at risk for reentrant ventricular tachy-
cardia (VT) originating from infarct scar.1 
In the past decades, early reperfusion therapies such as thrombolysis and primary percu-
taneous coronary intervention (PCI) have significantly improved outcome after acute MI.2 
Early reperfusion during MI results in myocardial salvage and improved ventricular function 
but also influences size, transmurality and geometry of myocardial fibrosis, which may 
function as a substrate for ventricular arrhythmias.3-7 A fixed substrate may lead to reentrant 
tachycardias reproducible induced during electrophysiology study (EPS) and more than 90% 
of patients with sustained VT late after MI had the arrhythmia induced in the lab.8 However, 
these data were derived before the widespread availability of reperfusion therapy and the 
role for EPS in patients late after reperfused MI is less clear. Mapping studies demonstrated 
that the 3-dimensional geometry of the infarcted area may determine VT reentry circuit 
characteristics.9-12 In a small group of patients referred for treatment of VT late after MI, we 
previously demonstrated that early reperfusion affects the electroanatomical VT substrate.13 
In addition, cycle length (CL) of spontaneous and induced VTs was shorter in patients who 
underwent early reperfusion as compared to non-reperfused patients.
The aim of the present study was to evaluate the affect of early reperfusion during acute 
MI on VT inducibility, induced VTCL and the occurrence of spontaneous VT during follow-
up in a larger population of patients with prior MI in one coronary territory who underwent 
EPS before implantable cardioverter defibrillator (ICD) treatment.
Methods
Patients	
Since 1996, information on all patients who received an ICD at the Leiden University Medi-
cal Center was prospectively collected in the departmental Cardiology Information System 
(EPD-Vision®, Leiden University Medical Center). Patient’s history, baseline characteristics 
and results of studies before ICD-implantation were recorded. For the current study, all 
consecutive patients (1) with a prior MI in a single coronary territory and documented 
reperfusion strategy during the index MI; (2) without evidence of reversible ischemia 
assessed by coronary angiogram and nuclear imaging at the time of evaluation, and (3) who 
underwent EPS before ICD implantation were included. Patients with documented sponta-
neous monomorphic VT or ventricular fibrillation (VF) in the absence of a reversible cause 
were considered as secondary prevention ICD recipients and asymptomatic patients with 
left ventricular ejection fraction (LVEF) <40% without prior documentation of a sustained 
ventricular arrhythmia primary prevention ICD recipients.14-16 
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All coronary angiograms performed in reperfused patients within 6 months before EPS 
were reviewed by an interventional cardiologist to evaluate the late patency of the infarct 
related artery. Patients with ≤ TIMI II flow of the infarct related artery were excluded from 
analysis. All patients were followed at our institute. 
Myocardial	infarction
The presence of prior MI was assessed using the definition for MI, as defined by the Task 
Force for the Redefinition of Myocardial Infarction.17 Either acute MI had to be documented, 
or evidence of prior MI had to be present, based on any of the following criteria: 1) develop-
ment of new pathological Q-waves with or without symptoms; 2) imaging evidence of a 
region of loss of viable myocardium that is thinned and fails to contract, in the absence of a 
non-ischemic cause; 3) pathological findings of a healed or healing MI.17
MI was considered to be present in more than one coronary artery region if the criteria 
for acute or prior MI were met for more than one of the regions provided by the three main 
coronary arteries. 
The treatment of prior MI was assessed using the patients’ medical charts. Patients were 
categorized as reperfused when TIMI flow grade 3 was achieved within 9 hours after onset 
of symptoms. Reperfused patients were subdivided into patients who had underwent pri-
mary PCI (defined as angioplasty and/or stenting without prior or concomitant fibrinolytic 
therapy)18 and patients who had received thrombolytic therapy. All other patients were 
categorized as non-reperfused. 
Electrophysiology	study	
Electrophysiological studies to test inducibility of VT were performed according to the cur-
rent international guidelines.19 Patients were studied in the post absorptive, non-sedated 
state. Antiarrhythmic drugs were discontinued for 5 half-lives, with the exception of amio-
darone. EPS consisted of up to three basic drive cycle lengths (600, 500 and 400ms) with 
up to three ventricular extrastimuli and burstpacing from the right ventricular apex and 
right ventricular outflow tract. The positive endpoint of EPS was reproducible induction of 
a sustained monomorphic VT (SMVT).19 Arrhythmias induced by anti-tachycardia pacing 
(ATP) to terminate the induced VT were not included in the analysis. 
Ventricular	arrhythmia	during	electrophysiology	study	
Ventricular arrhythmias were categorized according to the EHRA/HRS consensus docu-
ment.20 SMVT was defined as continuous VT with a similar QRS configuration from beat to 
beat lasting for more than 30 seconds or requiring an intervention for termination. Separately 
scored arrhythmia not considered diagnostic for the presence of fixed reentry circuits and 
therefore aspecific were polymorphic VT, defined as VT with continuously changing QRS 
configuration from beat to beat and VF.19
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For each patient, the mean CL of all induced SMVTs was calculated. Patients with missing 
data on one or more CLs were excluded from all analyses involving VTCL. Monomorphic 
VTs were categorized into the following four pre-defined subgroups according to CL: ≤250, 
251-286, 287-320 and >320 ms (corresponding to a rate of  ≥240, 240-210, 210-188 and 
<188bpm, respectively). A very fast VT was defined as a VT with CL ≤250 ms. 
Implantable	cardioverter	defibrillator	settings	and	follow-up
Defibrillators were programmed as follows: a ventricular arrhythmia monitor zone was 
programmed in all patients (150-188bpm). Ventricular arrhythmias faster than 188bpm were 
initially attempted to be terminated with two bursts of ATP followed by a defibrillator shock, 
if appropriate. In the case of a ventricular arrhythmia faster than 210bpm, device shocks 
were the initial therapy. Atrial arrhythmia detection was set to >170bpm with supraven-
tricular tachycardia discriminators enabled. Settings were adapted, only when clinically 
indicated (i.e. hemodynamic well tolerated VT at high rate; VT in the monitor zone).
Patient follow-up was scheduled every three-six months. Device interrogation printouts 
were checked for appropriate and inappropriate ICD therapy (ATP or shocks). Therapies 
were classified as appropriate when they occurred in response to VT or VF and as inap-
propriate when triggered by sinus or supraventricular tachycardia, T-wave oversensing, or 
electrode dysfunction. 
In both primary and secondary prevention ICD recipients, the correlation between 
treatment of acute MI and the occurrence of first spontaneous monomorphic VT during 
follow-up was assessed. 
Statistical	analysis	
Dichotomous and categorical data are displayed as numbers and percentages. Continuous 
data are expressed as mean ± standard deviation or median and interquartile range where 
appropriate. Patients were grouped according to acute MI treatment. Different groups were 
compared for 1) inducibility of SMVT, 2) mean CL of induced SMVTs, 3) inducibility of 
very fast VT (CL ≤250ms), and 4) the occurrence of first spontaneous VT during follow-up in 
primary and secondary prevention ICD patients. Data were analyzed by means of the Chi-
square test, the Student’s t-test or the Mann-Whitney U-test as appropriate. For the Student’s 
t-test, equal variances were assumed if Levene’s test for equality of variances showed a 
p-value >0.05. Univariate relationships between baseline parameters and the mean CL of 
induced VTs were analyzed with linear regression analysis. For each variable, the effect 
on the mean CL with a 95% confidence interval (95%-CI) was calculated. Variables with 
a p-value <0.10 were further evaluated in a multivariate model, using backward stepwise 
selection. At each step, the least significant variable was discarded from the model, until all 
variables in the model reached a p-value <0.25. 
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The cumulative incidence of first spontaneous VT during follow-up in primary and 
secondary prevention ICD patients was analyzed by method of Kaplan-Meier. The effect of 
acute MI treatment on the risk of spontaneous VT was assessed in a Cox regression model. As 
with linear regression analysis, first, univariate analyses were performed and variables with 
a p-value <0.10 were further evaluated in a multivariate model, using backward stepwise 
selection. At each step, the least significant variable was discarded from the model, until all 
variables in the model reached a p-value <0.25.
All analyses were performed with SPSS for Windows, version 17.0 (SPSS, Chicago, IL). 




Since 1996, 996 patients with prior MI in one coronary artery region received an ICD at 
the Leiden University Medical Center. Of these patients, 511 had a documented reperfu-
sion strategy and underwent EPS before ICD implantation and after exclusion of reversible 
ischemia. Five patients (1%) were excluded due to lack of late patency of the infarct related 
artery. The remaining 506 patients (87% male, age 63 ± 11 years) comprised the studied 
sample. The presenting and documented arrhythmia was SMVT in 221 patients (44%) and 
VF in 113(22%); 172 patients (34%) had no prior sustained arrhythmia. The majority of 
patients had a depressed left ventricular ejection fraction (36 ± 13%). Mean QRS duration 
was 115 ± 29 ms and mean creatinin clearance was 79±39mL/min. Medication during EPS 
included amiodarone in 22% and ACE-inhibitors or ATII-antagonists in 75% of patients. 
Baseline characteristics are summarized in Table 1.
Myocardial	infarction	treatment	
One-hundred-nine (22%) of 506 patients were treated with reperfusion therapy during the 
acute MI and 397(78%) were not reperfused. Of the 109 reperfused patients, 65(13%) under-
went primary PCI and 44(9%) received thrombolytic therapy. Before electrophysiological 
evaluation, the infarct-related artery was patent in 97(89%), collaterally perfused in 11(10%) 
and bypassed in one (1%) of the initially reperfused patients. In non-reperfused patients, the 
infarct-related artery was patent in 140 (35%), occluded in 116(29%), collaterally perfused 
in 88(22%) and bypassed in 53(13%). Patients who were reperfused were younger than 
non-reperfused patients (59±11 vs. 65±10, p<0.001), presented less often with SMVT (22% 
vs. 49%, p<0.001) and had a shorter interval between MI and electrophysiological evalu-
ation (median 1.6, IQR 0.2 – 5.9 vs. median 10.5, IQR 2.1 – 17.5, p<0.001). In addition, 
reperfused patients had an anterior MI more frequently (72% vs. 52%, p<0.001), a shorter 
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QRS-duration (median 100, IQR 90 – 120 vs. median 110, IQR 100 – 138, p=0.001), were 
less often treated with amiodarone (12% vs. 25%, p=0.001) but were more likely to receive 
betablockers (53% vs. 40%, p=0.014).
Inducibility	of	ventricular	arrhythmia	
In 422 patients (83%), at least one ventricular arrhythmia was inducible: SMVT was induced 
in 351(69%) patients, 45 of them were also inducible for polymorphic VT or VF. In 71(14%) 










Male sex 440 (87%) 341 (86%) 99 (91%) 0.176
Age, years 65 (57 – 71) 66 (58 – 73) 60 (51 – 68) <0.001
Presenting arrhythmia
    Sustained VT
    Ventricular fibrillation 












    Anterior








Years from MI to EPS 7.5 (0.9 – 15.0) 10.5 (2.1 – 17.5) 1.6 (0.2 – 5.9) <0.001
LVEF, % 36 ± 13 35 ± 13 37 ± 13 0.180
NYHA Classification
    I
    II
    III














QRS duration, ms       110 (94 – 130) 110 (100 – 138) 100 (90 – 120) 0.001
Renal clearance, mL/min* 79 ± 39 77 ± 41 85 ± 27 0.066
Documented AF or atrial 
flutter
89 (18%) 69 (17%) 20 (18%) 0.823
Current smoking 126 (25%) 94 (24%) 32 (29%) 0.253
Amiodarone 111 (22%) 98 (25%) 13 (12%) 0.004
ß-blocker 217 (43%) 159 (40%) 58 (53%) 0.014
ACE-inhibitor or ARB 380 (75%) 291 (73%) 89 (82%) 0.070
* Renal clearance was determined with the formula of Cockroft-Gault. 
Data are expressed as number (percentages), mean ± standard deviation or median (interquartile 
range). ACE = angiotensin converting enzyme, AF = atrial fibrillation, ARB = angiotensin receptor 
blocker, ICD = implantable cardioverter defibrillator, LVEF = left ventricular ejection fraction, MI = 
myocardial infarction, NYHA = New York Heart Association, EPS = electrophysiology study, VT = 
ventricular tachycardia
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one VT morphology in 222(63%) and two or more different morphologies in 129(37%) 
patients. Inducibility for SMVT was similar in reperfused and non-reperfused patients 
without prior documentation of sustained VT or VF (56% vs 58%, p=ns). However, in the 
secondary prevention group inducibility for SMVT was significantly lower in reperfused 
patients as compared to non-reperfused patients (56% vs 79%, p=0.001).
Ventricular	tachycardia	cycle	length
In 37(11%) out of 351 patients with inducible SMVT, one or more induced VTCL was 
unknown, these patients were excluded from VTCL analyses. In the remaining 314 patients, 
the mean CL was 280±61 ms (Table 2). In 161(51%) patients, at least one monomorphic fast 
VT (CL ≤250) was induced.
Reperfused patients had a shorter mean CL of the induced VT than non-reperfused 
patients (247±40ms vs. 287±63ms, p<0.001, Table 2). This difference was even more 
pronounced when patients who underwent primary PCI were compared to non-reperfused 
patients (238±40ms vs. 287±63ms, p<0.001). Patients treated with thrombolysis also had a 
significantly shorter mean CL than non-reperfused patients, but the difference was smaller 
(260±37ms vs. 287±63ms, p=0.038). After exclusion of patients on amiodarone during 
EPS the induced VTCL remained significantly shorter in reperfused patients (244±40ms vs. 
274±58ms, p<0.001). Of importance, reperfused patients were more often inducible for 
very fast VT (CL ≤250ms) than non-reperfused patients (71% vs. 47%, p=0.001, Figure 1). 
The difference was mainly attributable to patients treated with primary PCI, while patients 
treated with thrombolysis had a similar percentage of very fast VT, as compared to non-
reperfused patients. Univariate and subsequent multivariate analysis identified the following 
five variables as independently affecting the mean CL of induced VTs: no reperfusion, QRS 
>120 ms, presenting arrhythmia, use of amiodarone and age. After adjustment, no reperfu-
sion at MI was correlated with 17ms (95%-CI 0-34 ms, p=0.048) increase in VT CL at EPS 
(Figure 2).






All patients 314 280 ± 61 NA NA
Non- reperfused 258 287 ± 63 NA NA
Reperfused 56 247 ± 40 40 (27 – 53) <0.001
   Thrombolysis 23 260 ± 37 27 (2 – 53) 0.038
   Primary PCI 33 238 ± 40 49 (27 – 70) <0.001
*when compared to non-reperfused patients. 
CI = confidence interval, CL = cycle length, NA = not applicable, PCI = percutaneous coronary 
intervention.
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Spontaneous	ventricular	tachycardia
The 172 primary prevention ICD recipients were followed for a median of 28 months 
(IQR 11 – 45). During follow-up, spontaneous VT, triggering appropriate ICD therapy was 
observed in 51(30%) patients. The cumulative incidence of first appropriate therapy was 
13% (95% CI 8-18%) at one year, 22% (95% CI 15-28%) at two years, and 30% (95% CI 
22-39%) at three years follow-up. 
The three year cumulative incidence of first appropriate device therapy was 36% (95% CI 
26-47%) in non-reperfused patients and 18% (95% CI 7-29%) in reperfused patients (Figure 
3). Cox regression modeling demonstrated that non-reperfused patients exhibited a more 
than doubled risk for spontaneous VT (hazard ratio 2.2, 95% CI 1.2- 4.3, p=0.010). 
The 334 secondary prevention ICD recipients were followed for a median of 37 months 
(IQR 9–68). Spontaneous VT occurred in 170(51%) patients. The three year cumulative 
incidence of first appropriate device therapy was 38% (95% CI 32-44%) in non-reperfused 
patients and 26% (95% CI 12-39%) in reperfused patients (Figure 4). In this population with 
prior sustained ventricular arrhythmia, MI treatment did not significantly correlate with the 
occurrence of spontaneous VT during follow-up (hazard ratio 1.4, 95% CI 0.9-2.3). 
Figure	1.	Cycle length of the fastest induced monomorphic ventricular tachycardia, categorized into 
4 subgroups. Percentages are for all patients with induced monomorphic ventricular tachycardia in 
the specific group.
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Figure	2.	Forest plot of the effect of baseline parameters on the mean cycle length of induced 
monomorphic ventricular tachycardias. For example, in multivariate analysis, patients who did not 
receive reperfusion therapy at the index MI on average had a 17 ms (95% CI 0 – 34 ms) longer VT 
cycle length (i.e., a slower VT), as compared to patients who did receive reperfusion therapy. AF = 
atrial fibrillation, CI = confidence interval, LVEF = left ventricular ejection fraction, MI = myocardial 
infarction, EPS = electrophysiology study,VA = ventricular arrhythmia, VF = ventricular arrhythmia, 
VT = ventricular tachycardia.
Figure	3.	Kaplan-Meier curve for the occurrence of first appropriate ICD therapy in primary 
prevention ICD patients with reperfusion vs. no reperfusion at prior acute myocardial infarction. 
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Discussion
Early reperfusion therapy for acute MI has dramatically increased over the last decenniums 
and is likely to influence the chronic arrhythmogenic substrate for reentrant tachycardias 
after infarct healing. 
 The current study evaluates the effects of early reperfusion during acute MI on VT induc-
ibility, induced VT CL and occurrence of spontaneous VT late after the index MI. Reperfused 
patients who presented with sustained VT or VF were less likely inducible for monomorphic 
VT as compared to non-reperfused patients. Reperfused and non-reperfused patients without 
prior sustained arrhythmia had comparable VT induction rates; however reperfused patients 
were less likely to experience spontaneous VT during follow-up. Among inducible patients 
VTCL of induced VTs was significantly shorter and inducible VT was more often very fast 
VT (CL ≤ 250 ms) in reperfused patients. These differences were even more pronounced in 
patients treated with primary PCI as compared to thrombolytic therapy. After adjustment 
for potential confounders, treatment of the index MI appeared to have an independently 
significant effect on the mean CL of induced VTs. 
Early	reperfusion	during	MI	and	inducibility	of	VT	
Former studies performed before the widespread availability of reperfusion therapy have 
demonstrated that in patients with coronary artery disease VT was inducible in 92% of 
patients who presented with sustained VT and in 83% of patients who presented with car-
diac arrest due to VF.8 Accordingly, 79% of the non-reperfused patients in our study who 
Figure	4.	Kaplan-Meier curve for the occurrence of first appropriate ICD therapy in secondary 
prevention ICD patients with reperfusion vs. no reperfusion at prior acute myocardial infarction.
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presented with sustained VT or VF were inducible for monomorphic VT. In contrast, in only 
56% of reperfused patients with documented VT or VF monomorphic VT was inducible. 
Although all patients had a chronic substrate as spontaneous arrhythmias occurred in the 
absence of a reversible cause the sensitivity of an EPS for substrate assessment after reperfu-
sion therapy seems to be low. This finding is of clinical importance if EPS is performed for 
the evaluation of patients who present with unexplained syncope due to non-documented 
VT or during ablation procedures of VT if non-inducibility of monomorphic VT is considered 
as endpoint for ablation. 
Acute reperfusion has resulted in a lower prevalence of spontaneous and induced 
ventricular arrhythmias in the acute phase of MI.4, 21-23 In small series, 9-48% of patients 
receiving thrombolysis were inducible for ventricular arrhythmias as compared to 88-100% 
of patients without reperfusion therapy.24, 25 However, the arrhythmogenic substrate caus-
ing late ventricular arrhythmias may develop over time. In our series, EPS was performed 
in the chronic healing phase of MI. Of interest, non-reperfused and reperfused patients 
without prior spontaneous arrhythmia showed high inducibility rates of 58% and 56%, 
respectively. However, during follow-up the three year cumulative incidence of appropriate 
device therapy was 36% in non-reperfused patients and only 17% in reperfused patients. 
This finding suggest that despite the presence of an arrhythmogenic substrate the value of 
EPS to predict VT occurrence is lower in reperfused patients as compared to non-reperfused 
patients. 
Effect	of	early	reperfusion	and	inducible	VTCL
Early reperfusion during MI results in myocardial salvage and reduced mortality during 
follow-up.3 Histological studies in patients and animal models of acute MI have shown that 
the duration of coronary artery occlusion is proportionally correlated to the size and trans-
mural extent of myocardial scar.4, 5, 26 Scar size and geometry are important determinants for 
the reentrant circuit geometry and may contribute to  occurrence and cycle length of VT.9, 27 
We recently demonstrated that reperfused patients referred for ablation of recurrent VT 
late after MI appeared to have smaller and less confluent electroanatomical scars with thick 
layers of surviving myocardium found at histology. Interestingly, the CL of spontaneous and 
induced VTs was shorter in reperfused than in non-reperfused patients likely due to the 
observed differences in scar geometry after reperfusion therapy.13 The association between 
acute reperfusion therapy and shorter inducible VTCL was confirmed and extended, as the 
present study is conducted in a large population of post-MI patients also including patients 
without previously documented ventricular arrhythmia. In addition, we adjusted for all 
baseline characteristics that affect induced VTCL.
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Limitations
Our study was performed in a selected population of ICD recipients with prior MI and 
low LVEF, who are not representative for the general population with prior MI. In addition, 
our cutoff of 9 hours for early reperfusion is arbitrarily chosen. Furthermore, we studied 
induced VTs, and our findings do not necessarily apply to spontaneous VTs. However, in the 
previous study by Wijnmaalen et al., spontaneous VTs were taken into account and similar 
differences were found, as compared to induced VTs. Finally, therapy for acute MI was 
not randomly assigned and time from MI to EPS differs between groups, which could have 
resulted in selection bias. However, since primary PCI has been shown to be the preferred 
treatment for acute MI, a study in which patients would be randomly assigned to primary 
PCI, thrombolysis or conservative treatment is ethically unacceptable and therefore, selec-
tion bias is now inevitable in studying the effects of reperfusion. To correct for it, we adjusted 
for baseline characteristics using linear regression and could demonstrate that reperfusion 
independently affects the CL of induced VTs.
Conclusions
There are important differences in VT inducibility, induced VTCL and occurrence of sponta-
neous VT in the chronic phase of MI between patients with and without successful reperfu-
sion during acute MI. Reperfused patients who present with sustained VT/VF are less likely 
inducible for monomorphic VT. Despite similar VT induction rates in patients without prior 
documented sustained arrhythmias, reperfused patients are at lower risk for spontaneous VT. 
However, early reperfusion is associated with faster induced VT. 
These findings suggest important differences in the chronic arrhythmogenic substrate after 
reperfusion, which gives rise to faster VT and which might be less reliably assessable by EPS. 
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Background: After surgical ventricular restoration (SVR) for ischemic cardiomyopathy, ven-
tricular tachycardias (VTs) are an important reason for postoperative morbidity and mortality. 
Objective: To elucidate the VT substrate, VT characteristics and outcome of radiofre-
quency catheter ablation (RFCA) in patients with VT after SVR.
Methods: Twelve(3%) of 416 patients referred for RFCA for VT after myocardial infarction 
in three centers had underwent SVR. After induction of VT, left ventricular (LV) electro-
anatomical mapping was performed. Ablation target sites were identified by entrainment, 
substrate and/or pace mapping.
Results: Four(33%) patients presented within the perioperative period with incessant VT, 
8(67%) presented with incessant or recurrent VT late after SVR (VT cycle length 453±102ms). 
The region of surgical scar was identified by electroanatomical mapping in 11 patients. 
Twenty-eight VTs (cycle length 384±95ms) were induced. The VT exit was bordering the 
surgical scar in 20(71%) VTs, 15 of which at the septal side. All VTs were abolished in 5 
patients, in 4 only the clinical VTs were abolished, in 1 re-inducibility was not tested. In 
2 patients ablation failed after which surgical ablation was performed successfully. During 
follow-up 3(25%) patients died (non-arrhythmic deaths) all had presented early after SVR. 
Two(17%) experienced recurrent VT.
Conclusion: VT after LV SVR seems to have a bimodal presentation, one third presented 
with incessant VT in the acute postoperative phase, having a high mortality. Two thirds 
presented late after SVR, in these patients RFCA is usually effective. Successful ablation sites 
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Introduction
Surgical ventricular restoration (SVR) of the left ventricle (LV) is a potential treatment option 
for patients with extensive LV scar due to ischemic cardiomyopathy.1 Commonly used 
techniques are endoventricular repair with or without the use of a patch and aneurysmec-
tomy with linear repair.1-3 In the early and late postoperative period ventricular arrhythmias 
are the second most important cause of death and an important reason for morbidity in 
these patients.1, 4 It has been demonstrated that surgical scars and patch material influence 
occurrence and characteristics of reentrant monomorphic ventricular tachycardias (VTs) 
in patients after repair of congenital heart disease and in patients after corrective valve 
surgery.5, 6 Despite the growing number of patients undergoing SVR, there are no systematic 
studies of the substrate and the characteristics of sustained monomorphic VTs contributing 
to the postoperative morbidity and mortality.
This study aimed to elucidate the VT substrate, VT characteristics and outcome of catheter 
ablation in patients with recurrent VT after SVR. 
Methods
Patients
Clinical records of 416 patients referred for radiofrequency catheter ablation (RFCA) for 
symptomatic VT late after myocardial infarction during 4.0±2.6 (range 2-7) consecutive 
years in three centers (Brigham and Women’s Hospital, Leiden University Medical Center, 
Hamburg University Hospital) were reviewed and 12 patients (3%) were identified who 
had LV reconstructive surgery defined as surgical ventricular restoration (SVR) by endoven-
tricular patch-plasty or LV aneurysm resection. General contraindications for endocardial 
catheter ablation were absence of vascular access to the LV, echocardiographic evidence of 
mobile LV thrombus, combined aortic and mitral valve replacement and unstable angina. 
All patients who underwent catheter ablation after SVR were included in the study. Data 
regarding patient characteristics, clinical history and acute outcome were obtained from the 
medical record. 
Electrophysiological	study	and	mapping
All patients underwent electrical programmed stimulation (EPS) and LV electroanatomical 
(EA) mapping. The EPS-protocol consisted of 3 drive-cycle lengths (600, 500 and 400ms) 
and up to 3 ventricular extrastimuli from 2 right ventricular sites and burst pacing. The 
positive endpoint of EPS was the induction of VT lasting >30s or requiring termination for 
hemodynamical instability. Bipolar endocardial electroanatomical voltage mapping of the 
RV and/or LV was performed in all patients, facilitated by a 3D EA mapping system (CARTO 
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XP EP system, Biosense Webster Inc, Diamond Bar, CA, USA) during sinus or paced rhythm. 
A 4mm or 3.5mm tip, irrigated quadripolar mapping catheter (NaviStar or Navistar Thermo-
Cool, Biosense Webster Inc, Diamond Bar, CA, USA) was used inserted via a transvenous 
or retrograde aortic approach. Electroanatomical scar was defined by voltage criteria. Elec-
trogram amplitudes ≤0.5mV were defined as dense scar, voltages >0.5mV and ≤1.5mV7, 8 
as scar borderzone. At low amplitude sites pacing was performed with 10mA at 2ms pulse 
width. Sites with a pacing threshold >10mA were tagged as electrically unexcitable scar 
(EUS).9 
Identification	and	ablation	of	VT	circuits
Hemodynamically tolerated VT were mapped and ablated during VT. Target sites for abla-
tion were sites with an isolated mid-diastolic potential where pacing entrained the VT with 
concealed fusion and a post pacing interval within 30ms of the VT cycle length (CL) and a 
stimulus-to-QRS interval <70% of the VTCL. For fast and hemodynamically non-tolerated 
VT, exit sites were identified and targeted on the basis of pace-mapping during SR, with a 
paced QRS morphology similar to the VT QRS morphology indicating a potential reentry 
circuit isthmus site. Pacing was performed at the electroanatomical scar borderzone and at 
sites where electrograms with low amplitude fragmented components, double potentials 
and/or isolated late potentials could be recorded during sinus rhythm. Substrate modifica-
tion by linear ablation lines along the scar border extending lesions at exit sites or through 
identified isthmus was performed at the discretion of the operator. Complete procedural 
success was defined as the absence of any inducible monomorphic VT at the end of the 
ablation procedure. Partial success was defined as successful ablation of the clinical or 
presumed clinical tachycardia and ablation failure if the clinical or presumed clinical VT 
could not be successfully ablated. Definitions and ablation strategy used were alike in the 
three participating centers.
Follow-up
As a rule all antiarrhythmic drugs, with exception of intravenous drugs, were continued 
after the ablation procedure and at discharge from the hospital. Data regarding survival 
was collected (from the social security death index for the US patients and from long-term 
follow-up visits for the Netherlands and German patients). The date of last contact, heart 
transplantation or death was considered the date of last follow-up. 
Results
The characteristics of the 12 patients (all male, age 64±8yr) after myocardial infarction and 
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VT had occurred before surgery in 3 patients. The indication for surgery had been conges-
tive heart failure in 11 patients and inferior wall rupture due to acute inferior infarction in 
1 patient. SVR reshaping the LV with an endoventricular patch was performed in 8 and 
aneurysm resection in 4 patients respectively. Concomitant procedures were mitral/tricuspid 
valve repair in 5, coronary artery bypass grafting in 9, and endocardial encircling cryoabla-
tion for VT in 1 patient. The LV ejection fraction at referral was 25±9%.  
VT had been refractory to class III (amiodarone in 10) or to a combination of class I and 
III antiarrhythmic drugs in all patients. In 3 patients a previous RFCA attempt in another 
center had failed. Four (33%) patients presented early, within the perioperative period (<30 
days) after surgery with an incessant monomorphic VT. The other 8 (67%) patients presented 
with incessant monomorphic VT (2), electrical storm (1) or recurrent VT (5) 3.8±1.4 years 
after LV reconstructive surgery. Prior to ablation, 17 different VT morphologies with a CL of 
453±102ms were documented. The mean VTCL of patients presenting in the early postop-
erative phase was 496±87ms and in those presenting late after SVR 430±106ms. VT was 
hemodynamically tolerated and was relatively slow (CL >400ms) in 8 patients. At referral, 9 
(75%) patients had an implantable cardioverter defibrillator (ICD).
Electrophysiological	evaluation	and	mapping
A total of 28 monomorphic VTs (CL 384±95ms) were induced (2.3±1.2 per patient). VT 
characteristics are provided in table 2. Sustained polymorphic VT was induced in none of 
the patients. Electroanatomical mapping of the LV was performed in 11 patients. In 1 patient 
(patient 2) only RV mapping was performed since the patient presented with left bundle 
branch block like VT and the LV was not safely accessible due to coexisting mitral valve 
endocarditis. In the 11 patients with LV mapping an area of EUS or very low voltage was 
present in the region of reconstructive surgery. In all patients in whom patch material was 
used at surgery, the location of the endoventricular patch was clearly demarcated as an area 
of confluent EUS or absence of detectable electrograms (figure 1 and 3).  Data regarding 
mapping strategy and location of VT circuits is summarized in table 2. The exit of the VT 
reentry circuit was mapped to the border of the EUS or very low voltage area consistent with 
surgical scar or patch material in 20 of the 28 (71%) induced VTs, including at least one VT 
in all 11 LV mapped patients. The majority of VT exits (15 of 20 VTs) were on the septal side 
of the repair whereas 4 VT were mapped to another border of the patch or surgical scar and 
1 exited simultaneously at multiple patch borders. Seven of the 15 VTs mapped to the septal 
portion of the scar had a right bundle branch block (RBBB) type configuration, the remainder 
had a left bundle branch block configuration. No clear pattern in surface ECG morphology 
and location of surgical scar or patches was found. The reentry circuit was distant from the 
surgical scar for 3 VTs in 2 patients. Four VT’s in 3 patients were not mapped because they 
were hemodynamically untolerated, fast VTs (CL<300ms) and were not targeted for ablation 
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because of unknown clinical significance in two patients or non-inducibility after ablation 
of other VTs in one patient.
Figure	1.	Patient 5, in whom RFCA failed to abolish any of the 5 VTs that appeared to originate 
from behind the endoventricular patch. Panel A shows the morphologies of VT 1-5 (sweep-speed 
100mm/s). Panel B shows the sagittal plane of a multislice CT scan after intravenous contrast 
demonstrating a space occupied with scar tissue (indicated by the word ‘scar’) that is excluded 
from the left ventricular cavity by the endoventricular patch. Panel C shows the endocardial 
bipolar voltage map with the locations of the exit sites of VT 1-5 bordering the endoventricular 
patch and indicated by arrows. (colorcoding as in the colorbar, gray is electrically unexcitable 
scar representing the patch), voltage >1.5 mV is purple. Panel C shows the 3-dimensional 
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Ablation	
A single ablation procedure was performed in 9 patients; in 3 patients a repeat procedure 
was performed because of VT recurrence. RF application consisted of single lesions based 
on activation and entrainment mapping in 9 and linear lesions based on substrate and pace-
mapping in 3 patients. 
No sustained VT of any type was inducible in 5 patients, in 4 patients the clinically 
documented VTs were no longer inducible but another VT remained inducible, in 1 patient 
Figure	2.	Example showing the activation and entrainment mapping of VT1 and VT2 in patient 5 
(figure 1). The exits of VT3 – VT5 were identified using only activation or pacemapping. Panel A: 12 
lead QRS morphology of VT1 and VT2. Panel B: Electroanatomical activation maps of the LV during 
VT1 (top) and VT2 (bottom). The endoventricular patch was identified as an area of unexcitable scar 
and tagged in gray. Activation time is according to the colorbar with the earliest activation displayed 
in red. The white arrows indicate the site of earliest endocardial activation, entrainment mapping 
and RF application (red tags). Panel C: Intracardiac bipolar electrograms recorded from the distal, 
mid and proximal electrode pairs of the ablation catheter at the border of the endoventricular 
patch for VT1 and VT2. Panel D: Entrainment mapping of VT1 shows concealed entrainment while 
capturing the second electrogram component with an S-QRS interval of 25ms identical with the 
E-QRS, which is consistent with a VT exit site. Pacing at this site entrained the VT with concealed 
fusion with a post pacing interval (PPI) of 481ms, which equaled VTCL. VT2 could be entrained with 
concealed fusion with a PPI of 486ms (VTCL = 504ms) and a S-QRS interval of 50ms. (for	figure	
in	color	see	page:	263)
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inducibility was not tested at the end of the procedure (patient 10). In 2 patients ablation 
failed to terminate the clinical VT. Both had presented with incessant VT. In one patient 
(patient 5) the endocardial exits of 5 VTs were mapped to the border of the repair area (figure 
1 and 2), but ablation at these sites failed to terminate VTs suggesting that the critical isthmus 
of the VTs was located deep to the patch. In this patient cardiac computed tomography scan 
(MSCT) revealed that the patch was inserted in the LV septum with tissue visible between 
the patch and the pericardium, and a percutaneous epicardial approach was not attempted 
(figure 1). In the other patient (patient 2), LV mapping and ablation was not performed due 
to coexisting mitral valve endocarditis, with a possible risk of embolization. There were 
no procedural complications. Both patients with ablation failure underwent repeat surgery 
because of incessant VT with subendocardial resection combined with cryoablation of the 
residual borderzone in the first and subendocardial resection combined with RF-ablation of 
the residual borderzone and mitral valve replacement in the second patient. 
Outcome
There were no procedure related complications. Two (50%) patients with VT presenting 
<30 days after initial surgery died within the perioperative period. The cause of death was 
heart failure in one and sepsis in the other patient. The median follow-up after RF ablation 
in the remaining 10 patients was 24 months (interquartile range 11 – 39 months). All 10 
surviving patients were discharged with an ICD. Eight were free of any VT during follow-up. 
Two patients had VT recurrence, in both no VT was inducible after the first procedure. One 
additional patient with VT presenting <30 days after surgery died 3 months after catheter 
ablation due to heart failure. There were no arrhythmic or sudden cardiac deaths.
Discussion
The number of patients undergoing SVR as treatment for patients with heart failure due 
to ischemic cardiomyopathy is increasing.1 Present indications include heart failure after 
prior myocardial infarction with a dilated or aneurysmal LV.3, 10, 11 In a pooled analysis of 
multiple studies, ventricular arrhythmias accounted for 16.6% of early mortality (n=12,331) 
and 17.2% of late mortality (n=3,729) in patients following SVR.1 In patients with an ICD 
implanted for primary or secondary prevention, 14.4% had appropriate ICD shocks in the 
first year after SVR, the majority within the first two months.4 
Catheter ablation is an important therapeutic option for controlling recurrent ventricular 
tachycardia late after acute myocardial infarction. However, although only 12 patients 
were included, the present study is the largest series of post infarction SVR patients with 
VT studied with catheter mapping and attempted ablation. Patients (3%) were drawn from a 
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centers. Due to the referral nature of the population, it is not possible to further determine 
the incidence VT after reconstructive surgery approachable by catheter ablation. 
The presentation of patients seems to be bimodal. One third of the patients presented 
within the early postoperative period. The indication for ablation in these patients was inces-
sant VT refractory to pharmacological treatment, most in the setting of postoperative heart 
failure or sepsis. Patients were accepted for ablation after consultation of the cardiothoracic 
surgeon and careful evaluation of possible risks and benefits of the procedure. Considerations 
included individual patient characteristics, other treatment options, available resources and 
operator experience. In these severely ill patients catheter ablation was regarded as a last 
resort to control life threatening ongoing VT.  
The other two thirds presented with incessant or frequent episodes of VT late (3.8 years) 
after surgery. These patients were otherwise in relatively stable condition and selection crite-
ria for ablation were similar to other patients presenting with post myocardial infarction VT.
The majority of patients had relatively slow VT (mean CL 438±100ms) due to myocardial 
reentry. The long CL may be partly due to the antiarrhythmic drug regime with a combina-
tion of class I and III drugs used in 7 patients. However, it is interesting to speculate that the 
large scars present in patients who are considered for SVR may be more likely to provide 
large and/or slow reentry circuits.12-14 
Although SVR improves hemodynamics and reduces wallstress15 it does not completely 
eliminate the substrate for myocardial reentry as a significant portion of the myocardial scar 
is left behind the inserted patch for stability and hemostasis. 
Electrophysiologic	characteristics	and	ablation
High density electroanatomical catheter mapping identified a low voltage area consistent 
with surgical scar or patch material in all LV mapped patients. Importantly, patch material 
could be demarcated as a confluent area with no detectable electrograms or EUS in all 
patients in whom endoventricular patch plasty was performed. The border of patch materials 
and surgical incisions was adjacent to at least some part (usually the exit) of the reentry 
circuit of 86% of targeted VTs. The majority of VT reentry circuits were mapped to the septal 
border of the endocardial patch or surgical scar. This is in concordance with previous find-
ings by Josephson et al who found a septal origin in 56% of post-MI VTs mapped during 
surgery.16 Of interest, 7 of 15 VTs with a septal exit site had a RBBB like morphology and no 
clear pattern in surface ECG morphology and location of surgical scar was observed. This 
suggests that activation of the remaining ventricles might be modified by surgery. A major 
concern for these patients is the possibility that the VT circuit is beneath the patch material or 
in the excluded LV, where it would not be amenable to endocardial ablation. Importantly, in 
the majority of patients (10 of the 12 patients) this was not a major impediment to ablation, 
as at least portions of reentry circuits were identified on the endocardium. All successful 
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ablation sites were in the endocardial LV. RFCA acutely abolished all VTs in 5 (42%) and the 
clinical VT in 4 (33%) patients after one or two RFCA procedures. Two recently conducted 
multicenter trials assessing the effect of RFCA for recurrent or incessant post MI VT reported 
acute success rates of 81% abolishing the clinical VT.17, 18 The similar acute success rate 
of 75% in the present study despite advanced heart failure and the presence of surgical 
scar and patch material is encouraging. In one patient, failure of ablation was potentially 
attributed to exclusion of the reentry circuits, from the endocardium by LV patch material 
(figure 1). In this patient repeat surgery with subendocardial resection and cryoablation of 
the borderzone was required to abolish incessant VTs, and was successful. This example 
suggests that intraoperative treatment of a potentially arrhythmogenic substrate that will 
be excluded from the endocardium is important, particularly the septal portion of the scar. 
Routine use of encircling cryoablation19 or subendocardial resection16, 20, as previously 
described for the treatment of VTs, may be considered.  
Presentation of incessant sustained monomorphic VT in the early postoperative phase was 
associated with an in hospital mortality of 50% due to heart failure or sepsis, which likely 
reflects the poor condition of these patients. In contrast, none of the patients presenting late 
after SVR died during follow-up. All patients were discharged from hospital with an ICD, 
and only two (20%) had recurrent VT during a median follow-up of 24 months. Although 
the patient population was small, the low recurrence rate is remarkable since recent studies 
have reported that the recurrence rate of VT after RFCA in post MI patients is approximately 
50% in the first 6 to 12 months, in both patients with and without incessant VT.17, 18 
Limitations
The sample size included in the study was relatively small and due to a referral bias 
the selected population of post SVR patients may not be entirely representative. To our 
knowledge however this is the first study reporting on the findings and outcome of catheter 
ablation for VT in this population. Furthermore, the presumption that the reentry circuit 
of the VTs in one patient was isolated from the ventricles by the patch was based on the 
fact that endocardial ablation failed. However, it is supported by the distribution of VT exit 
sites around the patch, the findings at the CT scan (figure 1) and the fact that after surgical 
removal of the scar behind the patch the patient remains free of any VT recurrence. In 
addition, a CT scan was available in one patient who underwent successful ablation and in 
this patient the space behind the inserted patch was evidently smaller. (Figure 3) 
Conclusion
Sustained monomorphic VT after LV reconstructive surgery seems to have a bimodal pre-
sentation, with one third presenting with incessant VT in the acute postoperative phase, 
having a high mortality. For the majority, who present with VT years after surgery, RFCA is 
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the endocardium. Successful ablation sites are frequently located at the border of surgical 
scars and patch material. Patch material overlaying the substrate of VT may prevent success-
ful RFCA ultimately necessitating surgical ablation of VT in some patients. 
Figure	3.	Patient 7, in whom RFCA was successful, abolishing 2 VTs by applying RF energy at the 
septal side of the endoventricular patch. Panel A shows the morphologies of VT 1-2 (sweep-speed 
100mm/s). Panel B shows the sagittal plane of a multislice CT scan after intravenous contrast 
showing a small apical scar behind the endoventricular patch if compared to patient 5 (figure1). 
Panel C shows the endocardial bipolar voltage map with the locations of the exit sites of VT 1-2 
bordering the endoventricular patch and indicated by arrows (color  coding as in the color bar, 
gray is electrically unexcitable scar representing the patch). Panel C shows the 3-dimensional 
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Catheter ablation targeting the arrhythmia substrate has become an important therapeutic 
option for patients with different types of ventricular tachycardia (VT). The aim of the current 
thesis was to study the determinants for the substrate causing VT, the VT characteristics and 
outcome specifically after invasive treatment and to develop techniques that facilitate and 
thereby potentially improve outcome after catheter ablation. Chapter 1 provides an over-
view of the current literature regarding the different underlying substrates for monomorphic 
VT and the applied ablation techniques. 
In part I determinants of the VA substrate and techniques for substrate identification were 
studied in patients referred for catheter ablation of VA. After identification and localization 
of the substrate catheter ablation has the potential to specifically target these regions thereby 
preventing VA recurrence. The potential advantage of multimodal imaging of the VT substrate 
and related anatomical structures integrated with the electroanatomical information during 
catheter ablation could be demonstrated. Differences in VA substrate between patients are 
likely to impact clinical outcome which was further addressed in part II. 
Part	I
Discrimination between idiopathic (non scar-related) and scar-related LBBB pattern VA has 
important clinical implications. In chapter 2 we hypothesized that the VA QRS morphology 
is influenced by the presence of ventricular scar allowing electrocardiographic discrimina-
tion of VA arising from structurally normal versus scarred myocardium. Twelve-lead ECGs of 
297 LBBB pattern monomorphic VA were recorded during radiofrequency catheter ablation 
(RFCA) procedures. QRS morphology characteristics associated with scar-related VA were 
identified in retrospective analysis of 118 LBBB pattern VA (95 scar-related, 23 idiopathic) 
to develop a stepwise algorithm, that was prospectively tested in 179 LBBB pattern VA (120 
scar-related, 59 idiopathic).
The diagnosis of scar was based on sinus rhythm surface ECG, cardiovascular imaging 
and electroanatomical catheter mapping. A precordial transition beyond V4, notching of the 
S-wave downstroke in lead V1 or V2 and a duration from the onset of QRS to the S-nadir in 
V1>90ms were independent predictors for scar-related VA. The proposed algorithm classi-
fied a VA as scar-related if any of these criteria was met. If none of the criteria was present a 
VA was classified as idiopathic. In prospective validation the algorithm was highly sensitive 
(96%) and specific (83%) for the identification of scar-related LBBB pattern VA. We therefore 
concluded that the QRS morphology of VA is different between scar-related and idiopathic 
VA. A simple ECG algorithm is sensitive for identifying scar-related LBBB VA, which can be 
helpful in guiding further evaluation of these patients.
In chapter 3 the value of reversed polarity of adjacent bipolar electrograms to predict a 






evaluated. Twenty-five consecutive patients undergoing RFCA for RVOT arrhythmia were 
studied. Electrograms of ablation sites and of points within a 15mm radius to the successful 
site were evaluated for local activation time (LAT), unipolar electrogram morphology and 
the presence of reversed polarity of adjacent bipolar electrograms. Electrogram characteris-
tics of successful ablation sites were compared to non-successful ablation sites. The spatial 
distribution of each electrogram characteristic was studied. Successful ablation sites more 
often demonstrated reversed polarity and had an earlier LAT than non-successful sites. A 
wide spatial distribution was observed for unipolar electrograms with a QS-configuration 
around the successful ablation site. Mapping based on LAT and reversed polarity had a 
higher predictive value for a successful ablation site than mapping based on LAT and QS-
configuration. The presence of reversed polarity therefore has a high predictive value for 
successful ablation sites in focal idiopathic RVOT arrhythmias and is likely to reduce the 
number of RFCA applications.
Reperfusion therapy during acute myocardial infarction (AMI) results in myocardial salvage 
and improved ventricular function but may also influence the arrhythmogenic substrate for 
ventricular tachycardia (VT). Chapter 4 used electroanatomical mapping (EAM) and infarct 
histology to assess the impact of reperfusion on the substrate and on VT characteristics late 
after AMI.	Thirty-six patients referred for treatment of VT 13±9yrs after AMI were studied. 
Fourteen patients with early reperfusion during AMI were compared with 22 non-reperfused 
patients. Spontaneous and induced VTs and the characteristics of EAM were analyzed. 
Twenty-seven patients were treated by RFCA. Ten patients (non-reperfused 6) were treated 
by ventricular restoration with intraoperative cryoablation in 9. During surgery biopsies were 
obtained from the resected core of the infarct. VT cycle length of spontaneous and induced 
VTs was shorter in reperfused patients (reperfused 299±52/270±58ms, non-reperfused 
378±77/362±74ms, (p=0.01)). An EA patchy scar pattern was present in 71% of reperfused 
and in 14% of non-reperfused patients (p=0.004). The proportion of EA dense scar was 
smaller in reperfused patients (24±18% vs. 45±21%, p=0.02). Histological assessment in 
10 patients revealed thick layers of surviving myocardium in 75% of reperfused but in none 
of non-reperfused patients. Scar size and pattern defined by EAM are different between VT 
patients with and without reperfusion during AMI. Less confluent EA scars match with thick 
layers of surviving myocardium on histology. Early reperfusion and less confluent electro-
anatomical scar are associated with faster VTs.
Substrate based ablation of VT relies on electroanatomical voltage mapping (EAM). Integra-
tion of scar information from contrast-enhanced magnetic resonance imaging (CE-MRI) with 
EAM may be of additional value during ablation procedures. Chapter 5 assessed the relation 
between electrogram voltages and CE-MRI scar characteristics using real-time integration 
and reversed registration.
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Fifteen patients without implantable cardiac defibrillator referred for VT ablation after 
myocardial infarction underwent CE-MRI. Real-time integration of CE-MRI derived scar 
meshes with EAM of the left ventricle (LV) and aortic root was performed using the left main 
stem (LM) and the CARTO surface registration algorithm. Merging of CE-MRI meshes with 
EAM was successful with a registration error of 3.8±0.6mm. After the procedure voltage 
amplitudes of each mapping point were superimposed on the corresponding CE-MRI loca-
tion using the reversed registration matrix. Infarcts on CE-MRI were categorized by trans-
murality and signal intensity. Local bipolar and unipolar voltages decreased with increasing 
scar transmurality and were influenced by scar heterogeneity. VT reentry circuit isthmus 
sites were correlated to CE-MRI scar location. In 3 patients VT isthmus sites were located 
in scar areas not identified by EAM. This study showed the feasibility of integration of MRI 
derived scar maps with EAM during VT ablation. CE-MRI identifies non-transmural scars and 
infarct gray zones not detected by EAM according to currently used voltage criteria and may 
provide important supplementary substrate information. 
Epicardial substrate determination and RFCA for VA is limited by the presence of coronary 
arteries and epicardial fat. In Chapter 6 we aimed to evaluate epicardial ablation failure 
using real-time integration and reversed registration of MDCT data and EAM. Twenty-eight 
patients underwent combined endo-epicardial EAM. Cardiac MDCT was performed to 
visualize coronary anatomy and epicardial fat distribution. Prior to ablation, MDCT these 
data were loaded into the 3D EAM system. Irrigated-tip ablation was withheld within 5mm 
from a coronary artery confirmed by coronary angiography. All EAM data were extracted 
and superimposed on the MDCT using reversed registration matrix. In all patients image 
registration was successful and accurate (registration accuracy 2.8±1.3mm). Forty-six VA 
were induced, 25(54%) were abolished by catheter ablation, and 21(46%) were not. In 
10 VA no target site was identified. In 7 VA of ablation was withheld due to proximity of 
coronary arteries and in 2 to proximity of the His-bundle at the target site. In 4 VA applied 
RF energy was not effective. At ineffective ablation sites the mean epicardial fat thickness 
was 16.9±6.8mm (range 7.3– 22.2mm). In contrast, epicardial fat thickness at successful 
ablation sites was 1.5±2.1mm (range 0–6.1mm, p<0.001). In conclusion Real-time image 
integration of pre-acquired MDCT information is feasible and accurate. Epicardial fat layers 
of >7mm and the presence of coronary arteries are important reasons for epicardial ablation 
failure which can be predicted based on MDCT integration. 
Part	II
Improvement of left ventricular ejectionfraction (EF) after RFCA of frequent premature 






PVCs have normal LVEF. In these patients subtle and early forms of PVC induced left and 
right ventricular (RV) impairment may not be detected by standard echocardiographic 
techniques. Chapter 7 aimed to assess the effect of frequent PVCs on ventricular function in 
patients with preserved LVEF.
Forty-nine patients with recent onset, frequent PVCs (burden 26±13%) and 25 healthy 
controls were studied. Thirty-four patients with PVCs underwent successful RFCA. Two-
dimensional echocardiography was performed at baseline and follow-up. LV volumes and 
LVEF were calculated by Simpson’s rule. Tricuspid annulus plane systolic excursion and 
fractional area change were calculated to assess RV function. Multidirectional LV strain 
(radial, circumferential, longitudinal) and RV free wall longitudinal strain were calculated by 
two-dimensional speckle tracking imaging. At baseline LVEF, volumes and RV dimensions 
were normal in patients and controls. Speckle tracking imaging demonstrated reduced LV 
and RV strain in PVC patients as compared to controls. At follow-up there were no changes 
in LVEF, LV volumes and RV dimensions and function in successfully treated by RFCA and 
untreated patients. However, radial, circumferential and longitudinal strain improved sig-
nificantly in patients after RFCA but remained unchanged in untreated patients. Frequent 
PVCs can induce subtle cardiac dysfunction detected by speckle tracking imaging analysis 
in patients without apparent cardiomyopathy. RFCA can successfully eliminate PVCs and 
improve cardiac function. 
In chapter 8 long-term arrhythmia recurrence rate and outcome in patients with scar-related 
right VT with and without a diagnosis of arrhythmogenic right ventricular cardiomyopathy 
(ARVC/D) was assessed. Sixty-four patients presenting with non ischemic scar-related VT 
of RV origin were studied. Scar was identified by electroanatomical mapping, contrast-
echocardiography and/or MRI.Twenty-nine (45%) patients were diagnosed with ARVC/D 
according to TF criteria (TF+) and 35 (55%) with RV scar of undetermined origin (TF-) at the 
end of follow-up (64±42 months). Patients were treated with anti-arrhythmic drugs, RFCA 
and/or ICD implantation. VT recurrence-free survival for TF+ and TF- was 76% vs. 74% at 
1yr and 45% vs. 50% at 4yr (p=ns). Patients with fast index VT (CL≤250ms, n=31) were 
more likely to experience a fast VT during follow-up than patients with a slow index VT 
(CL>250ms, n=33) (61% vs. 3%, p<0.001). We concluded that scar-related RV VTs have a 
high recurrence rate in TF+ and TF- patients. Patients presenting with a fast index VT are at 
high risk for fast VT recurrence and may benefit most from ICD therapy. 
Chapter 9 aimed to to extend the findings demonstrated in chapter 4 in a larger population 
of post AMI patients who underwent electrophysiological evaluation prior to implantation 
of an implantable cardioverter defibrillator (ICD). Five-hundred-six patients with prior 
MI who underwent electrophysiology study before implantation of an ICD for primary or 
secondary prevention were assessed. Patients were classified according to the reperfusion 
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strategy (reperfusion (thrombolysis (n=44) or percutaneous coronary intervention (n=65)) vs. 
no reperfusion (n=397)) during AMI.
Monomorphic sustained VT was inducible in 351 (69%) patients. Inducibility in reper-
fused and non-reperfused patients was similar in primary prevention patients (56% vs. 58%) 
but significantly higher for non-reperfused patients in secondary prevention patients (56% 
vs. 79%, p=0.001). Induced VT cycle length was shorter (247±40 vs.287±63, p<0.001) and 
very fast VT (cycle length ≤250 ms) was more often induced in reperfused patients (71% 
vs.47%, p=0.001). In primary prevention patients, non-reperfusion was associated with a 
doubled risk for first spontaneous VT during follow-up. This study showed that there are 
important differences in VT inducibility, induced VT cycle length and occurrence of sponta-
neous VT in the chronic infarct healing phase between patients with and without successful 
reperfusion during AMI. These findings suggest differences in the chronic arrhythmogenic 
substrate and extend the findings of chapter 4.
After surgical ventricular restoration (SVR) for heart failure in ischemic cardiomyopathy, 
ventricular tachycardias are an important reason for postoperative morbidity and mortality. 
Chapter 10 aimed to elucidate the VT substrate, VT characteristics and outcome of cath-
eter ablation in patients with VT after SVR. Twelve (3%) of 416 patients referred for RFCA 
for VT after AMI in three centers had underwent previous SVR. After induction of VT, LV 
EAM was performed. Ablation target sites were identified by entrainment, substrate and/or 
pace mapping. Four (33%) patients presented within the perioperative period after surgery 
with an incessant VT, 8(67%) presented with incessant or recurrent VT late after SVR (VT 
cycle length 453±102ms). The region of surgical scar was identified by EAM in 11 patients. 
Twenty-eight VTs (cycle length 384±95ms) were induced. The VT exit was bordering the 
surgical scar in 20(71%) VTs. All VT were abolished in 5 patients, in 4 only the clinical 
VTs were abolished, in 1 re-inducibility was not tested. In 2 patients ablation failed after 
which surgical ablation was performed successfully. During follow-up 3 (25%) patients died 
(non-arrhythmic deaths) all had presented early after SVR. Two (17%) experienced recurrent 
VT. VT after LV SVR therefore seems to have a bimodal presentation, one third presented 
with incessant VT in the acute postoperative phase, having a high mortality. Two thirds 
presented late after SVR, in these patients RFCA is usually effective. Successful ablation sites 
are frequently located at the border of surgical scars and patch material. 
Conclusions	en	future	perspectives
In patients presenting with clinically apparent VA identification and characterization of the 






Initial discrimination between scar-related and idiopathic (non scar-related) VA is manda-
tory since patients with scar-related VA may be at risk for sudden cardiac death while the 
latter are generally considered benign. The VA surface ECG may provide an immediate elec-
trocardiographic criterion to indicate whether ventricular scar is likely to be present, and 
can inform further evaluation. Since the diagnosis of idiopathic VA is still one of exclusion, 
this evaluation may require extensive non-invasive and invasive assessment and (CE-)MRI 
is considered as goldstandard to detect scar. However, electroanatomical catheter mapping 
is a sensitive tool to identify concealed forms of myocardial scar that are not detected by 
imaging modalities, and is therefore of incremental value. 
In contrast to other treatment modalities like antiarrhytmic drugs or implantable defibril-
lators RFCA has the ability to abolish the substrate of VA. Over the last decades the role of 
RFCA has expanded due to development of new techniques and broadening of indications. 
Idiopathic	VA
Despite a good prognosis idiopathic VA can cause severe symptoms. Furthermore frequent 
idiopathic PVCs have reversible detrimental effects on ventricular function that may range 
from subclinical dysfunction detected by echocardiographic strain imaging to overt reduc-
tion in LV ejection fraction. Due to the high ablation success for idiopathic VA catheter 
ablation has become a first line therapy for symptomatic VA or VA presumed to cause 
ventricular dysfunction. The accuracy of catheter mapping to identify ablation target sites 
can be further improved using ‘reversed polarity’ as novel criterion in addition to LAT and 
the presence of a QS morphology of the unipolar signal. The clinical relevance of frequent 
PVCs in asymptomatic patients without LV dysfunction in the unselected general population 
is not fully understood. Identification of more sensitive indicators identifying patients who 
are at risk for clinically significant LV functional deterioration is needed before “preventive” 
RFCA in these patients can be recommended.   
Scar-related	VT
The underlying heart disease affects the substrate that determines VT characteristics. Better 
understanding of the VT substrate in different diseases and individual patients is important 
for the improvement of mapping and ablation strategies. The majority of patients with scar-
related VT has experienced prior myocardial infarction. Much of our understanding of the 
VT substrate after MI is based on animal models of a chronically occluded coronary artery 
typically resulting in dense scar with only a small scar borderzone and on interaoperative 
mapping studies in patients with a chronically occluded artery. However, currently early 
reperfusion strategies have become the standard treatment of acute MI. Early reperfusion 
seems to be associated with less dense and less confluent electroanatomical scars, which 
was confirmed by histology. Small areas of dense scar and thicker infarct border zones 
may result in shorter isthmus length and faster conduction. This affects spontaneous VT 
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occurrence, VT inducibility and VT characteristics like cycle length. Whether a patchy 
pattern of electroanatomic scar after reperfusion will pose a challenge in substrate-based 
mapping and ablation needs further evaluation
In patients with VT after SVR for ischemic cardiomyopathy the reentry circuit is com-
monly related to the surgical scar or patch material identified by catheter mapping and 
RFCA can be highly effective the treatment of VT and prevention of recurrence. 
If scar is identified as the substrate for VT originating from the RV patients are at risk for 
VT recurrence and sudden death irrespectively of the diagnosis of ARVC/D. Patients who 
present with fast VT and right ventricular scar are at high risk for fast VT recurrence despite 
intervention and may benefit most from ICD therapy.
Catheter	ablation
In patients with scar-related VT development of substrate based techniques, irrigated tip 
catheter ablation and the introduction of an percutaneous epicardial approach in selected 
patients has rendered many VT previously considered ‘untreatable’ approachable for 
ablation. Advances in substrate imaging technologies and their integration during ablation 
procedures may provide more insights into the substrates and may guide VT ablation. 
CE-MRI allows for the visualisation of the three-dimensional geometry of myocardial 
fibrosis and is the gold standard for the detection of subendocardial and non-transmural 
scar. Real time integration of CE-MRI derived scar information with electroanatomical map-
ping is feasible and accurate and allows for visualisation of intramural or epicardial scars 
undetected by voltage mapping and scar characteristics during the procedure. After image 
integration detailed mapping can be limited to the region of interest and areas incorrectly 
identified as scar can be easily identified. Furthermore, animal studies have shown that the 
detailed scar geometry as assessed by in vitro CE-MRI can predict the location of VT reentry 
circuits. Future evaluation should focus on whether and how in vivo CE-MRI can predict the 
location of reentry circuits which could be of great value aiding catheter ablation. 
The determination of epicardial substrate by electroanatomical mapping and catheter 
ablation is limited by the presence of epicardial fat and coronary arteries. Integration with 
pre-acquired MDCT images can facilitate real-time visualization of coronary arteries and 
the distribution of epicardial fat during epicardial mapping and ablation and thereby aid 
the interpretation of local electrograms and identify potential sites unsuitable for ablation. 
Conclusions
It is the underlying substrate determining VA characteristics. Understanding the substrate in 
different diseases and individual patients is crucial for the treatment of VA. RFCA is able to 
abolish the substrate causing arrhythmias. The use of new mapping criteria and integration 







Ventriculaire ritmestoornissen (VR) treden op in patiënten met en zonder structurele 
hartziekten. In patiënten met onderliggende structurele hartziekten is verlittekening van het 
myocard doorgaans het substraat voor ventriculaire tachycardiën (VT). Het mechanisme 
dat ten grondslag ligt aan VT is cirkelgeleiding (reëntry) met een kritische isthmus in het 
litteken gebied. Patiënten die zich met een dergelijke ritmestoornis presenteren lopen risico 
op acute hartdood. Door het gebruik van inwendige cardioverter defibrillator (ICD) kan 
dit risico sterk worden gereduceerd. ICD’s kunnen echter optredende VT alleen stoppen, 
vaak door een electroshock. Aanvulllende behandelingen die VT voorkomen zijn daarom 
van groot belang. Katheterablatie heeft de potentie, door modificatie van het onderliggend 
substraat, toekomstige VT in patiënten met structurele hartziekten te voorkomen.
In patiënten zonder structurele hartziekten hebben VR vaak een focale oorsprong. 
Idiopatische ritmestoornissen worden over het algemeen als benigne beschouwd en hebben 
een goede prognose. Deze VR kunnen wel tot klachten leiden en in enkele gevallen de 
hartfunctie negatief beïnvloeden. Daarom heeft katheterablatie ook bij de behandeling van 
deze ritmestoornissen toenemend een belangrijke plaats. 
Het doel van dit proefschrift was enerzijds het bestuderen van de determinanten van het 
substraat dat VT veroorzaakt, VT eigenschappen en het beloop na invasieve behandeling van 
VT. Anderzijds werd beoogd technieken te ontwikkelen die katheter ablatie ondersteunen 
en daarmee mogelijk verbeteren.
In hoofdstuk 1 wordt een overzicht gegeven van de huidige literatuur betreffende de 
verschillende typen substraat voor monomorfe VT en de toegepaste ablatie technieken.
In deel I worden determinanten van het VR substraat en technieken voor substraat identi-
ficatie bestudeerd in patiënten die werden verwezen in verband met katheterablatie van VR. 
Na identificatie en lokalisatie van het substraat kan dit door katheterablatie gericht worden 
behandeld waardoor herhaling van de ritmestoornis kan worden voorkomen. Verder worden 
de voordelen van de integratie van beeldvorming van substraat en omliggende anatomische 
structuren met electroanatomische mapping bestudeerd. 
Deel II behandelt de invloed van verschillen in het substraat tussen individuele patiënten 
op klinische uitkomstvariabelen. 
Deel	I	
Het onderscheid tussen idiopatische (niet litteken gerelateerde) en litteken gerelateerde 
linker bundeltak blok type VR heeft belangrijke klinische implicaties. In hoofdstuk 2 werd 
geëvalueerd of de QRS morfologie van het VR oppervlakte ECG kan discrimineren tussen 






Twaalf-afleidingen ECG’s van 297 linker bundel tak blok (LBTB) type monomorfe VR 
werden vastgelegd tijdens catheter ablatie procedures. QRS morfologische eigenschappen 
die gerelateerd zijn met litteken gerelateerde VA werden geïdentificeerd in een retrospec-
tieve analyse van 118 LBTB type VR om een algoritme te ontwikkelen dat vervolgens 
prospectief werd getest in 179 LBTB type VR. De aanwezigheid van myocard litteken werd 
gediagnostiseerd op basis van het sinusritme ECG, cardiovasculaire beeldvorming en elec-
roanatomical katheter mapping. Een precordiale transitie verder dan V4, notching van de 
S-wave downstroke in afleiding V1 of V2 en een duur van het begin van het QRS complex 
tot de nadir van de S-wave in V1 >90ms waren onafhankelijke voorspellers voor litteken 
gerelateerde VR. Het voorgestelde algoritme classificeerde een VR als litteken gerelateerd 
als deze aan een van deze criteria voldeed. Als geen van deze 3 criteria van toepassing 
waren werd een VR als niet litteken gerelateerd geclassificeerd. Het algoritme bleek zeer 
sensitief (96%) en specifiek (83%) voor het identificeren van litteken gerelateerde LBTB type 
VR in de prospectieve evaluatie. De conclusie van deze studie was derhalve dat de QRS 
morfologie van een VR verschilt tussen litteken gerelateerde en niet litteken gerelateerde VR. 
Litteken gerelateerde VR kunnen worden geïdentificeerd aan de hand van een eenvoudig 
ECG algoritme waarop verdere diagnostiek kan worden ingezet. 
In hoofdstuk 3 wordt geëvalueerd of omgekeerde polariteit (reversed polarity) van aan-
grenzende bipolaire electrogrammen terechte ablatiepunten voor het behandelen van 
idiopatische rechter ventrikel uitstroombaan (RVOT) VR kunnen identificeren. Vijfentwintig 
patiënten die katheter ablatie voor RVOT VR ondergingen werden bestudeerd. Electrogram-
men van ablatie punten en mapping punten in een 15mm radius werden beoordeeld op 
locale activatietijd, de morfologie van het unipolaire signaal en het voorkomen van reversed 
polarity van bipolaire electrogrammen. Electrogram eigenschappen van geslaagde en niet 
geslaagde ablatiepunten werden vergeleken. Verder werd de partiële distributie van elk 
electrogram bestudeerd. Electrogrammen met een unipolair QS morfologie werden gevon-
den in een relatief groot gebied rondom het geslaagde ablatiepunt. Mapping gebaseerd op 
locale activatie tijd en reversed polarity kon een goed ablatiepunt beter voorspellen dan 
mapping gebaseerd op unipolaire QS morfologie en locale activatietijd. Reversed polarity 
heeft daarom een sterke voorspellende waarde voor geslaagde ablatie in focale idiopatische 
RVOT VR. Het gebruik van reversed polarity kan resulteren in een verminderd aantal kath-
eter ablatie applicaties. 
Reperfusie therapie tijdens een acuut myocard infarct (AMI) leidt tot minder schade aan 
het myocard en een betere cardiale functie. Vroege reperfusie therapie kan echter ook het 
substraat voor later optredende VT’s beïnvloeden. In hoofdstuk 4 wordt electroanatomische 
mapping en beoordeling van infarct histologie gebruikt om de invloed van reperfusie 
behandeling op substraat en VT eigenschappen laat na het myocard infarct te beoordelen. 
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Veertien patiënten met VT die vroege reperfusie hadden ondergaan tijdens het AMI werden 
vergeleken met 22 patiënten met VT die geen reperfusietherapie hadden ondergaan tijdens 
het AMI. Zevenentwintig patiënten werden behandeld met katheterablatie en 10 met 
chirurgischekamer reconstructie met chirurgische cryoablatie in 9. De cyclus lengte van 
spontane en geïnduceerde VT was significant korter in patiënten die reperfusie therapie had-
den ondergaan. In gereperfundeerde patiënten was het electroanatomische litteken minder 
homogeen dan in niet gereperfundeerde patiënten. Histologische evaluatie van het litteken 
in geopereerde patiënten toonde dikke lagen van overlevend myocard in gereperfundeerde 
maar niet in niet gereperfundeerde patiënten. 
Litteken grootte en patroon verschillen tussen vroeg gereperfundeerde en niet gere-
perfundeerde patiënten. Minder homogeen litteken en vroege reperfusie tijdens AMI zijn 
geassocieerd met snellere VT. 
Katheterablatie gericht op substraat gebruikt electronanatomical voltage mapping om lit-
teken te visualiseren. Contrast enhanced MRI (CE-MRI) is de gouden standaard om  de 
3-dimensionale structuur van verlittekend myocard te visualiseren. Hoofdstuk 5 onderzoekt 
de relatie tussen locale electrogram amplitudes (voltages) en littekengegevens gevisualiseerd 
door MRI in vijftien patiënten die een ablatie ondergingen voor VT na een myocardinfarct. 
CE-MRI gegevens konden tijdens de ablatie procedure nauwkeurig worden samengevoegd 
met de electroanatomische voltage maps. Hierbij kon CE-MRI in een derde van de patiënten 
littekengebieden identificeren die niet waren gedetecteerd door voltagemapping. Verder 
werden locale voltages vergeleken met de gegevens van de CE-MRI en bleek er een duideli-
jke relatie tussen afnemend electrogramvoltage en toenemende litteken transmuraliteit en 
intensiteit. Deze studie heeft laten zien dat integratie van CE-MRI met kathetermapping 
tijdens ablatie procedures van aanvullende waarde kan zijn. 
Identificatie van epicardiale substraat en ablatie van epicardiale VR wordt bemoeilijkt door 
de aanwezigheid van coronair arteriën en epicardiaal vetweefsel. 
In hoofdstuk 6 wordt het gebruik van computed tomography (CT) beelden om coronair 
en vet anatomie tijdens ablatie te visualiseren geëvalueerd. CT scans werden gemaakt in 28 
patiënten die een endo- en epicardiale VT ablatie ondergingen. CT beelden werden succes-
vol geintegreerd met electranatomical mapping tijdens de ablatie procedure. Tijdens en na 
de prodecure werden CT, coronair angiografie en mapping en ablatie gegevens vergeleken. 
CT scan bleek een adequate 3-dimensionale anatomie van de coronairen weer te geven. 
In 7 van de 46 opgewekte VR is afgezien van ablatie omdat de oorsprong te dicht bij een 
coronair arterie lag. Verder was er bij toenemende dikte van de epicardiale vetlaag een 
afname van locaal gemeten voltage. De dikte van epicardiaal vet ter plaatse van niet effec-
tieve ablatie applicaties was 16.9±6.8mm (range 7.3– 22.2mm). Op locaties waar ablatie 






CT data met electroanatomische mapping worden gebruikt om de anatomie van coronair 
arteriën en epicardiaal vetweefsel te visualiseren tijdens ablatie procedures. Een epicardiale 
vetlaag van >7mm en de aanwezigheid van coronair arteriën zijn belangrijke factoren die 
het falen van ablatie kunnen veroorzaken. 
Deel	II
Het is beschreven dat de linker kamer ejectiefractie (EF) kan verbeteren na ablatie van 
frequente premature ventriculaire extrasystolen (PVCs). De meeste patiënten met frequente 
PVCs hebben echter een normale ejectiefractie. Subtiele en vroege vormen van PVC geïn-
duceerde verminderde cardiale functie kunnen echter worden gemist door conventionele 
echocardiografische technieken. In hoofdstuk 7 wordt het effect van frequente PVCs op de 
ventriculaire functie in patiënten met een behouden EF bestudeerd.
Met behulp van 2D echocardiografie werd in 49 patiënten met frequente PVC’s (waar-
van 34 een geslaagde ablatie onderging) en 25 controle patiënten de ventriculaire functie 
geëvalueerd. Naast LVEF, ventriculaire volumina en tricuspid annulus plane systolic excur-
sion werd ook multidirectionele strain gecalculeerd op basis van speckle tracking imaging. 
Bij presentatie waren de LVEF, volumina en RV dimensies normaal in patiënten en 
controles. Speckle tracking imaging toonde echter verminderde strain in patienten met fre-
quente PVC’s in vergelijking met controles. Na verloop van tijd was er geen verandering in 
LVEF, volumina en RV dimensies in patienten die al dan niet een geslaagde catheter ablatie 
ondergingen. Strain parameters echter verbeterde significant in patiënten na een geslaagde 
ablatie. Hieruit volgt dat frequente PVC’s subtiele cardiale dysfunctie kunnen veroorzaken 
die kan worden gedetecteerd met speckle tracking evaluatie in patiënten zonder evidente 
cardiomyopathie. Catheter ablatie kan resulteren in eliminatie van PVC’s en verbetering van 
subtiele dysfunctie. 
In hoofdstuk 8 wordt het herhaalrisico en uitkomsten in 64 patiënten met litteken gerela-
teerde VTs uit de rechter ventrikel bestudeerd. Negenentwintig patiënten met en 35 zonder 
de diagnose van arrhythmogene rechterkamer cardiomyopathie (ARVC) werden vergeleken. 
Litteken werd geïdentificeerd door middel van electroanatomische mapping, echocardio-
grafie en/of MRI. De behandeling bestond uit medicamenteuze therapie catheter ablatie en/
of ICD implantatie. Het optreden van VTs was vergelijkbaar tussen patiënten met en zonder 
ARVC. De recidief kans was hoog ondanks behandeling. Patiënten die presenteerden met 
een snelle VT  (CL≤250ms) hadden een hoger risico op een recidief snelle VT en hebben om 
die reden waarschijnlijk het meeste baat bij een ICD. 
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Hoofdstuk 9 beoogt de bevindingen gedaan in hoofdstuk 4 te staven in een grotere populatie 
van 506 patiënten na een myocardinfarct. Deze patiënten ondergingen een electrofysiolo-
gisch onderzoek voor implantatie van een ICD voor primaire of secundaire preventie van 
ventriculaire ritmestoornissen. Zij werden geclassificeerd naar vroege reperfusie behandel-
ing (groep 1: reperfusie (trombolyse & percutane coronaire interventie), groep 2: geen 
reperfusie). 
Tenminste 1 monomorfe VT was induceerbaar in 69% van de patiënten.
In de populatie met een ICD implantatie voor primaire preventie was de induceerbaar-
heid vergelijkbaar tussen groep 1 en 2. De induceerbaarheid was echter significant hoger 
in groep 2 in de subpopulatie van patiënten met een ICD voor secundaire preventie. De 
cycluslengte van de geïnduceerde VTs was korter in groep 1 in vergelijking met groep 2. 
Verder was non-reperfusie geassocieerd met een verdubbeling van het risico op optreden 
van VT in de primaire preventie populatie. Deze studie laat zien dat er belangrijke ver-
schillen zijn in VT induceerbaarheid, VT cycluslengte en optreden van spontane VT tussen 
gereperfundeerde en niet gereperfundeerde patiënten. 
Ventriculaire ritmestoornissen zijn een belangrijke oorzaak van postoperatieve mortaliteit 
en morbiditeit na een chirurgische linker kamer reconstructie (SVR) als behandeling voor 
ischaemisch hartfalen.
In hoofdstuk 10 wordt het substraat, VT eigenschappen en uitkomst na katheterablatie in 
patiënten na SVR belicht. Uit een populatie van 416 patiënten in 3 centra verwezen voor 
katheterablatie van late VT na AMI hadden 12(3%) een SVR ondergaan. 
Vier (33%) presenteerden zich met aanhoudende VT in de perioperatieve periode en 
8 (67%) met aanhoudende of herhaalde VT laat na de operatie. In 11 patiënten kon het 
operatie litteken worden geïdentificeerd met catheter mapping. Eenenzeventig procent van 
de VT had een reentrycircuit grenzend aan chirurgisch litteken. In 9 patiënten konden alle of 
alleen de klinische VT succesvol worden geableerd. Presentatie in de vroege postoperatieve 
fase was geassocieerd met een hoge mortaliteit. Daar tegenover staat dat katheterablatie laat 
na SVR een hoge slagingskans heeft. 
Conclusies	en	toekomstperspectief
In patiënten die zich met VR presenteren is identificatie en karakterisering van het substraat 
van centraal belang voor het bepalen van behandeling en prognose. 
Initieel heeft het maken van onderscheid tussen litteken gerelateerde en niet litteken 
gerelateerde VR vergaande consequenties, aangezien litteken gerelateerde VR kunnen 






Het oppervlakte ECG van de VR kan in een vroeg stadium een indicatie geven of er 
myocardiaal litteken aanwezig is en de aanleiding zijn voor verdere evaluatie. Aangezien 
‘idiopathische VR’ een diagnose is die ‘per exclusionem’ wordt gesteld kan dit leiden tot 
uitvoerige non-invasieve en invasieve onderzoeken. Op dit moment wordt CE-MRI bes-
chouwd als de gouden standaard voor de detectie van littekenweefsel. Kathetermapping 
is echter een zeer gevoelig instrument om verborgen vormen van myocardiaal litteken te 
identificeren en is daarom van aanvullende waarde naast beeldvorming. 
In tegenstelling tot farmacotherapeutische behandeling of behandeling met een ICD heeft 
katheterablatie het vermogen substraat van VR weg te nemen. De rol van katheterablatie is 
in de afgelopen jaren aanzienlijk gegroeid door de ontwikkeling van nieuwe technieken en 
verbreding van indicatiestelling. 
Idiopathische	VR
Ondanks het feit dat idiopatische VR een goede prognose heeft kunnen deze wel tot ernstige 
symptomen leiden. Verder kunnen idiopathisch PVC’s, een vaak reversibel, negatief effect 
hebben op de ventriculaire functie. Deze afname van functie varieert van een subklinische 
dysfunctie alleen detecteerbaar door middel van strain echocardiografie tot duidelijke 
afname van de linker kamer ejectiefractie. Dankzij de hoge slagingskans is katheterablatie 
voor idiopathische VR de belangrijkste behandeling geworden voor symptomatische PVC’s 
en voor PVC’s waarvan wordt aangenomen dat ze de kamerfunctie beïnvloeden. 
De nauwkeurigheid van kathetermapping om ablatie target sites te identificeren kan 
worden verbeterd door ‘reversed polarity’ als mapping criterium te gebruiken naast locale 
activatietijd en morfologie van het unipolaire signaal. 
De klinische relevantie van frequente PVC’s in asymptomatische patiënten zonder LV 
dysfunctie in de algemene populatie is niet volledig begrepen. Voordat ‘preventieve’ PVC 
ablatie kan worden aanbevolen is het belangrijk gevoeligere indicators te identificeren om 
patiënten met een risico op achteruitgang van de LV functie te detecteren. 
Litteken	gerelateerde	VT
Het is het onderliggend ziektebeeld dat het substraat voortbrengt. De morfologie van het 
substraat bepaalt vervolgens de eigenschappen van de VT. Kennis van het VT substraat in 
verschillende ziektebeelden en individuele patiënten is belangrijk voor het verbeteren van 
mapping- en ablatie strategieën. 
Het grootste deel van de patiënten met litteken gerelateerde VT heeft daarvoor een AMI 
doorgemaakt. De meeste kennis van het VT substraat na AMI is gebaseerd op diermodellen 
van een chronisch geoccludeerde coronair arterie en intraoperatieve mapping studies in 
patiënten met een chronisch geoccludeerde coronair. Dit resulteert gewoonlijk in een dens 
litteken met daaromheen een beperkt randgebied. Op dit moment is echter vroege reperfu-
sie de standaard behandeling van AMI. Vroege reperfusie is geassocieerd met minder dens 
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en minder homogeen electroanatomisch litteken, dit werd bevestigd met histologie. Kleine 
gebieden van dens litteken en meer infarct randgebied kan resulteren in kortere isthmus 
lengte en snellere geleiding. Dit beinvloed het optreden van spontane VT, VT induceerbaar-
heid en eigenschappen zoals cyclus lengte. Of substraat gebaseerde ablatie bemoeilijkt 
wordt door een patchy litteken patroon moet verder worden geëvalueerd.
In patiënten die zich presenteren met VT na SVR voor ischaemische cardiomyopathie is 
het reëntry circuit vaak gerelateerd aan chirurgisch litteken of patch materiaal. Katheterab-
latie kan zeer effectief zijn dit type VT te behandelen en herhaling te voorkomen.
Bij litteken gerelateerde VT uit de rechter kamer is er een aanzienlijk risico op herhaling 
en mogelijk acute hartdood onafhankelijk of de diagnose ARVC al dan niet wordt gesteld. 
Patiënten die zich met een snelle rechter ventrikel tachycardie presenteren hebben een hoog 
risico op opnieuw snelle VT in de toekomst en hebben daarom waarschijnlijk het meeste 
baat bij ICD therapie. 
Katheterablatie
De ontwikkeling van substraat gerichte technieken, gekoelde katheterablatie en de introduc-
tie van de percutane epicardiale benadering heeft er toe geleid dat veel eerder als ‘onbe-
handelbaar’ beschouwde VT nu benaderbaar zijn voor ablatie. Vooruitgang in beeldvorming 
van het substraat en de integratie hiervan tijdens ablatieprocedures kan het inzicht in het 
substraat voor VT verbeteren en leidend zijn voor ablatie. 
CE-MRI kan de 3-dimensionale geometrie van myocardiale fibrose visualiseren en is de 
gouden standaard voor het detecteren van subendocardiaal en non-transmuraal litteken. 
CE-MRI informatie kan worden geïntegreerd met electroanatomische mapping tijdens de 
ablatie procedure. Hiermee kunnen epicardiaal en intramuraal litteken worden gedetect-
eerd dat gemist wordt door enkel voltage mapping. Na CE-MRI integratie kan gedetailleerde 
mapping worden beperkt tot een interessegebied en kunnen gebieden die onterecht als 
laag voltage zijn aangemerkt worden geïdentificeerd. Hierbij komt dat in diermodellen 
is aangetoond dat litteken geometrie afgebeeld met hoge resolutie CE-MRI de locatie van 
reëntrycircuits kan voorspellen. Verder onderzoek naar of en hoe CE-MRI reëntrycircuits kan 
voorspellen in patiënten is noodzakelijk aangezien dit van aanzienlijke waarde kan zijn bij 
catheterablatie. 
Een belangrijke beperking van epicardiale substraatmapping is de aanwezigheid van 
epicardiaal vetweefsel en coronairarteriën. De integratie van CT beelden met electroanato-
mische mapping kan de anatomie van epicaridaal vet en coronairen visualiseren. Deze 
techniek kan bijdragen aan correcte interpretatie van electrogrammen en plaatsen identifi-







Het onderliggend substraat bepaalt de eigenschappen van een VT. Kennis en begrip van 
het substraat in verschillende ziektebeelden en in individuele patiënten is cruciaal voor 
de behandeling van VT. Katheterablatie kan het substraat dat ritmestoornissen veroorzaakt 
wegnemen. Het gebruik van nieuwe mapping criteria en integratie van beeldvormende 
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Example of a patient presenting with VT due to non-ischemic cardiomyopathy in whom combined 
endocardial and epicardial catheter ablation was performed using image integration of CE-MRI 
derived data sets and electroanatomical substrate mapping techniques during sinus rhythm. 
A and C. Successful integration of the CE-MRI derived LV and aortic cusp anatomy with the LV 
endocardial electroanatomical voltage map (EAVM) (voltages>1.5mV defined as normal and color 
coded in purple) using the left main coronary artery (LM) as a single landmark for registration. 
B. The fluoroscopy image shows contrast injection through the ablation catheter (MAP) to confirm 
its position in the LM. Other catheters shown are located at the right ventricular apex (RVa), 






Example of a patient presenting with frequent highly symptomatic non-sustained idiopathic VT 
in whom combined endo- and epicardial electroanatomical mapping and ablation was performed 
facilitated by integration of CT derived anatomy. 
A. 12-lead QRS of the non-sustained VT.
B. Endocardial activation mapping showing limited maps of the aortic cusps (AoSV), great cardiac 
vein (GCV), right ventricular outflowtract (RVOT) and left ventricle (LV). Earliest local activation time 
(LAT) was recorded in the GCV but ablation at this site was not successful. C. A limited epicardial 
activation map overlaying the endocardial maps; epicardial LAT during VT is earlier than the earliest 
LAT in the GCV. 
D. Short axis slice of contrast enhanced multislice computed tomography scan (CT) showing the 
left and right ventricles (LV and RV) and pericardial fat in the interventricular groove and RV lateral 
wall. 
E and H. Different views of CT derived anatomy showing the proximal aorta, left main coronary 
artery and pulmonary artery with overlaying CT derived mesh of the epicardial surface. Color 
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Page	72	 Figure	3. Electroanatomical 
activation map of a right ventricular 
outflow tract arrhythmia (posterior 
view). Local activation time (LAT) 
is color coded with isochronal 
steps of 5 ms according to the 
color bar. The white dotted line 
delineates the area around the 
successful ablation site (red tag) 
that demonstrated a unipolar QS-
configuration. Black-with-green 
icons indicate areas demonstrating 
unipolar QS-configuration and white-
with-red icons correspond to the 
area demonstrating a unipolar rS 
configuration. 
Page	23	 Figure	4.	Mapping	criteria	for	focal	idiopathic	ventricular	arrhythmias
Example of a patient presenting with frequent symptomatic premature ventricular contractions 
(PVCs) successfully ablated from the right ventricular outflow tract (RVOT). 
A. 12-lead ECG of the PVC QRS.  B. Limited activation map or the RVOT (local activation time (LAT) 
color coded according to the colorbar, reference R-peak of surface ECG lead II)
C. Fluoroscopy images showing the left anterior oblique (LAO) and right anterior oblique (RAO) 
views. The ablation catheter is located at the successful ablation site (MAP) and the reference 
catheter in the CS/GCV. 
D. Intracardiac signals at the successful site show (1) LAT of 26ms prior to the PVC QRS onset, (2) 
the presence of reversed polarity of bipolar adjacent electrograms recorded from the distal and mid 
electrode pair of the mapping catheter and (3) an unipolar QS configuration.




Page	90	 Figure	2. Left ventricular electroanatomical voltagemaps of six patients. Bipolar voltages 
are color coded according to the colorbar. Voltages <1.5mV were considered abnormal. The 3 maps 
on the left hand side are obtained in reperfused patients and the 3 on the right in non-reperfused 
patients. The scar pattern is patchy in reperfused and homogeneous in non-reperfused patients. 
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Page	93	 Figure 3. Representative slides of transmural biopsies from the core infarct zone in 2 
patients (H&E stain). Panel A: small mid wall fibrosis surrounded by thick viable myocytes bundles 
in a patient after early reperfusion and with a patchy pattern of EA scar. Panel B: mural thinning 
with dense transmural fibrosis in a non-reperfused patient with a homogeneous pattern of EA 
scar with only interspersed cardiomyocytes. Panel C: average wall thickness of the area of most 
extensive fibrosis in myocardial biopsies of reperfused (n=4; 2.0±0.6 mm) and non-reperfused 




Page	94	 Figure	4 The relation between viable myocytes and fibrosis was characterized. Five 
patterns of local histological scar were identified (A-E). The presence of any of these types in 
the assessed core infarct region was scored and compared to the presence of reperfusion 
and the pattern of electroanatomical scar in the 10 patients in whom histological assessment 
was performed. Three representative examples of EA maps (patient 1, 5 and 6) are shown, the 
assumed area that was resected by the surgeon is indicated. 
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Page	105	 Figure	1. Preprocedural processing consisted of drawing endo- and epicardial ventricular 
contours using the short axis CE-MRI slices (panel A), defining intensity and transmurality of scar  
(yellow= gray-zone, red= core infarction, panel B) and creating color coded endocardial (panel 
C&E) and epicardial (panel D&F) surface meshes. Panels C&D show coding for percentage of 






106	 Figure	2. During the procedure 3-D CE-MRI derived meshes (purple represents scar, green 
represents normal myocardium) were integrated with the electroanatomical voltage maps (color-
coding as in the colorbar). After the procedure color-coded mapping points were superimposed on 
the CE-MRI slice at the corresponding location (color-coding as in the colorbar).
Figure	4.	Representative examples of a patient in whom CE-MRI derived mesh matched the EAVM 
(panel A, B) and of a patient with additional scar-areas identified by CE-MRI not detected by EAVM 
(panel C, D). Panels A and C show the bipolar voltage maps (color-coding as in the colorbar) and 
corresponding endo- and epicardial MRI derived surface meshes coded for transmurality (purple 
represents scar, green represents normal myocardium). Panels B and D show a representative long 
axis CE-MRI slice with superimposed mapping point locations (mapping point bipolar amplitudes 
are color coded as in voltage maps). 
260 Page	126	 Figure	2. Electroanatomical activation map (EAAM) of an idiopathic ventricular arrhythmia and image integration. Panel A: Endocardial EAAM of the left ventricle (LV), right 
ventricle outflow tract (RVOT), aorta (Ao) and great cardiac vein (GCV). Similar activation time of the 
LV, RVOT and GCV was observed. The final fusion image (FFI) was registered with the endocardial 
EAAM, using the left main artery (LM) (right). The white triangle demonstrates the predicted 
epicardial target site in the vicinity of the left anterior descending artery (LAD), covered by >4mm 
fat. Panel B: Limited epicardial EAAM confirmed the earliest activation within the predicted site not 
suitable for ablation. Cx=Circumflex coronary artery; RCA=right coronary artery.
Page	127	 Figure 3. Registration accuracy in 2 patients comparing the distance between the 
catheter tip and coronary arteries on integrated multi-detector computed tomography (MDCT) 
images and coronary angiography in a right (RAO) and left (LAO) anterior oblique view. Upper 
panel: limited activation mapping identified a target site located on the left anterior descending 
artery (LAD) on both MDCT and angiography. Lower panel: the target site (based on pace-mapping) 




Page	136	 Figure	6. Panel A: Gross pathology of the heart of the patient who died 4 weeks after 
ablation. Panel B: Final fusion image. Panel C: Fusion of the multi-detector computed tomography 
(MDCT) anatomy with the epicardial electroanatomical voltage map in a modified anterolateral 
(top) and posterolateral (bottom) view. The ablation site in the vicinity of the circumflex coronary 
artery is indicated. Comparison of panel A and B shows a good correlation between epicardial 
fat distribution by pathology and the MDCT derived epicardial fat mesh (white dotted lines). The 
black line indicates the atrioventricular groove; the anterolateral low voltage area (color coded as 
indicated) is compatible with subepicardial scar in the absence of epicardial fat. 
LV=left ventricle, RV=right ventricle, RVOT=right ventricle outflow tract.
Page	176	 Figure	5. Right ventricular 3-D electroanatomical bipolar voltage maps of a TF- (left) and 
a TF+ (right) patient. Voltages are color-coded according to the corresponding color bar. Normal 
voltage is defined as electrogram amplitude >1.5mV displayed in purple. The TF- patient had 
recurrent VT’s with different morphologies originating from a single small RV free wall scar area. 
Scar was only identified by voltage mapping. The TF+ patient had multiple low voltage areas. VT 
was successfully terminated at the lateral tricuspid annulus.
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Page	210	 Figure	1. Patient 5, in whom RFCA failed to abolish any of the 5 VTs that appeared 
to originate from behind the endoventricular patch. Panel A shows the morphologies of VT 
1-5 (sweep-speed 100mm/s). Panel B shows the sagittal plane of a multislice CT scan after 
intravenous contrast demonstrating a space occupied with scar tissue (indicated by the word 
‘scar’) that is excluded from the left ventricular cavity by the endoventricular patch. Panel C 
shows the endocardial bipolar voltage map with the locations of the exit sites of VT 1-5 bordering 
the endoventricular patch and indicated by arrows. (colorcoding as in the colorbar, gray is 
electrically unexcitable scar representing the patch), voltage >1.5 mV is purple. Panel C shows the 




Page	211	 Figure 2. Example showing the activation and entrainment mapping of VT1 and VT2 in 
patient 5 (figure 1). The exits of VT3 – VT5 were identified using only activation or pacemapping. 
Panel A: 12 lead QRS morphology of VT1 and VT2. Panel B: Electroanatomical activation maps of 
the LV during VT1 (top) and VT2 (bottom). The endoventricular patch was identified as an area of 
unexcitable scar and tagged in gray. Activation time is according to the colorbar with the earliest 
activation displayed in red. The white arrows indicate the site of earliest endocardial activation, 
entrainment mapping and RF application (red tags). Panel C: Intracardiac bipolar electrograms 
recorded from the distal, mid and proximal electrode pairs of the ablation catheter at the border of 
the endoventricular patch for VT1 and VT2. Panel D: Entrainment mapping of VT1 shows concealed 
entrainment while capturing the second electrogram component with an S-QRS interval of 25ms 
identical with the E-QRS, which is consistent with a VT exit site. Pacing at this site entrained the VT 
with concealed fusion with a post pacing interval (PPI) of 481ms, which equaled VTCL. VT2 could 




Page	215	 Figure	3. Patient 7, in whom RFCA was successful, abolishing 2 VTs by applying RF 
energy at the septal side of the endoventricular patch. Panel A shows the morphologies of VT 1-2 
(sweep-speed 100mm/s). Panel B shows the sagittal plane of a multislice CT scan after intravenous 
contrast showing a small apical scar behind the endoventricular patch if compared to patient 5 
(figure1). Panel C shows the endocardial bipolar voltage map with the locations of the exit sites of 
VT 1-2 bordering the endoventricular patch and indicated by arrows (color  coding as in the color 
bar, gray is electrically unexcitable scar representing the patch). Panel C shows the 3-dimensional 
reconstruction of the CT images merged with the endocardial voltage map.
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